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ABSTRACT 
Bone repair devices made from degradable polymers, such as poly lactic acid (PLA) 
have limitation in terms of matching the mechanical property requirements for bone 
repair, both initially and for the duration of repair. For this reason the use of totally 
degradable phosphate glass fibre (PGF) reinforced PLA composite has proved 
attractive. A crucial part of the success of such implants is maintenance of interfacial 
integrity between the polymer matrix and reinforcement phases of the composite. It 
is well known that most fibre reinforced composites loose 50% or more of their 
strength due to interfacial integrity loss. In this study candidate chemical treatments 
for PGF reinforced PLA composite are being investigated in terms of their 
reactability, biocompatibility, effect on interfacial mechanical properties and 
degradation behaviour of these composites. 
As a crucial part of this project, phosphate based glass (PBG) formulations were 
devised and assessed for structural, thermal, degradation and cytocompatibility 
variations with varying P2O5 or Fe2O3 content. Selected formulations were drawn 
into fibres and tested for single fibre tensile strength. Finally, a glass formulation 
(P45Ca16Mg24Na11Fe4, number indicates percentage molar concentration of 
oxides) was selected for surface modification and composite production.      
Chemical surface treatments were selected on the basis of potential to react with 
PBG and PLA. Mode of chemical interaction between PBG and surface treatments 
chemicals were analysed using surface analyses techniques (FTIR and XPS). It was 
found that aminopropyltriethoxy silane (APS), etidronic acid (EA) and 
hexamethylene diisocyanate (HDI) were linked through covalent bonds, other agents 
making hydrogen bonds with PBG. Chemical treatments were optimised and 
   iv 
investigated for their effect on interfacial shear strength (IFSS) between 
polymer/glass, wettability and degradation behaviour. Chemically treated PBG was 
also assessed for cytocompatibility of elution products, short±term direct contact 
with MG63 osteosarcoma and long term direct contact with primary human 
osteoblasts. All selected surface treatment chemicals except amino phosphonic acid 
(APA) improved the interfacial bond between PBG and PLA.  However, the 
covalently linked agents (HDI, APS and EA) saw up to 4±fold improvement in IFSS. 
SPLA also improved the IFSS significantly, which was attributed to the presence of 
several ±OH groups. There was no significant effect on degradation rate of PBG. All 
agents demonstrated acceptable cytocompatibility for their elution products and in 
direct contact.  
Selected chemicals (APS, EA, SPLA and HDI) were investigated further in PGF 
reinforced PLA composite. PGF mats (UD or non±woven), treated with surface 
treatment chemical were sandwich±pressed between PLA sheets. Flexural 
mechanical properties with degradation, water±uptake, degradation rate and 
cytocompatibility were tested. It was found that surface chemical treatment 
improved the initial flexural properties (APS, SPLA) and/or delayed the mechanical 
integrity loss (HDI, APS), latter was attributed to the reduced water±uptake and 
maintenance of relatively strong interface. Human osteoblasts were found to perform 
normal functions when cultured on prepared composites. 
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CHAPTER 1. INTRODUCTION 
1.1 Background 
Fracture fixation for major load±bearing bones rely significantly on the development 
of mechanically strong and biocompatible materials [1]. MDWHULDO¶VELRFRPSDWLELOLW\
is the ability for a biological or synthetic material to operate without obstructing the 
host tissue for short or prolonged periods [2]. Although the above simplistic 
definition still stands, due to its complexity Williams [3], has divided medical 
devices¶ biocompatibility into subgroups of long±term implantable devices, 
short-term implantable devices and tissue±engineering products, defining them 
separately. For the purpose of this project we can use the definition of long-term 
LPSODQWDEOH GHYLFHV ZKLFK VWDWHV WKDW ³7KH ELRFRPSatibility of a long-term 
implantable medical device refers to the ability of the device to perform its intended 
function, with the desired degree of incorporation in the host, without eliciting any 
XQGHVLUDEOH ORFDO RU V\VWHPLF HIIHFWV LQ WKDW KRVW´ [3]. For a typical implant, 
biocompatibility considerations include acute and local as well as systemic and 
chronic responses.  
Metallic devices that are currently used as fracture fixation implants include but are 
not limited to stainless steel, titanium, cobalt/chromium and alloys of these metals. 
The common problems encountered with metal implants include allergic reactions to 
the metal, foreign body reaction and disuse atrophy due to stress shielding [4]. 
$FFRUGLQJ WR :ROII¶V ODZ GLVXVH DWURSK\ GXH WR VWUHVV VKLHOGLQJ LV WKH QDWXUDO
resorption of bone due to the absence or reduction of necessary stress±induced 
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stimulation to the tissue to maintain its structure [4]. It is also suggested by Cater and 
Giori that an optimal stress is necessary for the development of bone during early 
stages of healing and maturation of healing bone [5]. Therefore, it can be deduced 
that transfer of force from the implant to bone is required during the healing period 
as fracture healing shifts from repair to remodelling. It is well known that the high 
stiffness of metal implants provides good initial support by taking off most of the 
load from healing bone. However, due to their very high modulus of elasticity (~60-
230 GPa), metal implants hinders structural maintenance in the later stages of 
remodelling [6, 7]. 
It has been a major challenge for bioengineers to develop a synthetic device which 
can replace the current metallic alloy±based implants for fracture fixation with a 
fixation device [8, 9] that could provide strong support in the early stages of the 
implant period and allow the gradual transfer of the load to the healing bone during 
the later stages [4].  
Different terms (e.g. degradable, absorbable, and resorbable) are being used to 
specify that a particular material will in time disappear after serving its function in a 
living organism. The American Society for Testing of Materials (ASTM) and the 
International Standards Organization (ISO) define degradable plastics as those which 
undergo a significant change in chemical structure under specific environmental 
conditions.  These changes result in a loss of physical and mechanical properties, as 
measured by standard methods. However, a material can only be classified as 
bioresorbable if it is absorbed through bioabsorption by the tissues and organs of 
organisms. To accomplish a time dependent load transfer, the material should be 
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biodegradable as well as resorbable at a controlled rate. The degradation products 
also need to be biocompatible as the body metabolises them.  
Bone repair devices made from degradable polymers alone, such as poly±(lactic acid) 
(PLA) have limitations in terms of matching the mechanical property requirements 
for bone repair, both initially and for the duration of repair [10, 11]. As a minimal 
requirement for load±bearing application, degradable polymer should possess initial 
mechanical properties closer to cortical bone i.e. tensile strength  in the range of 
100±200 MPa, compressive strength ~150 03D <RXQJ¶V PRGXOXV ~25 GPa and 
fracture toughness of around 8 MPa/m1/2. Table 1±1 provides different mechanical 
properties comparison of commonly used materials for bone fracture fixation 
applications. 
Table 1-1: Mechanical properties of commonly used materials for fracture fixation in 
comparison with human bone. PGA: polyglycolic acid, PLA: polylactic acid, SR: Self-
reinforced. 
Material 
Bending 
strength  
(MPa) 
Shear 
Strength  
(MPa) 
Elastic 
Modulus  
(GPa) 
Reference 
PGA 218 95 7 Christel 1980 [12] 
SR-PGA 330-415 260 13-18 Tormala 1992 [13] 
PLLA 40-140 - 5 to 10 Tormala 1998 [10] 
PDLA 200 - 9 Weiler 1996 
SR-PLA 228-274 140-152 5.4-8.4 Pihlajamaki 1992, Räihä 1993 [14, 15]  
Stainless steel 465±950 - 205±210 Navarro 2008[16] 
Titanium 620 - 100 Navarro 2008[16] 
Bone 100-200 68 7 to 40 Reilly 1974, Rho 1998  [17-19] 
Therefore, over the last two decades research has been focused on the development 
of composite materials that may provide solutions for the issues noted above. 
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Self-reinforced polymers have been developed with greater strength and improved 
<RXQJ¶V PRGXOXV [10, 13, 20, 21]. For example, self±reinforced poly±DL±lactide 
has been found to have moderate <RXQJ¶V PRGXOXV (~12 GPa) and acceptable 
biocompatibility, which made them useful as fixation screws. However, the strength 
was found to be insufficient for fixation of major load±bearing bones [10]. Totally 
degradable composites have also been fabricated with degradable fibres embedded 
within polymer matrix like PLA, poly (caprolactone) (PCL) and polyorthoester 
(POE), yielding tensile modulus values of 29.9 GPa.  Lin et al. tested PLLA 
reinforced with 55% (by volume) biodegradable calcium phosphate glass fibres [22]. 
The initial mechanical properties of their samples with unidirectional fibres were 
well characterised: tensile, compressive, flexural, and short beam shear strengths 
were 200, 186, 161, and 19 MPa respectively, and tensile and flexural moduli were 
29.9 GPa and 27 GPa respectively. However, samples retained only 35% and 45% of 
their tensile strength and modulus respectively after 23 days in buffered saline, pH 
7.4, at 37 °C. 
Recent work has explored degradable fibre reinforced composites, although the 
initial strength and modulus of the composites were found sufficient for load±
bearing applications, the above mentioned composite experienced rapid loss of 
mechanical properties when exposed to in±vitro aqueous conditions [7, 23, 24]. The 
rapid degradation of the composite would result in improper fixation of the fracture 
during the early stages of healing and compromise the bone repair process.  
This rapid drop in mechanical properties of the totally resorbable composites can be 
explained by two phenomena: the first, early hydration at the polymer±reinforcement 
interface which creates a molecular bonding gap and a stress concentration site 
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which prevent the transfer of stress from the polymer to the reinforcement. Polymer 
swelling is the second phenomenon which generates hydrostatic forces that could 
crack the reinforcement phase [7, 23, 24].  
Therefore, strengthening the interface and decreasing polymer swelling are vital for 
long lasting mechanical properties of totally resorbable composite implant. If the 
interfacial degradation can be controlled then incremental loading onto bone may be 
possible with healing time. 
Interfacial strength between polymer matrix and reinforcement can be improved by 
mechanical interlocking, plasma treatment or by promoting adhesion through surface 
treatments with suitable chemicals. However, only the chemical treatment approach 
was investigated during the course of the current project. The interface between the 
polymer and reinforcement phase was chemically bridged by using surface 
treatments agents.  
1.2 Hypothesis 
It is well established that the interface breakdown in composite material is a key 
factor responsible for the rapid loss of mechanical properties. This statement was 
also supported by previous work carried out at The University of Nottingham that 
[23-28]. The phosphate glass fibre reinforced polylactic acid composite material 
considered for this study breakdown due to the hydration of the material interface 
and polymer swelling, thus creating stress concentration sites in this region.  
For the purpose of this study, it was hypothesised that the biocompatible chemicals 
that have been demonstrated to be capable of reacting (either covalently or through 
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hydrogen bounding) with free hydroxyl ions present on the surface of similar 
material (silica glass/hydroxyapatite) could also be used to modify phosphate glass 
surface. It was hypothesised that after chemical treatment phosphate glass surface 
will have a functional group that could react with polyester through a strong covalent 
bridge.  It was expected that introduction of covalent bonds at the interface will 
improve interfacial integrity between two distinct phases of intended composite. 
Chemical treatment of phosphate glass surface, in some cases, may also introduce 
hydrophobicity at the interface which could provide better glass/polymer adhesion 
and cause delay in hydration in the region and help to reduce the internal stress of the 
system.  
A better interface will also enable further control over the retention of mechanical 
properties of composite by providing predictable/efficient load transfer between the 
two phases of the composite. It was also recognised that all the chemicals selected 
for this study and the degradation products of the composites after chemical 
treatment should be non±cytotoxic and biocompatible. 
1.3 Aims and Objectives 
The aim of current project was to develop a phosphate glass fibre reinforced 
polylactic acid composite for bone fracture fixation applications. The composite was 
intended to be used as a load bearing bone-plate/screw fixation system. In particular, 
initial mechanical properties and their retention were aimed to improve by improving 
phosphate glass fibre and polylactic acid interface using chemical surface treatment 
of phosphate glass fibre. Initial flexural properties exceeding cortical bone (strength 
100-200 MPa, Modulus = 10-30 GPa) and 70% properties retention after 4 weeks of 
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degradation were desirable [17-19, 29]. The proposed work in this thesis will cover 
the following specific objectives:  
1. Production of a composition of phosphate based glass (PBG) with a target 
degradation rate, ease of fibre drawing and cytocompatibility  
2. Identification of potential chemical treatments that can provide covalent link 
by reacting with both PBG and the polymer matrix 
3. Identification of chemical surface treatments that can increase the 
hydrophobicity of phosphate glass 
4. Development of a method to measure interfacial shear strength (IFSS) 
between PBG and PLA at a micro level and investigation of the effect of 
chemical agents on IFSS 
5. Assessment of the in±vitro cytocompatibility of surface treatments agents 
using indirect and direct contact methods with human osteoblast cells 
6. Synthesis and testing of chemically surface-treated phosphate glass fibre 
(PGF) reinforced PLA composite for flexural mechanical properties and 
cytocompatibility at a macro level.  
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CHAPTER 2. LITERATURE REVIEW  
2.1 Introduction 
This chapter reviews the literature on the structure and mechanical properties of bone, 
implantable fixation materials/devices, phosphate glasses and their properties, 
poly(lactic acid) (PLA) and its characteristics, chemical surface treatments and their 
mechanism to improve interfacial shear strength interfacial shear strength (IFSS) and 
finally biodegradable composites as fracture fixation devices.  
2.2 Bone 
Bone is a specialised form of connective tissue that provides internal support to the 
body in all higher vertebrates. In addition to its supportive function, it has several 
metabolic functions; it protects and encompasses the brain, the spinal cord and bone 
marrow, and plays an essential role in maintaining blood calcium levels and 
supporting haematopoiesis (the formation and development of blood cells) [30, 31]. 
Bones develop from an organic extracellular matrix, strengthened by the deposition 
of mineral. Although bones are hard and mineralized they are living tissue 
containing blood vessels and various cell types. A typical bone consists of a hard and 
compact outer shell (the cortex) which surrounds a hollow cavity that is filled with 
bone marrow. At specific locations, bone is strengthened with a fine network of 
sponge±like trabecular bone (Figure 2±1). The combination of the relatively dense 
cortex together with the relatively lighter trabecular bone gives the bone strength 
with minimal weight [30, 31]. 
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The mineral substance of bone is a calcium phosphate called hydroxyapatite (HA): 
Ca10(PO4)6(OH)2, which includes calcium phosphate, calcium carbonate, calcium 
fluoride, calcium hydroxide and citrate. The HA crystals are believed to be in the 
spaces between the collagen fibrils but their exact shape is under discussion [32]. 
The mineral phase of bone acts as an ion reservoir and largely responsible for the 
mechanical properties of bone. The mechanical properties of bone result from the 
impregnation of the soft organic matrix with the very hard and brittle HA crystals 
[30, 31, 33]. 
 
Figure 2-1: Structure of bone showing both compact (cortical) and trabecular 
(cancellous) bones. Osteon of compact bone and trabeculae of spongy bone are also 
highlighted along with blood supply for the bone [34]. 
2.2.1 Bone Cells 
Bone is a dynamic tissue that is continuously maintained and renewed by four 
different kinds of bone cells: 1) osteoclasts, 2) osteoblasts, 3) osteocytes, and 4) 
lining cells (Figure 2-2). Osteoclasts are located at the bone surface where they are 
responsible for resorption of bone tissue. They are giant multinucleated cells and 
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resorb bone via local acidification and secretion of specific proteases. Acidification 
is necessary to dissolve the mineral in bone, whereas the proteases degrade the 
proteins of the extracellular matrix [35]. Osteoblasts are the bone forming cells; they 
synthesise the organic matrix of bone by secretion of a wide variety of extracellular 
matrix proteins. In addition to matrix production, they also participate in the 
mineralisation process and in the control of osteoclast function [36-38]. At the 
terminal differentiation stage of an osteoblast when it is entrapped in its self±
produced bone matrix it is called an osteocyte. Osteocytes are the most abundant 
cells in bone they are sensitive to mechanical strains [39] and thus maintain bone 
remodelling by sensing mechanical strain and translate that strain into biochemical 
signals of resorption or formation related to the intensity and distribution of the 
strain signals [40]. They have a typical morphology with long thin cytoplasmic 
processes, which form a fine network of connections with other osteocytes and with 
the osteoblasts located at the surface of the bone (see osteocyte structures in Figure 
2±2). Another bone cell that is formed by osteoblastic differentiation is the lining cell. 
Lining cells cover the bone surfaces and thus separate the bone surface from the 
bone marrow. However, the exact function of bone lining cells is still unclear [38]. 
Bone can be defined as a self±repairing structural material that is capable of adapting 
its mass, shape and properties to the changes in mechanical and physiological 
requirements through its cells. During bone remodelling bone mass is controlled by 
the balance between osteoclastic bone resorption and osteoblastic bone formation. 
First osteoclasts resorb bone by acidification and secretion of a wide variety of 
proteases and, in turn, osteoblasts replace the resorbed bone by producing new bone 
matrix. 
 Chapter 2 Literature Review  11 
 
Figure 2-2: Sketch of cells concerned with the production, maintenance and modelling 
of the osteoid [41]. All forms of bone cells including osteoblast (bone former), osteoclast 
(bone eater), osteocytes (mature osteoblast) and bone lining cells are highlighted in 
their respective position within bone matrix.  
2.2.2 Bone Repair 
When fracture occurs, dense connective tissue and newly formed cartilage cover the 
fracture site to produce a fibro±cartilaginous callus to stabilise and bind the fractured 
bone. Meanwhile, osteoprogenitor cells differentiate into osteoblast cells that deposit 
new bone adjacent to both ends of the fracture site, invading the callus and replacing 
it with a bony callus. While compact bone is being formed, the bony callus is 
removed by the action of osteoclasts, and the gradual remodelling restores the bone 
to its original shape [42]. Bone repair can last from 6 to 12 weeks, but the healing 
process can be accelerated by the use of external materials such as plates and screws. 
2.2.3 Mechanical Properties of Bone 
The mechanical properties of bone can be measured by testing whole bone units or 
specimens prepared to isolate particular structural components. The mechanical 
properties of cortical bone have been reported extensively (Table 2-1). They can be 
measured via techniques such as: uniaxial compressive or tensile testing, or three or 
four±point bending for flexural properties. They have also been tested using 
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ultrasound techniques or micro and nano±indentation. Cortical bone exhibits a high 
degree of anisotropy. The values of mechanical properties are also reported to be 
dependent on animal species, bone location and testing conditions, age and disease. 
Testing conditions may also vary and affect the measured properties. for example, 
testing dry samples, testing wet samples at room temperature or 37 °C and 
embedding them or not [43].  For example, trabecular bone tested wet by three±point 
bending test method had an elastic modulus of 3.81 GPa [44], but an elastic modulus 
of 10.4 ± 3.5 GPa was reported for dry trabecular bone [19, 29]. Brear et al. 
determined the effect of variations in temperature (20±37 °C) on mechanical 
properties from a uniaxial compressive test. A 13 % decrease in the maximum 
strength at 37 °C was reported [45]. 
Table 2-1: Mechanical properties of human cortical and cancellous bone along with 
their testing conditions 
Cortical Bone 
Test method 
Strength 
(MPa ±  SD) 
Testing 
condition 
Reference 
Modulus 
(GPa) 
Testing 
conditions 
Reference 
Tension 130 ± 20 
Wet from 
various sites 
[17, 46] 14.1 Rewetted 
[17, 18, 
47] 
Compression 159 ± 4.1 Wet femur [17, 48] 10.4 Wet [17, 18] 
Bending 164 ± 29 Wet femur [17] 15.8 Wet [17] 
Cancellous Bone 
Tensile - - - 
10.4 ± 3.5 
14.8 ± 1.4 
Dry 
Wet 
[19, 29] 
Uniaxial 
Stress 
0.34-7.72 Fresh frozen [49] - - - 
Measuring the properties of cancellous bone is far more complex than cortical bone, 
due to the small dimensions of the individual trabeculae. It is speculated that 
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differences in moduli between cortical and cancellous bone are entirely due to the 
bone density. Thus, as can be seen in Table 2±1, some authors found value of elastic 
modulus of cancellous bone as high as those for cortical bone [17]. 
The Food and Drug Administration (FDA), USA has recommended the use of 
mechanical tests which are essential to demonstrate the effects of bone therapy [50]. 
However, in the scientific literature, the standardization of specific and reproducible 
mechanical tests evaluating properties of trabecular bone and compact bone has not 
been defined and there is a requirement to produce standardised test conditions and 
directions. 
2.3 Implant Materials 
Biomedical implants are used to restore, support or replace living tissue or organs 
that are SHUIRUPLQJ EHORZ D VDWLVIDFWRU\ OHYHO $Q LPSODQW¶V UHOLDELOLW\ KHDYLO\
depends on the corrosion, wear and fatigue resistance of the materials used to make 
the implant. The most important characteristics of implant metals are 
biocompatibility, strength (yield, tensile and fatigue) and corrosion resistance [16, 
51]. The material should be non±toxic, non±allergenic when placed in vivo, should 
not cause changes in plasma proteins or enzymes, should be inert and 
non carcinogenic and should have non mutagenic effects [16, 51]. Since the early 
1900s, metal alloys have been used for these applications mainly due to their 
physical and chemical properties, such as strength, durability and corrosion 
resistance. Biomaterials include a wide variety of materials, such as metals, ceramics 
and polymers [52]. Further to this, two classes of materials may be combined to form 
a composite, which is a relatively new class of biomaterial. A self±reinforced 
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polymer however, has the same chemical composition of matrix and reinforcement 
phase, it will also be classed as composite due to different orientation of 
reinforcement (e.g. polymer fibres) and matrix polymer.  
2.3.1 Metals 
Three main classes of metals have been used in orthopaedics today: stainless steel, 
cobalt±chromium alloys and titanium (as alloys and as commercially pure). 
Orthopaedic applications of metal alloys include joint replacement surgery 
(arthroplasty), bone fracture fixation (osteosynthesis) and in spinal and maxillofacial 
devices.  
For these materials to be considered as successful, they must have physical 
properties that allow the implant to perform the desired function, must be 
biocompatible or should not adversely affect the physiological environment. The 
corrosion resistance of metals and alloys is the key to the ease with which these 
materials interact with a particular environment [53]. 
Of the three families of metal alloys used today, stainless steel alloys 316 and 316L 
are probably the oldest [51]. Stainless steel is easy to machine, has a low content of 
impurities, and a high strength and ductility. However, poor erosion due to 
intergranular corrosion, pitting and fretting remained as a drawback for 316L [54]. 
Biocompatibility, and fatigue life of stainless steel is also considered inferior 
compared to other alloys.  Stainless steel can corrode inside the body when in a 
highly stressed and oxygen depleted region, making it suitable for use only in 
temporary implant devices, such as fracture plates, screws and hip nails [51, 55]. 
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Two types of cobalt chromium alloys; CoCrMo or vitallium (60% cobalt, 20% 
chromium, 5% molybdenum, and other substances like C, Fe, Ni, Mn and Si) and 
CoNiCrMo are being used. They have a higher corrosion resistance than the iron±
based alloys, and are resistant to fatigue and to cracking caused by corrosion, yet 
have failed because of fatigue fracture. The superior fatigue and ultimate tensile 
strength of the wrought CoNiCrMo alloy make it suitable for long term applications 
[16, 51, 56, 57]. 
Titanium alloys is another family of orthopaedic alloys. For approval by the FDA, 
they are required to be comprised of at least the following elements, titanium, 
aluminium, and vanadium. Titanium and its alloys are very popular biomaterials due 
to their high strength, low weight, low modulus of elasticity (~60 GPa) and excellent 
corrosion resistance, however, they suffer from low fracture toughness and poor 
wear properties [42]. 
2.3.2 Ceramics 
Ceramics are inorganic, non±metallic compounds with high strength and stiffness, 
resistance to corrosion and wear, and low density which makes them candidate 
material for a broad range of biomedical applications [58]. Ceramics can be used as 
implants in; dentistry as crowns, orthopaedics as joint and bone segment replacement 
and temporary bone repair devices [59]. Ceramics are also used as coatings for 
implants made of other materials to provide a biocompatible interface between the 
tissue and the implant [60]. Two most important ceramics in biomaterials are 
alumina and hydroxyapatite due to their high biocompatibility/bioactivity, high 
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compressive strength, wear resistance and high chemical stability in physiologic 
environment. 
2.3.3 Polymers 
There is a wide range of polymers used as biomaterials in number of different 
applications in human body with great success. The appropriate polymer should be 
chosen based on the body and tissue reactions, the mechanical and thermal properties 
and synthesis route. Examples of most commonly used polymers (Table 2-2) are; 
polymethylmethacrylate (PMMA), polytetrafluoroethylene (PTFE), polyurethane, 
polyvinylchloride (PVC), polydimethylsiloxane (PDMS) and polyesters like PLA, 
poly (glycolic acid) (PGA) and poly (caprolactone).  
Table 2-2: Applications and required properties of commonly used polymers in 
biomedical implants. PMMA: Polymethylmethacrylate, pHEMA: Poly(2-hydroxyethyl 
methacrylate), PE: polyethylene, PEO: polyethylene oxide, PP: polypropylene, PLGA: 
poly(lactic-co-glycolic acid) 
Application Properties and design requirements Polymers used 
Dental 
 stability and corrosion resistance, plasticity 
 strength and fatigue resistance, coating 
activity 
 good adhesion/integration with tissue 
 low allergenicity 
PMMA-based resins for 
fillings/prosthesis 
polyamides 
poly(Zn acrylates) 
Ophthalmic  gel or film forming ability, hydrophilicity  oxygen permeability 
polyacrylamide gels 
pHEMA and copolymers 
Orthopedic 
 strength and resistance to mechanical 
restraints and fatigue 
 good integration with bones and muscles 
PE, PMMA 
PLA, PGA, PLGA 
Cardiovascular 
 fatigue resistance, lubricity, sterilizability 
 lack of thrombus, emboli formation 
 lack of chronic inflammatory response 
silicones, Teflon, 
poly(urethanes), PEO 
Drug Delivery  appropriate drug release profile  compatibility with drug, biodegradability PLGA, silicones, HEMA 
Sutures  good tensile strength, strength retention  flexibility, knot retention, low tissue drag 
silk, catgut, PLGA, 
PP, nylon 
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2.3.4 Degradable Implants 
Different terms (e.g. degradable, absorbable, and resorbable) are being used to 
specify that a particular material will in time chemically disintegrate into its basic 
units (e.g. CO2 + H2O in case of polyesters) after serving its function in a living 
organism. Since degradable implant does not require to be removed they help to 
avoid complications associated with the presence of foreign materials in the body for 
a long period of time and also obviate the need of second surgery. For example, 
cobalt±chromium alloy has cobalt, chromium, nickel and molybdenum. There is a 
concern that the corrosion of cobalt±chrome in human body may release toxic ions 
into the body and thus possibly cause cancerous tumours [61].   
Key issues that are associated with degradable materials include the biocompatibility, 
toxic contaminants (e.g. residual monomers and stabilizers) leaching and the 
potential toxicity of degradation products and metabolic residues. Degradable 
materials therefore have to go through tougher scrutiny than their non degradable 
counterparts [50, 62].  
A natural tissue requires artificial support if it is weakened by disease, injury, or 
surgery. For example, during bone healing the degradable implant (screw, plate or 
nail) would provide temporary mechanical support until the broken bone healed and 
regained its strength.  Therefore, the degradation rate of the implant needs to be 
customised to the healing rate of the surrounding tissue. For example, if a degradable 
material is used within a fracture fixation device the degradation rate of that device 
should not be faster than the rate of bone formation, and the rate of loss of 
mechanical properties for a fixation device should closely match the increase in 
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tissue strength to guarantee a steady stress transfer from implant to healing bone [63, 
64].  
Biodegradable products that have passed through tough scrutiny and have 
successfully been used in orthopaedic surgery include bio±resorbable sutures, pins, 
and bone fixation screws for non±load±bearing applications. The number and variety 
of biodegradable materials suitable for implantable devices is small as compared to 
the wide range of material properties required for implants and devices for various 
applications.  
This gap in biodegradable material demand and limited availability of materials with 
suitable properties has forced researchers to develop composite biomaterials. The 
advantage of composite material is that they can be tailored to a particular 
application. A composite can be designed, within defined physical, chemical and/or 
mechanical properties depending on the base material properties.  
2.4 Glasses and Glass Properties 
Glass refers to a hard, brittle and amorphous solid, an inorganic product of fusion 
cooled to a rigid condition without crystallising. Common glasses contain silica as 
their glass former. However, some glasses do not contain silica as a major 
component or backbone these include fluoride glasses, phosphate glasses, germinate 
glasses and borate glasses [65]. 
2.4.1 Bioactive Glass 
Due to their active interaction with bone cells and potential as reinforcement 
bioactive glasses are being studied as implantable material. 
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Bioactive-glass is a family of non±degradable bioactive material which can develop 
a bond with bone [66, 67]. It is a silica based glass that contains phosphate, calcium 
and sodium: the Ca/P molar ratio has to be at least 5 as bioactive glasses with lower 
ratios do not make a bond to bone [68]. After implantation, alkali ion/hydrogen ion 
exchange occurs producing an alkali deficient surface. Si±O±Si bonds in the glass 
hydrolyse to give silanols, resulting in a silica gel layer. Calcium, phosphate and 
carbonate ions adsorb onto the glass surface and crystallise to form hydroxyl 
carbonate apatite, it is this layer which bonds to bone.  
Bioglass has been used extensively in non±load±bearing applications such as 
alveolar ridge augmentation and maxillofacial reconstruction. However, its use is 
limited by its brittleness, which present difficulties in shaping the implant and limits 
the applications [66]. 
2.4.2 Phosphate Glass 
Phosphate glass is a special class of optical glasses that uses P2O5 as a network 
former like SiO2 in silicate glasses. P2O5 is one of the four Zacarhiason glass 
forming oxides; the other three are SiO2, GeO2 and B2O3. Due to the fast degradation 
of phosphate glass in aqueous environments, the research about its structure, 
properties and application was very limited. Van Wazer et al. suggested that with the 
addition of 30% molar fraction metal oxide, the degradation rate of phosphate glass 
can be reduced significantly [69]. 
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2.4.2.1 Phosphate Glass Structure 
The phosphate glass is formed by network linkages between the PO4 tetrahedra. In 
vitreous P2O5, these groups are connected to neighbouring units by three of their four 
vertices; one place is occupied by a terminal, doubly±bonded oxygen atom (DBO). 
The addition of metal oxide causes depolymerisation of the network with breaking 
the P±O±P links [69-73].  
The tetrahedra are classified using the Qi WHUPLQRORJ\ ZKHUH ³L´ UHSUHVHnts the 
number of bridging oxygens per tetrahedron (shown schematically in Figure 2-3). 
The networks of phosphate glasses can be classified by the oxygen to phosphorus 
ratio, which sets the number of tetrahedral linkages, through bridging oxygens, 
between neighbouring tetrahedra [74-76].  
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Figure 2-3: Phosphate based glass tetrahedra in Qi terminologyZKHUH³L´UHSUHVHQWV
the number of bridging oxygens per tetrahedron.  
Phosphate glasses can be made with a range of structures, from a cross±linked 
network of Q3 tetrahedra (vitreous P2O5) to polymer±like metaphosphate chains of 
Q2 WHWUDKHGUDWR³LQYHUW´JODVVHVEDVHGRQVPDOOS\UR41) and orthophosphate (Q0) 
anions, depending on the [O]/[P] ratio as set by glass composition [74-76].  
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2.4.2.2 Classification of Phosphate 
Phosphates are defined as compounds which contain P±O linkages. The P±O has a 
bond length of 1.62 Å, with bond angles of 130° at the O atoms and 102° at the P 
atoms. 
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Figure 2-4: Schematic diagram of typical phosphate bridge; adapted from [77]. 
According to Graham [77], orthophosphates contain discrete [PO4]±3 ions while 
pyrophosphates and metaphosphates are now known as condensed phosphates, 
which are formed by repeated condensation (polymerisation) of tetrahedral [PO4] 
units, this result in chains of tetrahedra, each sharing the oxygen atom at one or two 
corners of the [PO4] tetrahedron. 
Condensed phosphates are divided into three sub categories: linear polyphosphates, 
cyclophosphates (metaphosphates), and ultraphosphates. These are the most widely 
used families of phosphates and thus most of the research has been carried out in this 
field. 
2.4.2.2.1 Linear Polyphosphates: ([O]/[P] > 3.0) 
These are the salts of the linear poly±phosphoric acids. Figure 2-5 shows structure of 
linear polyphosphates. The basic building block of linear polyphosphate is the 
orthophosphate ion [PO4]±3. This can be denoted as the first member of chain series, 
with the di± and tri phosphate being the second and the third members, respectively. 
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Many polyphosphate are under research but alkali and alkaline earth metal salts have 
received most attention. 
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Figure 2-5: Schematic diagram of linear phosphate showing basic building  block and a 
general formula structure for linear phosphate where n is an integer greater than 1, 
adapted from [77]. 
The long chain polyphosphates were originally called metaphosphates, and have 
been confused with ringed compounds. If the number of units in the polymer µn¶ is 
very large, the formula of a chain polyphosphate [(PO3)n±1 PO4]n+2 becomes 
indistinguishable from that of a true metaphosphate. The long chain compounds are 
sometimes termed as linear metaphosphates [77].  
2.4.2.2.2 Cyclophosphates ([O]/[P] = 3.0) 
According to IUPAC metaphosphate should be indicated with the term cyclo. It is 
the family of ring compounds with the composition [PnO3n]±n, where n can have any 
value. 
They can be prepared by heating orthophosphates and on hydrolysis produce 
corresponding polyphosphate and then eventually split into orthophosphates ions 
(Figure 2-6) [77].  
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Figure 2-6: Preparation and hydrolysis of cyclo±phosphate 
2.4.2.2.3 Ultraphosphate: (2.5= < [O]/[P] < 3.0 ) 
The ultraphosphates are one of the simplest compositions. If the bridging oxygen 
(BO) of one PO4±3 tetrahedral in phosphate glass is attached with neighbouring PO4±3 
tetrahedral, then it is called as metaphosphate or Q2 species. On the other hand, if it 
consists of three BOs it is known as Q3 units or ultraphosphate and its structure is a 
3D network.  
2.4.2.3 Classification of Phosphate With Respect to Modifiers 
Phosphate glass can also be classified into different categories with respect to 
number of network modifiers included in the structure. 
2.4.2.3.1 Vitreous Glass ([O]/[P] = 2.5) 
A glass produced by P2O5 only, without using any additives, is called a vitreous 
phosphate glass. Some work has been carried out but is limited due to its poor 
durability in aqueous environment.  
2.4.2.3.2 Binary Phosphate Glasses 
By introducing network modifiers like Ca or Na, the structure and properties of the 
glasses can be changed significantly. Generally, when an alkali oxide is added to 
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phosphate glasses, the structural groups change from Q3 to Q2 to Q1 to Q0 depending 
on the change in the ratios of M2O (or MO)/P2O5 changes from 0 to 1 to 2 and to 3 
as depicted in the Figure 2-7 [69-73]. 
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Figure 2-7: Schematic diagram of metal cation effect on phosphate tetrahedra; 
structure adapted from [73]. 
Figure 2±7 also indicates different species of condensed glasses, classified into four 
groups on the basis of P2O5 to M2O ratio. 
P2O5 + 3 M2O (orthophosphates)        
P2O5 + 1 to 2 M2O (pyrophosphates) 
P2O5 + 1 M2O (metaphosphates) 
P2O5 + <1 M2O (ultraphosphates) 
A large amount of work has been carried out to understand the complex structure of 
these glasses [74-76, 78-80].  According to Van Wazer, the phosphate glass network 
is formed mainly by the linkages between the PO4 tetrahedra. In case of vitreous 
P2O5, these groups are connected to adjacent units by three of their four vertices; one 
place is occupied by a terminal, doubly bonded oxygen atom (DBO). Addition of 
metal oxide results in a depolymerisation of the network with breaking P±O±P links 
[69-73]. For several compositional series of glasses, this breakage is confirmed by 
determining the frequencies of phosphorous atoms in tetrahedral units with different 
numbers of links using P magic angle spinning nuclear magnetic resonance (MAS±
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NMR) [76] and by O (ls) X±ray photoelectron spectroscopy (XPS) [81] obtaining 
the ratio of bridging to NBO WHUPLQDOVLWHV+RZHYHULQ+RSSH¶VWKHRUHWLFDOPRGHO
based on published data, and knowledge about the ultraphosphate region, in addition 
to the depolymerisation process there are other structural principles at work [78]. For 
a simple system consisting of the P2O5 network former to which a metal oxide is 
added, initially there is a large excess of terminal oxygen atoms in the pure P2O5. As 
the metal (M) is added, it initially occupies positions with high M±O coordination 
numbers surrounded by terminal oxygen atoms on M±O±P bridges. However, as the 
M content increases, a point is reached at which all the terminal oxygen atoms 
occupy this M±O±P state. As the M content is now further increased, a modified 
random network develops.  
2.4.2.3.3 Ternary Phosphate Glasses 
Ternary phosphate glass is a system that contains two oxides other than phosphate. A 
significant amount of work has been carried out on this type glasses, particularly 
Na2O±CaO±P2O5 system of glasses [82-87]. The addition of oxides helps to reduce 
the degradation rate of phosphate glass. For example, Ahmed et al. reported 
variation in degradation rate between 0.58×10±3 mg cm-2 h-1 for P50Ca40Na10 to 
1.55×10±4 mg cm-2 h-1 for glass P45Ca40Na15 (numbers after element symbols 
indicate molar concentration of oxides) [85]. 
2.4.2.3.4 More Complex Glass Systems 
Adding more modifiers may result in more complex but useful glasses and could 
potentially give more control over degradation rate of the glass. A significant amount 
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Na2O±CaO±K2O±MgO±Fe2O3 and more recently titanium or strontium oxides as 
modifier with P2O5 network±former [88-95]. Degradation products from the 
phosphate glasses containing modifiers like calcium, magnesium, strontium, silver, 
and/or copper could open new application for phosphate glasses. For example 
glasses containing calcium or strontium are reported to be favourable for osteoblastic 
bone regeneration [85, 86, 96]  and 10% CuO doped glasses were found most 
effective in killing the pathogen staphylococcus epidermidis [93].   
2.4.2.4 Phosphate Glass Degradation 
The rate of PBG dissolution is sensitive to its composition and it can be varied from 
a few hours (e.g. binary sodium phosphate glasses) to years (e.g. lead iron±phosphate 
glasses) [97]. Factors affecting the rate of hydrolysis of a condensed phosphate 
solution are: the number of corners shared by the PO4 tetrahedra in the structure, the 
temperature, pH and concentration of ions within media [98]. 
According to Bunker et al. PBGs dissolve uniformly due to acid or base catalysed 
hydration of the polymeric phosphate network. He also suggested that the dissolution 
mechanism involves hydration of entire chains rather than cleavage of P±O bonds by 
hydrolysis [99].  
One the other hand, based on a real time dissolution study of phosphate glass and 
dissolution theory of silica glass, suggesting that the degradation process for silica 
glass is initially nonlinear due to an ion exchange process followed by a linear glass 
dissolution process, a two±step dissolution theory for calcium phosphate glass was 
devised by Rineheart et al.  It was suggested that initial hydration of the P±O±P 
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chains followed by stoichiometric dissolution of both the phosphate chains of the 
network and the cationic modifier ions are shown in Figure 2-8 [100].  
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Figure 2-8: Proposed scheme for CaP glass dissolution showing initial hydration of the 
P±O±P chains followed by stoichiometric dissolution; adapted from Rinehart et al. 
Although, this theory is well accepted amongst the researchers [85, 89, 92, 101, 102] 
no further work was carried out to provide practical evidence on glasses with simple 
and modified structure with cations such as Fe3+ or Al3+. 
2.4.2.4.1 Effect of Modifier on PBG degradation 
From the work carried out on binary, ternary and quaternary PBGs it is clear that 
change in molar concentration of different modifier induces change in degradation 
rate of the glass.  
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For example, a study was carried out on ternary glass systems P2O5±CaO±Na2O by 
fixing the P2O5 content to 45, 50 and 55 mol%, and varying the CaO content at 30, 
35 and 40 (molar %), it was reported that the dissolution rates reduced around an 
order in magnitude with an increase in CaO content [85]. The effect of CaO is well 
established now and is reported in many studies [83, 84, 86, 103]. However, these 
studies did not indicate effective minimum or maximum concentration of CaO 
content nor provided a comparison of CaO effect on degradation rate with other 
modifiers.   
Increase in Fe2O3 content has also found to reduce the degradation rate of the glass 
significantly, in fact effect of Fe2O3 solubility of PBG was found to be greater than 
any other modifier and it is attributed toward its function as network former in 
addition to network modifier [92, 104, 105]. For example, Strohner et al. studied a 
ternary (P2O5±Fe2O3±Na2O) phosphate glasses, containing from 14 to 43 mol% 
Fe2O3 and up to 13 mol% Na2O. They reported that the glasses containing more than 
25 mol% iron content demonstrated excellent chemical durability. The dissolution 
rate at 90°C in distilled water or in saline solution was up to 100 times lower than 
that of window glass. The durability of these glasses was attributed to the 
replacement of P±O±P bonds by stronger P±O±Fe2+ and P±O±Fe3+ bonds confirmed 
by Mossbauer±effect spectra [104]. 
MgO has been reported to have significantly reduced the degradation of phosphate 
glasses [89, 106].  The effect of MgO was evaluated in a quaternary glass system 
(P2O5±CaO±Na2O±MgO) and it was found that by replacing Ca2+ with smaller ionic 
radius Mg2+ the degradation rate of glass starts to decrease. However, no explanation 
of this unexpected behaviour was provided but, it reveals that not only valence but 
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the ionic radius of the network modifier affects the solubility of PBG [89]. Similar 
effect of MgO was reported by Ahmed et al. who found a decrease in degradation 
rate of almost two orders of magnitude between glass MgO 0 mol% and MgO 30 
mol% when NaO content was replaced in quaternary glass system 40P2O5±25CaO±
xMgO±yNa2O [106]. Ahmed et al. supported the magnesium anomaly observed in 
their experiments with previous reports by Suzuya et al., Hoppe et al., and Walter et 
al. who postulated that with higher MgO, phosphate glass structure changes from the 
open structure of the metaphosphate glass to a more compact structure. However, the 
reason for unexpected high decrease in degradation rate was left unanswered [78, 
107, 108].  
It can be deduced from all the studies reported above and research work reported in 
the literature that by changing the glass composition, some control over degradation 
rate can be achieved. The literature available on PBG dissolution studies have used 
different degradation medium (distilled water, PBS and HBSS) and a range of 
temperatures from room temperature, 37°C to 90°C and even variation in medium 
change time from continuous flow to static environment, this makes it difficult to 
compare results from various studies. Therefore, it would be desirable that standard 
testing condition (BSI±ISO 10993) be followed in order to correlate the results from 
different reports.  
2.4.2.5 Cytocompatibility Studies on PBGs 
Over the past few years an increased interest in PBGs for use as or within degradable 
implant materials has been observed. However, most of the research focused on 
glasses containing 40±50 mol% P2O5 or above. A number of cytocompatibility 
 Chapter 2 Literature Review  30 
studies have been carried out [89, 109-116]  some on ternary [88, 117]  and other on 
quaternary [100] PBG systems. Most of these studies focused on the analysis 
interaction of osteoblast like cell with PBG using alkaline phosphatase and alamar 
blue assays. As a general opinion, with increase in CaO within phosphate glass 
content the cytocompatibility of the glass tends to increase which was attributed to 
the slower degradation rate. A few studies have also reported the effectiveness of 
iron containing PBGs in cell adhesion and proliferation and attributed it to slow 
degradation rate of iron containing phosphate glasses [85, 114, 115].  
Bitar et al investigated the cellular response on glasses in ternary system 50P2O5±
xCaO±(50±x)Na2O with x between 30 and 48 mol%. The cytocompatibility of the 
glasses was assessed using human osteoblasts and fibroblasts which were seeded 
directly on glass discs and assessed for adhesion, proliferation, and maintenance of 
phenotypes. Results of this study indicated that higher calcium content supported the 
attachment, growth and maintenance of differentiation of both cell lines. This 
improvement was attributed to the fact that an increasing CaO content decreases the 
solubility of the glasses. However, no correlation between glass chemistry and 
degradation products on the results was proposed [110]. 
Salih et al. tested the cell compatibility of glasses in the system 45P2O5±xCaO±(55±
x)Na2O (where, x varies between 8 and 40 mol %) using two human osteoblast cell 
lines (MG63 and HOS TE85). Cells were cultured on tissue culture plastic with glass 
extracts in the medium, cell proliferation and gene expression was assessed. Here the 
results showed that extracts of highly soluble phosphate glasses inhibit the growth 
and antigen expression while glasses with lower solubility and high Ca2+ ion releases 
improved proliferation of cells and expression of different antigens. The authors 
 Chapter 2 Literature Review  31 
however speculated that the difference in pH and leaching of different ionic species 
would have affected the cell proliferation and protein expression but stated that the 
observed effect of glass extracts on cell proliferation and protein expression had no 
clear reason [84].    
Glass elution extracts in cell±material interaction experiments can give results which 
probably do not represent the actual interaction of cells in direct contact with the 
material. To confirm this Navarro et al. tested the cytocompatibility of two glasses in 
the system 44.5P2O5±44.5CaO±(11±x)Na2O±xTiO2 where x was 0 and 5 mol%. 
Human skin fibroblasts were cultured in medium containing glass extracts alongside 
cells directly cultured on glass plates simultaneously, cytotoxicity and proliferation 
were measured. Their results demonstrated that the information given by two 
methods cannot be considered as equivalent. They also verified that the in vitro 
behaviour (toxicity, adhesion and proliferation) of soluble phosphate glasses is 
adjusted by the solubility of the glass. While the glass free of titania, which 
demonstrated a solubility 10 times higher than the titania containing glass, 
demonstrated more toxic response in cell cultures, cell adhesion was enhanced. In 
the same study Navarro et al. also suggested that it is difficult to estimate the in vivo 
behaviour of the cells with the in vitro results of cell±material interaction. The 
titania±IUHHJODVVZDVHYDOXDWHGLQUDEELW¶VGRUVDO subcutaneous tissue and showed a 
good biocompatibility and did not present any adverse reaction, even with its rapid 
solubility. This was supported with the argument that within an in vivo model, the 
local chemical changes are buffered by the physiological environment and 
continuous circulation of body fluids helped to smooth local conditions [118].  
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Franks et al. investigated the response of a human osteosarcoma cell line (MG63) to 
glasses of the quaternary system 45P2O5±(32±x)CaO±23Na2O±xMgO, where x was 
between 0 and 22 mol%, glass extracts in different dilutions were used to evaluate 
the cell compatibility of the glass samples; an MTT test was used to measure cell 
proliferation. Here, results of the cell proliferation assay suggested that the growth of 
MG63 cells in the presence of glass extracts of four different dilutions remained 
largely unaffected. After five days in culture, enhanced cell proliferation was 
reported for some cases, particularly for those glasses containing 7 mol% MgO or 
more. However, the reasons for the apparent beneficial effect of these glasses have 
not been addressed [89]. 
Skelton et al. [115] also studied the effect of increasing CaO on the behaviour of 
osteoblast and osteoblast±like cells in the ternary glass system 50P2O5±(50±x)±CaO±
xNa2O, where x was either 2, 4, 6, 8 or 10. It was suggested that the degradation 
products and other factors like pH were causing an unfavourable effect on osteogenic 
cell adhesion, proliferation, differentiation and cell death due to the fast dissolution 
rates of these glasses. Only PBG containing 48 mol% CaO was able to support some 
osteogenic proliferation and early differentiation [115].  
Ahmed et al. [109] investigated phosphate glass fibres (PGF) for use as cell delivery 
vehicles for cell transplantation purposes. Fibres in the system P2O5±CaO±Na2O±
Fe2O3 containing fixed 50 mol% P2O5, and varying CaO (30, 35 and 40 mol %) and 
Fe2O3 (1 to 5 mol %) balancing with Na2O were tested with focus on their 
biocompatibility using a conditionally immortal muscle precursor cell (MPC) line. 
Cells were cultured directly onto the glass fibre surface and their ability to replicate 
and differentiate in vitro was studied. It was suggested that adding 4 to 5 mol% 
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Fe2O3 to the original P2O5±CaO±Na2O ternary composition reduced the glass 
degradation rate significantly and sufficient cell attachment and proliferation was 
achieved. 
In another study on much more complex glass system, P2O5±CaO±CaF2±MgO±ZnO, 
Lee et al. seeded a murine pre±osteoblast MC3T3±E1 cell line in order to determine 
the cytocompatibility of glasses with about 44 mol% P2O5. Proliferation, 
differentiation and calcification were assessed. It was reported that no significant 
difference in cell proliferation was found on the phosphate glass and tissue culture 
polystyrene (TCP) controls, therefore it was concluded that the glass was non±
cytotoxic. It was also reported that the cell metabolic activity was significantly 
enhanced and promotion of bone±like bumps formation by the calcium phosphate 
glass was observed at seven days or after. Apparently the phosphate glass enhanced 
both differentiation and calcification of MC3T3±E1 cells [116]. 
Uo et al. investigated the cytotoxicity of water soluble ternary (Na2O±CaO±P2O5) 
glasses with increasing P2O5 and CaO contents. They found that cytotoxicity 
increased with greater than 50% P2O5 content, whilst decreasing with CaO content. 
This effect was attributed to a reduction in pH and higher ion concentration in the 
media. However, the glass studies in Motohiro Uo et al. study were all fast 
degrading and thus they reduced the pH of the distilled water from 7 to 1 [119]. 
Abou Neel et al. investigated the effect of Fe2O3 addition to ternary and quaternary 
phosphate glasses and illustrated a positive effect of increasing Fe2O3 content on 
osteoblast±like cells which was attributed toward the reduced solubility of the glass 
as discussed and seen above. It was suggested that an addition of 4 to 5 mol% Fe2O3 
 Chapter 2 Literature Review  34 
in the system (50 P2O5±30 Na2O±(20±x) CaO) is suitable for desirable cell response 
[92]. 
Quinternary compositions (37P2O5±29CaO±10MgO±24Na2O in mol %) with 
additions of silica and titanium were recently investigated by Brauer et al. [101]. 
They showed that addition of TiO2 decreased the solubility of the glass in water and 
in simulated body fluid. It was hypothesised that dissolution rates of the glasses 
affect the proliferation of osteoblast±like cells (MC3T3±E1.4 murine preosteoblast). 
Cells were cultured over 24 and 72 h, the results demonstrated increasing cell 
proliferation with decreased solubility of the glass. It is recommended that resorbable 
bio±materials need the adjustment of degradation rate so as to facilitate cell adhesion 
and proliferation. 
Soluble phosphate glasses have the potential to be used as degradable hard/soft tissue 
fixation materials. The results published in the literature can be important for some 
applications in the field of biomaterials for bone repair or also in the field of tissue 
engineering for the development of substrates with controlled dissolution rates. The 
control over PBG degradation rates is the key advantage which seems to play 
important role for implant materials and tissue engineering. However, most of the 
studies failed to provide correlation between the observed results with glass 
chemistry, pH and degradation products and only emphasised solubility of the glass. 
It is desirable that the effect of different ionic species leached from the glass on the 
cell functions should also be studied and discussed separately. 
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2.4.3 Biodegradable Polymers 
Biodegradable polymers can be classified as natural (e.g. fibrin, collagen, chitosan, 
and gelatine) and synthetic polymers (e.g. PLA, PGA, PCL, and POE). 
Biodegradable polymers in general have a number of advantages over other 
materials in medical applications. Synthetic polymers offer key advantages like 
ability to tailor mechanical properties and degradation rate to suit a variety of 
applications. They are easy to process and can be moulded into various shapes with 
required features. Furthermore, polymer chemistry allows us to incorporate various 
functional groups and bioactive agents which can assist tissue in±growth. 
Among the families of synthetic polymers, the polyesters family has been the most 
attractive choice for medical applications because of, ease of degradation by 
hydrolysis of ester linkage, degradation products being resorbed through the 
metabolic pathways in some polymers and choice to tailor the structure and to adjust 
degradation rates. Biodegradable polyesters like PLA, PGA and PCL have also been 
reported as potential materials for tissue engineering applications  [120]. PGA, PLA, 
PCL and their copolymers have been used in a number of clinical applications such 
as; resorbable sutures; drug delivery systems and orthopaedic fixation devices (pins, 
rods and screws) [121, 122]. 
A comprehensive summary of the properties of biodegradable polymers was 
presented by Pathiraja A.Gunatillake and Raju Adhikari in their review of 
biodegradable polymers and which is summarised in  Table 2-3 [123]. 
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Table 2-3: Thermal, mechanical, and degradation properties of degradable polymers 
used as biomaterials. Properties are representative of bulk material without any 
reinforcement or cross linking.  
2.4.3.1 Poly (Lactic Acid)  
PLA belongs to the family of aliphatic polyesters commonly made from 
alpha-hydroxy acids. PLA is a thermoplastic of high±strength and modulus that can 
be synthesised from renewable resources to be used in industry as packaging 
material or the biocompatible, bioabsorbable medical device market. PLA is easy to 
process using standard plastics processing equipment to yield film, fibres or moulded 
parts [124]. 
PLA is a rigid thermoplastic polymer that can be semi-crystalline or totally 
amorphous, depending on the stereo±purity of the polymer backbone. L(±)±lactic 
Polymer Tm (°C) Tg (°C) 
Strength or 
elastic modulus 
Degradation 
time (Months) 
Degradation  
Products 
PGA 225 to 230 35 to 40 7 GPa (Modulus) 6 to 12 GA 
PLLA 173 to 178 60 to 65 
2.7 GPa 
(Modulus) 
>24 LLA 
PDLLA amorphous 55 to 60 
1.9 GPa 
(Modulus) 
12 to 16 D,LLA 
PDLA/PGA 
(85/15) 
amorphous 50 to 55 2 GPa (Modulus) 5 to 6 D,LLA+GA 
PCL 58 to 63 ±60 to ±65 0.4 GPa (Modulus) >24 Caproic acid 
PPF _ _ 
2±30 MPa 
(compressive) 
composition 
dependent 
FA/PPG/PAFA 
PCH _ _ 
1.3 GPa 
(Modulus) 
12 
Dicaboxalic 
acid 
PC _ _  Very slow Tyrosine/CO2 
PU/LDI+PCL _ _ 
8±40 MPa tensile 
strength 
1 to 2 
Lysine, caproic 
acid 
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acid is the natural and most common form of the acid, however, D(+)±lactic acid can 
also be produced synthetically. It is one of the few polymers in which the stereo±
chemical structure can easily be modified by polymerising a controlled mixture of 
the L± or D±isomers to yield high molecular±weight amorphous or crystalline 
polymers that can be used in food industry and are generally recognized as safe 
(GRAS) [125] . PLA degrades by simple hydrolysis of the ester bond and does not 
require the presence of enzymes to catalyse this hydrolysis. The rate of degradation 
is dependent on the size and shape of the article, isomer ratio and temperature. 
2.4.3.1.1 Synthesis of PLA 
PLA can be synthesised by both direct condensation of lactic acid and most 
commonly by the ring±opening polymerization of the cyclic lactide dimer, as shown 
in Figure 2-9. 
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Figure 2-9: Synthesis methods for high molecular weight PLA through ring opening 
polymerisation [124] 
Lactic acid (2±hydroxypropionic acid), the basic building block for PLA, is a highly 
water±soluble, three±carbon chiral acid that is naturally occurring and is most 
commonly found in the L(±) form. Tin compounds, especially tin(II) bis±2±
ethylhexanoic acid (tin±octoate), are preferred for the bulk polymerisation of lactide 
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due to their solubility in molten lactide, high catalytic activity, and low rate of 
racemisation of the polymer.  
The polymerisation of lactide monomer using tin octoate is generally explained via a 
coordination±insertion mechanism with ring opening of the lactide to add two lactyl 
units (a single lactide unit) to the growing end of the polymer chain shown in Figure 
2-10 schematically. 
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Figure 2-10: Ring opening polymerisation of lactic acid using Tin±octoate as catalyst 
[124] 
Typical conditions for polymerisation are 180°-210°C, tin octoate concentrations of 
100-1000ppm, and 2-5h to reach 95% conversion. 
2.4.3.1.2 Physical Properties of PLA 
Several reviews have been published indicating the physical properties of PLA 
(Table 2-4) [124, 126, 127]. To summarise these reviews, the physical properties of 
high molecular weight PLA are dependent on its transition temperatures for common 
qualities such as density, heat capacity, and mechanical and rheological properties. 
Depending on the stereochemistry and thermal history, in the solid state, PLA can be 
either amorphous or semi±crystalline. For semi±crystalline PLAs, Tg (~58°C) and Tm 
(130±230°C) are strongly affected by overall optical composition, primary structure, 
thermal history, and molecular weight. Above Tg, amorphous PLA undergoes 
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transition from glassy to rubbery and will behave as a viscous fluid upon further 
heating. Below Tg, PLA behaves as a glass with the ability to creep until cooled to its 
ȕ-transition temperature of approximately ±45 °C. Below this temperature PLA will 
only behave as a brittle polymer [127]. 
Table 2-4: Range of physical properties for PLA as reported in the literature [126-129] 
Properties Values 
Testing conditions or 
standard 
Molecular weight (Daltons) 100,000 to 300,000 - 
Glass transition temperature °C 66±70 ASTM D3417 
Melting temperature °C 130±216 ASTM D3418 
Crystallinity 10±40% Anhydrous 
Surface energy (dynes) 38 - 
Specific gravity 1.25 ASTM D792 
Melt±index range (g/10min) 2±20 ASTM D1238 
2.4.3.1.3 Degradation and Hydrolysis of PLA 
Degradation of the aliphatic polyesters occurs by bulk erosion. Degradation starts 
primarily with hydrolysis of the ester linkages, which occurs more or less randomly 
along the backbone of the polymer. It requires the presence of water according to the 
reaction schematically presented in Figure 2-11. 
CH
CH3
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O
O CH
CH3
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O CH
CH3
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OH CH
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O
OHOPLA + H2O PLA PLAPLA
 
Figure 2-11: Simplistic schematic for hydrolysis of PLA showing cleavage of ester 
linkages within polymer backbone. 
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In vivo studies have shown that monomeric acids can be eliminated from the body 
through the Krebs cycle (citric acid cycle), primarily as carbon dioxide and water in 
urine. The rate of hydrolysis of the polymer chain is dependent on large changes in 
temperature and pH or presence of catalyst. Therefore, very little difference is 
reported in rate of degradation at different body sites [130].  
2.4.3.1.4 Mechanical Properties of PLA 
Investigative work has been carried out to measure the mechanical properties of 
different PLAs. A summary of the research is given in the Table 2±5 [126-128, 131].  
Table 2-5: Mechanical properties of bulk L±PLA compared to D±PLA with an average 
molecular weight of 55000 Daltons. Mechanical characterization was performed on 
specimens maintained in anhydrous conditions [128, 131] 
Mechanical properties L±PLA D,L±PLA Standard used 
Yield Strength (MPa) 70 53 ASTM D882 
Tensile Strength (MPa) 66 44 ASTM D882 
Elongation at Break (%) 7 5.4 ASTM D882 
Flexural Strength (MPa) 106 88 ASTM D790 
Notched Izod Impact (J m±1) 26 18 ASTM D256 
Vicat Penetration (°C) 59 52 ASTM D1525 
2.4.3.1.5 Biocompatibility of PLA 
PLA is known to degrade in the body as lactic acid which is normally present in the 
body. Lactic acid then enters Krebs cycle and is excreted as water and carbon 
dioxide (Figure 2-12). No significant amounts of accumulation of degradation 
products of PLA have been reported in any of the vital organs [63, 125, 132-134].  
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Figure 2-12: In±vivo degradation mechanism for PLA 
Both in±vitro and in±vivo studies have been carried out to establish the 
biocompatibility of PLA. Many studies suggest that these polymers are sufficiently 
biocompatible [133-135] although certain studies like Daniels et al and Verheyen et 
al suggest otherwise [136, 137]. 
Concerns about the biocompatibility of PLA have also been raised by Tayler et al. 
when toxic solutions were produced probably as a result of acidic degradation [138]. 
Another concern is the trigger of inflammatory response due to the release of small 
particles during degradation. It has been reported that as the material degrades, small 
particles break off which are phagocytised by macrophages and multinucleated giant 
cells. 
A summary of literature reviewed for biocompatibility is presented in the Table 2-6. 
It implies that conflicting reports for biocompatibility of PLA has been produced. 
Nevertheless, PLA is one of the biodegradable polymers (PLA, PCL, PGA, PDS 
used routinely) approved as an implant material by FDA/MHRA and has been used 
as pins, screws and sutures in surgical processes. 
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Table 2-6: In±vitro or in±vivo biocompatibility studies of PLA±based biomaterials and 
their outcomes 
Application Material Results Reference 
Sutures in pigs and rats Poly(lactic acid) 
Non±toxic and non±tissue 
reactive 
[135] 
In±vitro toxicity Poly(lactic acid) 
Poly(glycolic acid) 
Can produce toxic solutions [136] 
In±vitro cell response Poly(lactic acid) Slightly toxic [137] 
In±vitro pneumocytes 
culture 
3-D pore structure of 
PDLLA 
No toxic on pneumocytes also 
supported cell growth. 
[139] 
In±vitro osteoblast 
culture 
PLA based composite Non±toxic and cytocompatible [140] 
Concerns with biocompatibility seemed to accompany decomposition of the implants, 
it was accepted that the low molecular mass degradation products of the polymers 
were responsible for this, which could be due to sterilisation process [63].  
According to Daniels et al. local decrease in pH during degradation is one of the 
main reasons for an inflammatory response. In general, it can be concluded from the 
results reported for in vitro studies that PLA demonstrate satisfactory 
biocompatibility in the test systems. High concentrations of degradation products, 
however, had a toxic influence on the cell culture systems. This could explain the 
detrimental effects sometimes observed in bone tissue.  
2.4.4 Composite 
A Composite is a material with at least two distinct phases; a continuous phase (e.g. 
polymer) and a dispersed phase (e.g. glass fibres or particles). The continuous phase 
or matrix is responsible for making up the volume and transfer loads to the dispersed 
phase. The dispersed phase or the reinforcement is usually used for enhancing one or 
more properties of the composite [141, 142].  
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2.4.4.1 Types of Composite 
Composite can be divided into three major categories on the basis of matrix material: 
00&¶V Metal Matrix Composites; &0&¶V &HUamic Matrix Composites; 30&¶V 
Polymer Matrix Composites. Composites can also be categorized into five different 
categories on the basis of reinforcement: fibre; particle; flake; laminar or layered; 
filled composites (Figure 2-13). 
 
Figure 2-13: Different fillers (particle, flake, fibre) and respective composite. 
2.4.4.1.1 Fibre±Reinforced Composites 
Fibre±reinforced composites (FRCs) often aim to improve the strength to weight and 
stiffness to weight ratios (i.e. light±weight structures that possess strong mechanical 
properties). Glass or metal fibres are generally used as reinforcement within 
polymeric matrices. 
Fibres are available in three basic forms: continuous fibres (long, straight and 
generally lay±up parallel to each other); chopped fibres (short and generally 
randomly distributed); woven fibres (come in cloth form and provide 
multidirectional strength). Therefore fibre reinforced composite can then further be 
divided into: non±woven fibre reinforced composite; woven fibre reinforced 
composite; unidirectional fibre reinforced composite (Figure 2-14). 
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Figure 2-14: Schematic of fibre types: Unidirectional, Chopped & Woven 
Examples of fibre reinforced composites as implant material are summarised in 
Table 2-7. 
Table 2-7:  Examples of fibre reinforced composite used as medical implant material 
Fibre Type Matrix Reference 
Carbon fibre Epoxy resin Bradley 1980 [143] 
 PMMA Ekstrand et al 1987 [144] 
 polysulfone Latour and Black 1992 [145] 
 polycarbonate Latour and Black  1992[145] 
 
poly±ether±ether±
ketone 
Wenz et al.1990[146] 
 Polylactide 
Wan et al 2000[147], Zimmerman et al. 
1987 [148] 
Aramid (Kevlar) PMMA Pourdeyhimi et al, 1986, 1989 [149, 150] 
 Polysulfone Latour and Black 1992, [145] 
 Polycarbonate Latour and Black  1992 [145] 
Polyethylene fibre PMMA Pourdeyhimi et al 1989 [150] 
 poly(DL±lactic acid) Reddy et al 2008 [151] 
Bioactive glass fibre polysulfone Marcolongo et al. 1997, 1998 [152, 153] 
 Polycaprolactone Jiang 2005[154] 
Phosphate glass fibre PLA or PCL Table 2±8 
2.4.4.2 Biocomposite 
From structural point of view, like most living tissues (e.g. bone, skin, cartilage), 
composites are anisotropic and that is why an attractive choice for medical 
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application. Biocomposites were developed to obtain a wide range of mechanical and 
biological properties and hence optimising the structure and function of biomedical 
devices and their interaction with surrounding tissues. 
Different types of composites are already in use or currently under study to be used 
in the application of cardiovascular grafts, dental restorative and prosthesis materials, 
bone repair, tissue engineering, bone grafts, fracture fixation devices, joint prosthesis 
and even artificial cartilage, ligament and tendons [142, 155] 
2.4.4.2.1 Types of Biocomposites 
Other than the general classification of the composites, biocomposites can further be 
divided into three more categories based on their biodegradability: fully resorbable; 
partially resorbable; non±resorbable. 
Resorbable biocomposite are made from the fibres (PLA/PGA, phosphate glass fibre) 
and matrix (degradable polymers such as PLA, PCL, and POE) which are fully 
absorbable in the body. These are currently under intensive investigation for internal 
fracture fixation (osteosynthesis) applications [23, 24, 27, 140, 156-160]. They give 
at least two major advantages of avoiding removal operation and stress shielding, 
over metal fixation counterparts. 
2.4.4.3 PGF Reinforced Composite 
For a completely degradable composite, both the continuous phase and the 
reinforcement fibres should be degradable.  pRO\Į±hydroxy esters), especially PCL 
and PLA are the few synthetic polymers that have been approved for human clinical 
uses. However, low stiffness of these polymers (e.g. the elastic modulus of PLA 
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screws is about 3 GPa) in comparison to metal devices could allow excessive bone 
motion which is detrimental for satisfactory healing [155, 157]. 
Reinforcement of such polymers with totally resorbable reinforcement is therefore 
necessary for the development of a fully degradable compliant and strong fracture 
fixation device. Therefore, the use of degradable phosphate glass fibres is of special 
interest. 
A number of studies have shown the potential of PBG particulates or fibre reinforced 
PLA composite to be used for fracture fixation devices (Table 2-8) [23, 24, 27, 140, 
156-160]. Navarro et al. after the surface characterisation and cell response have 
concluded that the PGF reinforced PLA composite materials were biocompatible and 
showed flexural mechanical properties comparable to cortical bone which make 
them potential candidate for the production of degradable bone fixation devices 
[157]. 
Ahmed et al. [158] and Brauer et al. [140] investigated similar type of PGF 
UHLQIRUFHG FRPSRVLWH¶V GHJUDGDWLRQ SURILOH DQG PHFKDQLFDO SURSHUWLHV. They found 
that the flexural strength obtained for the composites matched the strength of cortical 
bone; however, the flexural modulus values were found lower than those for cortical 
bone (see table 2-8). 
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Table 2-8: Summary of selected investigations on phosphate glass fibre reinforced 
composites and their mechanical properties. PCL: Poly-caprolactone, PLA: 
poly-lacticacid, POE: poly-orthoester, PGF: phosphate glass fibre, MAmOL: 
methacrylate-modified oligolactide, UD: unidirectional. 
Matrix 
Reinforcement 
Flexural 
Strength 
Flexural 
Modulus Reference 
Vf (%) (MPa) (GPa) 
PCL 
10mm random binary PGF 
(6-18%) 
30 2.5 
Ahmed et al 
2008 
PCL 
Continuous UD quinternary 
PGF 
(10% wt) 
72 2.74 Khan 2010 
PCL (in situ polymerisation) 
Continuous UD quaternary 
PGF 
25% 
105±12 5.9±6 Khan 2009 
PCL (compression moulding) 
Continuous UD quaternary 
PGF 
25% 
55±8 2.1±0.3 Khan 2009 
POE 
Short random ternary PGF 
(0-50%) 
65-103 1.5-9.4 
Andriano & 
Daniels 
1992 
MAmOL 50 cm long quinternary PGF 115±11.9 16±2.4 
Brauer et al 
2007 
PLA 
10mm random quaternary PGF 
14% 
90 5 
Ahmed et al 
2008 
PLA 
Continuous UD and short 
random PGF (40-55%) 
120-350 10 to 30 
Parsons et al 
2009 
PLA 
Continuous UD and 10mm 
random Quinternary PGF 
(15-20%) 
106-115 6.8-9 
Felfel et al 
2010 
MAmOL 
30 cm quaternary PGF 
 
110-190 15-20 
Kobayashi et 
al 
2010 
Table 2±8 gives a summary of literature reviewed for the phosphate based glass fibre 
reinforced composite. Here flexural strength ranges from 30 MPa to 350 MPa and 
flexural modulus was reported to vary between 2.5 GPa and 30 GPa. This large 
variation in flexural mechanical properties is due to variation in polymer matrix 
(PLA, POE or PCL), strength of glass fibre, glass fibre fraction in polymer matrix, 
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fibre orientation and manufacturing process. It can be deduced from the literature 
reported in Table 2±8 that with high fibre volume fraction, unidirectional fibre 
orientation and in±situ polymerisation of strong polymer around phosphate glass 
fibres a high strength composite can be prepared. The resultant composite could 
potentially be used as load±bearing fracture fixation implantable device.  
2.4.5 Role of Interface   
Making a composite out of glass reinforced polymer can provide enhanced 
mechanical properties. However, polymers do not usually make strong mechanical or 
chemical bond with the glass. Combining glass and polymer to create composite 
materials is possible if an intermediary chemical agent is used. Surface treatment of 
filler (e.g. glass fibres) with chemicals can provide a covalent bridge between the 
two phases and/or suitable surface wettability (hydrophobicity) for polymer to 
adhere. 
Chemical substances capable of reacting with both the reinforcement and the 
polymer matrix of a composite with the help to two distinct functional groups 
present in their structure are known as coupling agents. They may also bond 
inorganic fillers or fibres to organic resins to form or promote a stronger bond at the 
interface. Chemical treatment of filer can also acts as compatibiliser between 
polymer matrix resin and glass fibre. Aminopropyltriethoxy silane (APS) is the most 
common silane used to treat common silicate glasses [161, 162].  
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2.4.5.1 Potential Surface Treatment Agents 
It is difficult to find suitable chemicals for biological uses as very limited range of is 
considered biocompatible and at the same time reactive to both polymer and glass. 
Especially, for glass or ceramic like materials there are very few chemicals available 
to functionalise glass/ceramic surface to mediate adhesion between the two phases of 
composite (filler and polymer) by altering wettability of filler and/or providing 
covalent coupling between two phases of composite. So far, reported suitable 
biocompatible surface treatment agents include, but are not limited to, conventional 
silane, various phosphonic acids, poly±(2-hydroxyethyl methacrylate), zirconate, and 
titanate. 
After reviewing the work previously carried out on glass/ceramic (fibre or particle) 
reinforced polymer composite to improve their interface, a summary is presented in 
the Table 2±9. 
Table 2-9: A summary of literature reviewed for chemical agents used to mediate 
polymer/glass interface within composites for biomedical applications. PGF: phosphate 
glass fibre, PLLA: poly-L-lactic acid, HA: hydroxyapatite, PP: polypropylene, APTES: 
aminopropyl triethoxy silane, NR: not reported, PPA: phosphonopropyonic acid. 
Surface 
treatment Matrix Reinforcement Evaluation method Outcomes Reference 
Silanes PLLA PGF Dissolution Strength Retention 
Increase mechanical 
properties 
Non toxic 
Andriano et 
al  
1991±1992 
Silanes PP Mica 
Morphology 
mechanical 
properties 
Adhesion 
Enhanced viscoelastic 
properties 
Yazdani et 
al 
2006 
Silanes degradable  polymers HA XPS 
Stable coverage of 
mineral filler 
thin silane coating 
presumed transparent 
for ions 
Dupraz et 
al 
1996 
Metoxy 
silanes PLLA HA 
Cell adhesion and 
contact 
Acute toxicity of 
silane 
dose±dependent 
toxicity of leachable 
Dupraz et 
al 
1996 
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silanol 
3±APTES HA ± Cell study/SEM 
Improved cell 
adhesion to  
collagen grafted HA 
Jung et al  
2007 
HEMA 
PMMA/Titani
a 
Hybrid 
± 
DSC/TGA,  
Morphological 
studies 
successful synthesis 
of hybrid  
material with greater 
thermal  
stability & 
smoothness 
Yeh et al 
2004 
HEMA 
methacrylate± 
modified  
oligolactide 
PGF 
Mechanical 
properties 
Cytocompatibility 
Bone equivalent 
moduli & strength 
No cytotoxicity, 
suitable for pre± 
osteoblasts 
Brauer et al 
2006 
Titanate PP Mica 
Mechanical tests 
fracture behaviour 
(SEM) 
Enhanced yield stress 
and  
flexural strength 
Bajaj et al 
1989 
Zircanate,  
silanes 
Titanates 
EVOH HA Tensile tests, SEM 
30% increase in 
modulus with 
acidic zirconate 
Vaz et al 
2002 
Allyl PA NR CAP FTIR/XPS 
Successful grafting of 
APA with CAP via 
C=C 
Phillips et 
al 
2005 
PPA Poly±EVA HA XRD/FTIRTEM/cyt
otoxicity 
successful grafting of 
PPA onto HA resulted 
in uniform dispersion 
of HA 
Pramanik 
et al 
2008 
PPA Chitosan phosphate HA FTIR/XRD/IFSS 
Homogenoius 
despersion of HA 
resulted in improved 
mechanical properties 
Pramanik 
et al 
2008 
PLA 
Oligomers PLA PGF 
GPC/DSC/NMR/ 
MALDI±TOF MS  
Barker et al 
2009 
Various 
PLA 
 Oligomers 
PLA PGF GPC/IFSS/XPS 
Oligomers with 
greater number of ±
OH ions in their FG 
showed improvement 
in IFSS 
Haque et al 
2010 
APS/PA/G
P/ALD 
PLA 
oligomers 
PLA PGF XPS/MALDI/IFSS 
Improvement in IFSS 
with ALD/GP/PLA 
Oligomers 
Haque et al 
2010 
HDI CHP PLA Biodegradability 
cytocompatibility 
Degradable, nontoxic 
CHP 
Dong et al 
2001 
HDI PEG/PBT HA Mechanical properties 
successful binding 
between polymer and 
HA resulted in 
improved mechanical 
properties 
Liu et al 
1997 
HDI PLA Bioactive glass 
 particles 
Cell studies 
mechanical tests 
Greater tensile 
strength 
Improved 
biocompatibility 
Liu et al 
2008 
Based on the literature reviewed and preceding work conducted within the 
University of Nottingham, a list of potential surface treatments (including coupling 
and grafting agents) was selected with the aim to investigate the effects of chemical 
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treatments on mechanical and biological properties of the composites produced. The 
proceeding section will provide basic chemical structure, reaction mechanism, 
reported effect on IFSS and cytocompatibility where available. 
2.4.5.1.1 Silanes 
Silanes coupling agents well known to self±assemble into mono±molecular and 
multi±molecular layers on surfaces such as glass or silicon dioxide. One end of the 
silane molecule typically has di or tri methoxy or ethoxy functionality whilst the 
other end normally has amine or ethoxy functionality. The ethoxy functionality is 
believed to condense with the hydroxyl functionality on the surface of the glass 
whilst the amine functionality can react with the polymer [161, 162]. To select a 
silane for a particular application, the organo reactive group must match the 
chemical structure and reactivity of intended polymer. For example, Vinyl silanes 
are used for the crosslinking of non-polar and non-reactive polymers such as 
polyethylene and ethylene copolymers requiring free radical mechanism. Generally, 
vinyl silanes are associated with an organic peroxide to initiate grafting reaction. On 
the other hand, amino silane can react with most thermoplastics and thermosets [163]. 
Silane hydrolysable group is an intermediate in the formation of silanol groups, for 
chemical bonding to the surface of the filler and the other end has organic±functional 
group that can also entangle with polymer molecular chains by physical type of 
interactions [164].  
Yazdani et al. incorporated a silane treated mica glass particles with poly±propylene 
and suggested a five step modification process of mica surface (Figure 2-15). 
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Hydrolysis: 
V: CH2=CH  ,  R: CH3
VSi(OR)3 + 3 H2O VSi(OH)3 + 3 ROH
 
Condensation: 
3 VSi(OH)3 OH Si
V
OH
O Si
V
OH
O Si
V
OH
OH + 2 H2O
Siloxane
Hydrogen±bounding: 
 
Rearrangement: 
O O O
H H H H H H
O O O
OH Si
V
O Si
V
O Si
V
OH
Glass surface
 
Surface grafting: 
O O O
OH Si
V
O Si
V
O Si
V
OH
Glass surface
 
Figure 2-15: A 5 step (hydrolysis, condensation, intermediate hydrogen bounding, 
rearrangement and surface grafting) coupling mechanism of silane on glass surface 
[164]. 
Various researchers have reported effectiveness of silanes on IFSS between silica 
based glasses and polymer matrix [164-166]. For example, Park and Jin reported an 
increase in interlaminar shear strength (ILSS) between E±glass fibre and unsaturated 
polyester matrix when a combination of two silanes methacryloxypropyltrimethoxy 
silane (90 wt%, MPS) and aminopropyltriethoxy silane (10 wt%, APS) in 
methanol/distilled water (95/5 volume %) was applied to the surface treatment of 
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glass fibres with different concentrations. It was reported at 0.2 molar concentration, 
ILSS was improved from ~16 MPa (control) to ~26 MPa [166]. However, the IFSS 
YDOXHV  IRU WKH VLODQH WUHDWHG SKRVSKDWH JODVV ¿EUHV3/$, obtained were 
similar to that of the control (untreated glass fibre) [25, 167]. Similar results were 
also obtained by Cozien±Cazuc [168] for both unsized and silane sized 
P40Na20Ca16Mg24 PGFs within a PCL matrix. The difference reported for the 
effectiveness of silanes on silica and phosphate based glasses could be due to the fact 
that the concentration used for PGFs (0.043 M) was much lower than that for silica 
based glasses (0.1±0.5 M). 
2.4.5.1.2 Phosphonic Acids 
Phosphonates or phosphonic acids are organic compounds containing C±PO(OH)2 or 
C±PO(OR)2 groups (where R=alkyl, aryl) (Figure 2-16). Phosphonates are 
effective chelating agents that bind tightly to divalent and trivalent metal ions, 
preventing them from forming insoluble precipitates (scale) and suppressing their 
catalytic properties. They are stable under harsh conditions. They are very soluble in 
water and in alcohol.  
P
O
R
OH
OH
 
Figure 2-16: Generic chemical structure for phosphonic acids 
In a study, specifically tailored organo±phosphonic acid has been synthesised to be 
used as a  with hydroxyapatite [169]. Prepared (2±Carboxyethyl phosphonic acid) or 
(1±propene±3±dihydroxy phosphonic acid) had a phosphonic acid group to react 
with glass and organic group for polymer. This tailored organo±phosphonic acid was 
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applied in a novel co±precipitation reaction to form a calcium phosphate/organo±
phosphonic acid co±precipitate. FTIR, FT Raman and solid state NMR spectroscopy 
was carried out which established that the phosphonic functional groups (P(O)(OH)2) 
of the organo±phosphonic acid appear to replace a proportion of the phosphate 
groups in the calcium phosphate. X±ray photoelectron spectroscopy confirmed the 
presence of reactive groups (C=C), from the organo±phosphonic acid, on the surface 
of the co±precipitate. However, no experimental evidence of prepared phosphonic 
acid on IFSS was reported. 
In the preparation of biocomposites, phosphate±based surface treatments (coupling 
agents) are being extensively used by various researchers in order to improve the 
compatibility between reinforcement and polymer matrix [169-172]. Greish and 
Brown have developed a biocompatible hydroxyapatite (HA)±Ca poly(vinyl 
phosphonate) composite for clinical applications[170, 171]. Tanaka et al. have 
reported the synthesis of surface±modified calcium hydroxyapatite with 
pyrophosphoric acid for use as bioceramics, particularly for orthopaedic applications 
[172]. All these studies suggested that phosphoric acid±based agents can be 
employed to enhance the interfacial bonding between reinforcement (HA±particles) 
and the polymer matrix. Therefore, these chemicals can improve the mechanical 
properties of the resulting composites. However, none of the studies directly 
measured the IFSS before and after chemical treatment. 
Considering the potential of phosphonic acids to react with ceramics, such as 
hydroxyapatite, a literature survey was carried out and three different phosphonic 
acids were selected to be investigated for their role. 
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2.4.5.1.2.1 Phosphonopropionic Acid 
Phosphonopropionic acid (PPA), also known as carboxyethyl phosphonic acid, has 
been used successfully to mediate interface between calcium phosphate nano±
particles and polymer matrix [173] and with PBG within the University of 
Nottingham, however, not much success in terms IFSS improvement was achieved 
in the latter [25]. It was assumed that the molar concentration and other reaction 
conditions need to be optimised to get the maximum coupling effect from PPA to 
improve IFSS between PBG and PLA.  
P
O
HO
OH
O
OH
 
Figure 2-17: Chemical structure for phosphonopropionic acid with two different 
binding sites for glass and polymer matrix. 
In a study, Andres et al showed that up to 24 weight% of 2±carboxyethyl phosphonic 
acid (PPA) could be applied onto anisotropic calcium phosphate nano±particles that 
are used for bone implants [173]. 
2.4.5.1.2.2 Etidronic Acid 
Etidronic acid is a bisphosphonate (BP), a class of bone±seeking compounds due to 
the strong affinity of the spatially±optimized anionic phosphonates to bone mineral. 
BPs originated from the inorganic pyrophosphonate, which binds to bone mineral 
surface and prevents its dissolution. By replacing the P±O±P linkage in 
pyrophosphates with the P±C±P linkage (Figure 2-18), BPs become resistant to 
hydrolysis, and exhibits a prolonged persistence in situ. Due to its potential to react 
 Chapter 2 Literature Review  56 
with ceramics like HA, as shown by Nancollas [174], it was a rational choice as 
surface treatment. 
P
O
OH
HO P
O
OH
OH
OH
 
Figure 2-18: Chemical structure for etidronic acid with two distinct functional groups 
to react with glass and polymer. 
Amongst the most common BPs, alendronate (ALD) has been used to improve IFSS 
between phosphate glass and polymer. The IFSS was reported to improve from 
~9.5 MPa to 12.9 MPa. However, no data on osteoblast interaction with ALD±
modified glass was provided [25].  
Alendronate in calcium phosphate (CaP) bone cement has been used as surface 
treatment and reported to have provoke worsening of the mechanical properties. 
MG63 osteoblasts cell line grown on the cements showed a normal morphology and 
biological tests demonstrated normal cell proliferation and viability. In particular, 
Alendronate promote osteoblast proliferation and differentiation, whereas they 
inhibit osteoclast function [175] . 
Due to similarity of structure (Figure 2-18) and evidence of its strong affinity toward 
HA etidronic acid was selected for this study.  
2.4.5.1.2.3 Amino±methyl Phosphonic Acid (APA) 
P
O
OH
HO NH2
 
Figure 2-19: Chemical structure for amino±methyl phosphonic acid with ±OH group to 
react with glass and NH2 to make covalent bond with polymer. 
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APA was purely selected on the basis of its structure (Figure 2-19); two possible 
-OH sites that could react with PBG surface and NH2 functionality that has the 
potential to react with polymer in the same way as the amine functionality in APS. 
2.4.5.1.2.4 Glycerol phosphate (GP) 
P
O
ONa
ONaO
HO
HO
+ x H2O
 
Figure 2-20: Chemical structure for glycerol phosphate, -OH group was expected to 
react with glass and ±ONa to provide reactive site for polymer.  
Reaction mechanism of glycerol 2±phosphate disodium salt and its effect on 
mechanical properties of composite were investigated within the University of 
Nottingham [25]. It is reported that GP reacted with the PBG by making P±O±Na 
bond and thus improved the IFSS from ~9 MPa (Control) to ~16 MPa (GP treated). 
[25] Therefore, in this study GP will be investigated further for IFSS as well as 
cytocompatibility assessment. 
2.4.5.1.3 PLA Oligomers 
At the University of Nottingham, research is being carried out to produce novel 
sizing agents with PLA oligomers (Figure 2-21) with different functional groups like 
Na, COOH, sorbitol, glycerol, and ethylene glycol ended PLA. From the results 
reported; Na and sorbitol ended PLA oligomers improved the IFSS significantly 
from 9±3 MPa (control) to ~17 MPa and 15 ± 2 MPa (Control) to 23 ± 3 MPa for 
sodium and sorbitol ended PLA treated samples respectively. [26] 
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Figure 2-21: Chemical structure for PLA±oligomer prior to functional group 
attachment 
It was reasoned that due to similarity in chemical structure to the matrix (PLA) 
PLA-oligomer showed a better quality of interfacial bonding between PGF and the 
PLA matrix. The functional end groups with a greater number of hydroxyl groups 
showed better compatibility (or attachment) toward PBG which was attributed to 
K\GURJHQERQGLQJEHWZHHQ¶VHQGIXQFWLRQDOLW\DQGPBG surface.  
To further investigate and establish the results sorbitol and sodium ended PLA 
oligomers will be investigated in this study with different IFSS test approach and 
cytocompatibility assessments. 
2.4.5.1.4 Hexamethylene Diisocyanate (HDI) 
HDI is a colourless or slightly yellow liquid with a melting point of ±67 °C. With a 
density of 1.05 g/cm³ (at 25 °C) HDI has a density just greater than water. The 
substance forms oily droplets in water and hydrolyses rapidly.  
C
N
O
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O
 
Figure 2-22: Chemical structure for hexamethylene diisocyanate before grafting on 
glass surface 
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Diisocyanate groups of HDI react with water to form the diamine [monomer for PU], 
and CO2, it can also react with the amine already formed by hydrolysis, resulting in 
oligo± and then poly urea. Hexamethylenediamine (HDA) is toxic and like other 
basic amines can cause serious burns and severe irritation.  
HDI is reported to be acutely cytotoxic and irritant to skin and eyes. Despite of 
reported toxicology issues there is evidence of HDI uses and effectiveness as: a 
cross±linker in protein production [176], modifier in drug delivery systems [177] and 
surface±modifier/coupler in biocomposites [178]. Conversely, there are number of 
reports on the effectiveness of HDI as surface modifier of CaHP ceramic [177-180]. 
Therefore, due to limited number of surface treatment chemicals available with the 
potential to increase the phase compatibility in polymer resin composites and the 
ability of isocyanate to react with hydroxyl groups of hydroxyapatite and PLA to 
form isocyanate±ended PLA, it was a rational choice as surface treatment for glass 
reinforcement.   
2.5 Conclusions 
From the literature surveyed for the purpose of this project, it can be concluded that 
totally resorbable composite for bone repair applications is required to avoid 
complications of rigid metal implant and removal surgery. However, materials 
available for such composite are very limited, especially totally resorbable 
reinforcement is limited to bast fibres/plant±originated fibres (e.g. flax, hemp, jute, 
ramie, kenaf, abaca), alginate fibres, polymer fibres (e.g. poly (lactic acid) and poly 
(hydroxyalkanoate) and phosphate glass (particles, fibres). Within phosphate glass 
compositions issues such as degradation rates, cytocompatibility of bulk glass and 
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degradation products and fibre drawing capability needs further research. Another 
problem of bioresorbable fibre reinforced composite which needs to be counter is the 
loss of mechanical integrity with degradation. This rapid loss of mechanical integrity 
has mainly been linked with loss of interfacial integrity between reinforcement and 
polymer matrix and polymer swelling. Functionalisation of reinforcement surface 
with chemical treatment is a likely solution to counter interfacial integrity loss. 
However, chemical agents capable of reacting with both polymer and glass are very 
limited. Additionally and more importantly biocompatibility of such surface 
treatments needs to be proven prior to their use in a biocomposite. 
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CHAPTER 3. PHOSPHATE GLASSES  
3.1 Introduction 
From the work conducted on binary, ternary and quaternary phosphate based glasses 
(PBGs), it is clear that a change in molar concentration of different modifiers induces 
a change in the solubility of the glass [82, 83, 85, 88, 92, 94-96, 99, 101, 102, 109, 
112, 114, 181, 182]. For example, in a study carried out on a ternary phosphate glass 
system based on 50P2O5±xCaO±(45±x)Na2O, it was shown that dissolution rates 
decreased an order in magnitude (2.7×10±6 g cm-2 h-1 to 5.1×10±7 g cm-2 h-1 ) with an 
increase in CaO content from 30 to 40 molar percentage [85]. Similarly, an increase 
in Fe2O3 content also reported to decrease the solubility of phosphate glasses by two 
order of magnitude from to 1.62×10±4 to 2.7×10±6 g cm-2 h-1 [92]. Similar effect of 
iron doping on solubility of phosphate glass has also been reported elsewhere [104, 
109, 114, 183]. Additionally, the effect of MgO was evaluated in a quaternary glass 
system and it was found that by replacing Ca with Mg the solubility of the glasses 
decreased [89, 181].  Degradation rate of 0.0122 g cm-2 h-1 was reported for ternary 
glass system 45P2O523Na2O32CaO (numbers before oxides represent molar 
percentage of oxide). After inclusion of MgO as a replacement of CaO the solubility 
rate was reported to reduce to 0.008 g cm-2 h-1 for 45P2O523Na2O10CaO22MgO. 
With regards to the results reported in these studies and the limitations of appropriate 
elements for incorporation into these glasses due to concerns about cytocompatibility, 
a range of glass formulations that are suitable for reinforcement application in fibre 
reinforced composites have been devised. The aim was to produce a glass for totally 
degradable fibre reinforced composite with a targeted degradation rate (in the range 
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10±6 and 10±7 g cm±2 h±1), low Tg (<500 °C), potential to be drawn into fibres and 
cytocompatibility.  
This chapter describes the fabrication and characterisation of novel quinternary 
phosphate glasses in the systems of 40P2O5±24MgO±16CaO±(20±x)Na2O±xFe2O3 
and (50±y)P2O5±24MgO±16CaO±yNa2O±4Fe2O3 where, x = 0, 2, 4 and y = 10, 5, 
2.5, 0. The characterisations include investigation of glass structure, thermal, 
degradation and in vitro cytocompatibility properties, considering the effect of 
varying Fe2O3 and P2O5 content. For the cytocompatibility studies MG63 
osteosarcoma cell line was used and correlations of cytocompatibility results with 
the glass degradation rate and chemical structure were explored. Finally glass 
formulations selected on the basis of targeted properties were drawn into fibres and 
tested for tensile strength using single fibre fragmentation test.  
The information collected for the properties of bulk phosphate glasses and glass 
fibres will be used to decide on glass formulations suitable as reinforcement for the 
intended composite.    
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3.2 Materials and Methods 
3.2.1 Glass Production 
Six glass compositions were prepared using the following precursors: NaH2PO4, 
CaHPO4, MgHPO4.3H2O, P2O5 and FePO4.2H2O (Sigma Aldrich, UK). The 
precursors were weighed out and mixed into a Pt/5%-Au crucible type BC18 
(Birmingham Metal Company, UK), which was then dried in a furnace at 350 °C for 
30 minutes, before being transferred to another furnace at 1100 °C for 90 minutes. 
The molten glass was poured onto a steel plate and left to cool to room temperature. 
Having obtained the Tg of the glasses, they were re±melted and poured into a 
graphite mould at 5 °C above the Tg value and left to anneal for 60 minutes. The 
furnace was then switched off and allowed to cool slowly to room temperature. The 
glass rods obtained from the mould were cut into 2 mm thick discs of 9 mm diameter 
using a low speed diamond wheel saw (Model 650, South Bay Technology Inc.). 
The codes allotted to the compositions investigated in this study can be seen in Table 
3-1.  
Table 3-1: Glass codes and their respective oxides within phosphate glass network, 
values represent molar percentage 
Glass code 
P2O5 CaO MgO Na2O Fe2O3 
(Mol %) 
P40 Fe0 40 16 24 20 0 
P40 Fe2 40 16 24 18 2 
P40 Fe4 40 16 24 16 4 
P42.5 Fe4 42.5 16 24 13.5 4 
P45 Fe4 45 16 24 11 4 
P50 Fe4 50 16 24 6 4 
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3.2.2 Material Characterisation 
3.2.2.1 Energy dispersive X-ray (EDX) 
Glass discs from each composition were polished using SiC paper and diamond 
cloths, with industrial methylated spirit (IMS) as eluent. These samples were then 
dried and cleaned with a dry air spray and mounted onto a sample holder before 
being carbon coated. Energy dispersive X±ray (EDX) analysis was conducted on an 
EDAX model DX 4 using ZAF quantitative analysis. The accelerating voltage was 
20 N9DQGWKHV\VWHP¶VUHVROXWLRQZDV eV, with an analysis time of 120 seconds. 
Standards used for analysis were jadeite (for Na), gallium phosphide (for P), 
wollastonite (for Ca), MgO (for Mg) and pyrite (for Fe). 
3.2.2.2 X±ray Photoelectron Spectroscopy (XPS) 
X±ray photoelectron spectroscopy was used to investigate the effect of changing 
composition on the structure (chain length) of PBGs. A Kratos AXIS ULTRA with a 
mono±chromated Al KD X±ray source (1486.6 eV) was operated at 15 mA and 
10 kV anode potential. For the XPS measurement, polished glass specimens were 
mounted onto a sample holder and readings were taken from 3 different areas. Drift 
in the electron binding energy of the peaks due to surface charging effects were 
corrected for by referencing to the adventitious C 1s peak at 285 eV.  
3.2.2.3 Fourier Transform Infrared Spectroscopy (FTIR) 
Infrared spectroscopy was performed on a Brüker Tensor 27 spectrometer, fitted 
with a mercury cadmium telluride (MCT) detector. Spectra were recorded in the 
UHJLRQRI WR ZDYHQXPEHUVXVLQJD VWDQGDUG0.,,*ROGHQ*DWHVLQJOH
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reflection attenuated total reflectance (ATR) system with heated plate (Specac ltd.). 
Samples were crushed and ground into a fine powder using a mineral mortar and 
pestle.  
3.2.2.4 Thermal Analysis 
Samples were ground to a fine powder using a pestle and mortar. Three main thermal 
parameters were measured: the glass transition temperature (Tg); the crystallisation 
temperature (Tc) and the melting temperature (Tm). The analysis was conducted on a 
Setaram differential thermal analyser (DTA) SDT±Q600 (TA instrument), using an 
inert nitrogen atmosphere and a heating rate of 20 °C min-1 up to a maximum 
temperature of 1000 °C. The data was baseline corrected by carrying out a blank run 
and subtracting this from the plot obtained. Analysis was conducted using Texas 
,QVWUXPHQW¶V7$8QLYHUVDO$QDO\VLVVRIWZDUH 
3.2.2.5 Density Measurement 
Density measurements were obtained using a Micromerities AccuPyc II 1340 
two-cell gas S\FQRPHWHU7KLVHPSOR\V$UFKLPHGHV¶SULQFLSOHRIIOXLGGLVSODFHPHQW
to determine the volume of solid objects, which can be converted to a density when 
the mass of the sample is known. Densities were measured using glass discs that 
were 9 mm diameter and 5 mm thick which were weighed using a 4 decimal places 
sensitive balance (Ohaus Analytical standard AS 200).  
3.2.3 Degradation and pH Study 
Glass discs (9 mm diameter, 4 mm thick) were placed into vials containing 30 ml of 
phosphate buffered saline (PBS), in accordance with the degradation standard test 
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conditions: ISO 10993±13:2010. These were then placed into an incubator at 37 °C. 
The starting pH was measured to be 7.50±0.1, using a bench top pH meter (pH 212 
Hanna instruments). At various time points, the discs were taken out of their 
respective containers and excess moisture was removed by blotting the samples dry 
with tissue paper. The solution was also changed at every time point. The sample 
weight was recorded at each time point using a 5 decimal point sensitive balance 
(Sartorius CP 225D). The data plotted as a percentage weight loss over time. The 
sample measurements were conducted in triplicate. The slope of the graphs gave a 
degradation rate in terms of percentage mass loss per hour, which was determined by 
fitting a straight line through the data and including the origin as a data point. 
Analysis of the pH of the supernatant was also conducted in addition to the weight 
loss measurement. 
3.2.4 Cytocompatibility Study 
3.2.4.1 Cell Culture 
MG±63 cells (human osteosarcoma), obtained from European Collection of Cell 
&XOWXUHV (&$&& ZHUH FXOWXUHG LQ &RPSOHWH 'XOEHFFR¶V 0RGLILHG (DJOH 0HGLD
&'0(0FRQVLVWLQJRI'XOEHFFR¶V0RGLILHGEagle Media supplemented with 10% 
foetal calf serum (FCS), 2% hepes buffer, 2% antibacterial/antimicrobial agents, 1% 
glutamine, 1% non±essential amino acids (Gibco Invitrogen, UK) and 0.85 mM of 
ascorbic acid (Sigma Aldrich, UK). Cells were cultured in 75 cm3 flasks (Falcon, 
Becton, Dickinson and Company; UK) at 37 °C in a humidified atmosphere with 5% 
CO2. Once confluent the cells were dissociated from the flask using 0.05 mg cm-3 
trypsin±EDTA in 10mM HEPES buffer and centrifuged at 1200 rpm for 4 minutes to 
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produce a pellet, which was re±suspended in fresh media. Cell concentrations were 
determined using a haemocytometer; viable cells were identified using trypan blue 
exclusion.  
Phosphate glass discs, of the formulations investigated, were sterilised using an 
autoclave and washed three times with PBS prior to cell culture. Tissue culture 
plastic (TCP) was used as a positive control for cell growth. Cells were seeded onto 
the disc sample surfaces at a concentration of 40,000 cells/cm2 and incubated at 
37 °C in a humidified atmosphere with 5% CO2 for 2, 48, 96 and 168 hours. 
3.2.4.2 Alamar Blue 
At the designated time points, culture medium was removed from the wells and the 
samples were washed three times with warm PBS. One millilitre of alamar blue 
solution (1:9 alamar blue: warm Hanks Balanced Salt Solution (HBSS)) was added 
to each well and incubated for 90 minutes. From each well 100 µl aliquots were 
transferred to 96-well plate in triplicate and fluorescence was measured at 530 nm 
excitation and 590 nm emission using FLx800 microplate reader (BioTek 
Instruments Inc). 
3.2.4.3 Alkaline Phosphatase Activity 
At the designated time points, cell culture medium was removed and the samples 
were washed three times with warm PBS prior to the addition of 1 ml deionised 
water to each well. Cells were lysed using a freeze/thaw technique three times. A 
50 µl aliquot of cell lysate was added to a 96-well plate along with 50 ml of the 
alkaline phosphatase substrate (p±nitrophenyl phosphate in diethanolamine HCI 
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buffer, pH 9.8). The micro plate was shaken gently and incubated for ~15 minutes 
before the absorbance was measured at wavelength of 405 nm with 620 nm reference 
using ELx800 microplate colorimeter (BioTek Instruments Inc). 
3.2.4.4 DNA Quantification 
Samples were washed and cells lysed using the freeze/thaw technique as described 
for the alkaline phosphatase method above. One hundred micro litre aliquots of cell 
lysate were transferred to a 96-well plate. DNA standards were prepared using calf 
thymus DNA (Sigma, UK) and TNE buffer (10 mM Tris, 2 M NaCl, and 1 mM 
EDTA in deionised water, adjusted to pH 7.4) as a diluent. One hundred micro litre 
of Hoechst stain 33258 was added to each well (1 mg of bis±benzimide 33258 in 
deionised water, further diluted to 1:50 in TNE buffer) and the plate agitated. 
Fluorescence was measured at 360 nm excitation and 460 nm emission using 
FLx800 microplate fluorimeter (BioTek Instruments Inc). DNA concentrations were 
derived from a standard curve generated by the software (KCjunior). 
3.2.4.5 Elution Study  
A cytotoxicity test for elution products (degradation products from PBG) was 
performed with neutral red uptake (NRU) by viable cells as the end point according 
to the ISO standard for biological evaluation of medical devices (10993±5 2009). 
The test involved following steps: PBG samples (9 mm diameter, 4 mm thick) were 
eluted in treatment media (DMEM + 10% HEPES) for seven days at 37 °C with 
standard 1 mg/ml mass to volume ratio. MG63 cells were seeded at a density of 
(1×104 cells/well) into 96-well plate to form a sub±confluent monolayer. After 24 
hours of incubation culture medium was removed and cells were exposed for 24 
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hours to the treatment medium over a range of four concentrations (100, 75, 50 and 
25%). Cells were then evaluated microscopically for morphological alterations and 
washed once with PBS. One hundred micro litre neutral red dye medium was added 
to the cells and the plates were incubated for 3 hours. The NR dye medium was then 
discarded and cells were washed once with PBS before adding 150 µl NR desorbing 
fixative to the cells. Subsequently plates were shaken for 10 minutes and NR 
absorption was measured at an optical density (OD) of 540±10 nm using an ELx800 
Microplate Colorimeter (BioTek Instruments Inc). 
3.2.5 Glass Fibre Production 
Phosphate glass fibres (PGF) with an average diameter of 20 µm were produced by 
melt±draw spinning using a dedicated in±house facility (see Figure 3-1). Fibres were 
collected on an aluminium drum covered with PTFE sheet. Fibre drawing 
temperature and drum speed were adjusted to 1200±1300 °C and 1200±2000 rpm. 
The fibres were annealed by using the following steps prior to use: ramp up the 
temperature to 250 °C at 20 °C/minute; ramp up again from 250°C to (Tg-5 °C) at 
1 °C/minute; hold for 90 minutes; ramp down to 350 °C at 0.25 °C/min; cool down 
to 25°C at 1°C/minute and finally hold the fibres at room temperature (in desiccators) 
for 24 hours before use. 
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Figure 3-1: Glass fibre drawing tower; glass is melted in the furnace (on the top) which 
is drawn into fibre and collected on the rotating drum (at the bottom). 
3.2.6 Single Fibre Tensile Test (SFTT) 
3*)¶VGLDPHWHUDQGWHQVLOHSURSHUWLHVZHUHPHDVXUHGE\XVLQJ0LWXWR\R6HULHV
LSM±500S laser diameter gauge and LEX810 tensile tester respectively. Samples 
were prepared by gluing a single fibre onto the tabs provided with UV curing glue. 
After measuring the diameter, samples were loaded onto tensile tester and the test 
was run in UVWin software. Where, tensile strength (Ɂ୤ሻ and modulus (E) was 
calculated using the following formulae: 
 Chapter 3 Phosphate Glass Study  71 
Ɂ୤ ൌ ୊౜୅౜        Equation 1 
Where: 	୤ is the maximum tensile force, in Newton; ୤ is the cross±sectional area, in square millimetres, of the filament 
୤ ൌ ൬ ?ూఽ౜൰ቀ ై ? ቁైଵି୏ቀ ?ూ ? ቁైൈ  ? ?ିଷ       Equation 2 
Where: 
ǻF is the difference in force, in Newtons, corresponding to the strain limits selected, 
depending on the nominal strain at break of the fibre, ୤ is the cross±sectional area, in square millimetres, of the filament, 
L is the gauge length, in millimetres, of the specimen, 
ǻL is the difference in length, in millimetres, corresponding to the strain limits 
selected, depending on the nominal strain at break İ of the fibre, as specified below. 
K is the system compliance, in millimetres per Newton. 
According to the carbon fibre testing standard ISO 11566 the following strain limits 
were used: 
İ   0.1 ± 0.6 strain 
İ  0.1 ± 0.3 strain 
İ  0.05 ± 0.15 strain 
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3.2.7 Statistical Analyses 
Mean values and standard errors were computed for at least three replicate samples 
from two iterations of experiments. Statistical analysis was performed using the 
prism software package (version 3.02, GraphPad software). Two±way analysis of 
variance (ANOVA) was carried out with the bonferroni post±test to compare the 
significance of change in one factor over time. The error bars on all the data 
represents standard error of mean unless mentioned otherwise. 
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3.3 Results 
3.3.1 Glass Composition  
EDX analyses confirmed the final glass compositions for the samples investigated 
(Table 3-2). All the formulations investigated were close in composition to the 
expected values, and were found within a 1±2% of the nominal composition. 
Table 3-2: Glass codes and their respective oxides (molar percentage) within phosphate 
glass network, as measured by EDX analysis. Values after ± represent standard 
deviation computed from three replicates 
Glass code 
P2O5 CaO MgO Na2O Fe2O3 
(mol%±standard deviation) 
P40 Fe0 41±1.6 16±1.1 24±1.9 19±1.6 0±0.0 
P40 Fe2 42±0.1 17±0.4 22±0.3 17±0.4 2±0.1 
P40 Fe4 41±0.1 16±0.4 23±0.5 16±0.1 4±0.1 
P42.5 Fe4 43±0.2 16±0.2 23±0.3 14±0.2 4±0.1 
P45 Fe4 46±0.2 17±0.5 22±0.4 11±0.7 4±0.2 
P50 Fe4 50±0.3 16±0.4 23±0.3 6±0.1 4±0.1 
3.3.2 Glass Structure  
For all the glass samples, there were five major IR bands present (Figure 3-2). These 
bands were positioned at approximately 1250 (asymmetric stretch NBO of O±P±O), 
1100 (symmetric stretch of non-bridging oxygen (NBO of O±P±O), 1050 (PO3 end 
groups), 900 (asymmetric stretch of P±O±P) and 700 (symmetric stretch of P±O±P) 
cm±1. It can be seen that the peaks at 700 and 1100 cm±1 were very broad. This can 
be explained by the fact that they consist of two overlapping peaks due to the 
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presence of more than 50% network modifiers like Na, Ca, Mg and Fe. It has been 
reported that sodium phosphate glasses containing smaller amounts of Ca or Mg 
produce four peaks at ~1250, 1100, ~900 and 750 cm±1 in IR spectra and with an 
increase in the amount of Ca or Mg the peaks at 1250 and 1100 cm±1, come closer to 
produce a single broad peak. As the levels of Ca or Mg increase, the peak positioned 
at the higher wavenumber decreases in favour of the growing peak at the lower 
wavenumber [184].  
 
Figure 3-2: FTIR±ATR spectra of PBG with increasing a) Fe2O3 content b) P2O5 
content showing change in glass structure within Q2 to Q1 species. 
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The peaks present are all generally believed to be due to vibrations within the 
phosphate tetrahedron which are summarised in Table 3-3. 
Table 3-3: Major peaks and their assignments from FTIR±ATR spectral analysis of 
phosphate glasses 
Band position and assignments for PBG 
Position (cm±1) Assignment 
1250 Asymmetric stretch NBO of O±P±O 
1100 Symmetric stretch of NBO of O±P±O 
1050 PO3 end groups 
990 PO± chain terminator 
900 Asymmetric stretch of P±O±P 
750 Symmetric stretch of P±O±P 
XPS helped probe the structure of the glass further by giving the signature binding 
energy peaks for different elements and their oxidation states. Two main O 1s peaks 
were detected at approximately 531.5 eV and 532.6 eV which were assigned to non±
bridging oxygen (NBO) and bridging oxygen (BO), respectively (see Figure 3-3).  
Given that all the compositions here lie outside the ultra±phosphate range, the 
number of BO and NBO for a given phosphate chain length can be predicted using 
the following equations:  
%2 [í 
NBO = 2x + 2 
Where, x is the phosphate chain length. These two equations can be combined to 
give the ratio of BO to NBO for a particular phosphate chain length: 
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Where, y is the ratio of BO/NBO. 
 
Figure 3-3: Representative high resolution XPS O1s spectra for a phosphate glass. 
According to Bunker et al [99] theoretical chain length (n) for a phosphate glass 
containing 50 mol% or less P2O5, can be calculated using the following equation: 
 ൌ  ?൤ሺ ? ൅  ? ? ൅  ? ?ሻ െ  ?൨ 
Where, 
M1 = Mole fraction of monovalent cation, Na  
M2 = Mole fraction of divalent cations, (Ca + Mg)  
M3 = Mole fraction of trivalent cation, Fe  
P = Mole fraction of phosphorus, P  
n = Number of phosphates in a chain   
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The results of theoretical chain length calculation are presented in Table 3-4 
alongside chain lengths measured by XPS. 
Table 3-4: BO/NBO ratios and chain lengths calculated using theoretical equations and 
XPS data. Values after ± represent standard deviation computed from three replicates. 
PBG Code 
BO/NBO 
(calculated) 
BO/NBO 
(measured) 
Chain length 
(theoretical ) 
Chain length  
(measured ) 
P40 Fe0 0.30 0.34±0.03 4.00 5.25±0.57 
P40 Fe2 0.26 0.31±0.03 3.33 4.26±0.41 
P40 Fe4 0.24 0.27±0.03 2.85 3.34±0.31 
P42.5 Fe4 0.28 0.34±0.05 3.69 5.25±0.57 
P45 Fe4 0.33 0.36±0.03 5.00 6.14±0.58 
P50 Fe4 0.42 0.47±0.03  32.33±0.33 
3.3.3 Density Measurement 
 
Figure 3-4: Density measurement of PBG measured using a pycnometer; Error bars 
represent standard error of mean where n=10. * indicating the statistical significance. 
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Figure 3-4 shows a ~51% increase in density with increased Fe2O3 in P40FeX 
compositions (where X= 0, 2 and 4) content and a ~48% decrease in density with 
increased P2O5 content with fixed (4%) Fe2O3 in all PYFe4 compositions (where Y= 
40, 42.5, 45 and 50). 
3.3.4 Thermal Properties 
The three major thermal features (glass transition (Tg), crystallisation (Tc) and 
melting (Tm) temperatures) were measured by DTA, Table 3-5. A significant 
increase in these thermal property values was seen with increasing Fe2O3 mol% as 
expected. However, with an increase in P2O5 content in glass containing 4% Fe2O3 
stability in Tg values was observed for glass containing 40 to 45 mol% P2O5. 
However, a significant increase in Tg and Tc thermal values was observed with 
50 mol% P2O5 content. Melting temperature on the other hand remained within 
30 °C (820±850 °C) between all iron doped glass compositions. 
Table 3-5: Thermal properties of the PBG samples measured by DTA; ± represents SD 
where n=3. 
 P40Fe0 P40 Fe2 P40 Fe4 P42.5 Fe4 P45 Fe4 P50 Fe4 
Tg (°C) 432 ± 1 460 ± 2 480 ± 1 480 ± 3 480 ± 1 495 ± 1 
Tc (°C) 610 ± 1 615 ± 2 614 ± 3 671 ± 2 708 ± 4 745 ± 4 
Tm (°C) 770 ± 2 737 ± 1 848 ± 2 822 ± 2 837 ± 3 832 ± 2 
3.3.5 Degradation Study 
Figures 3-5 and 3-6 represent graphs of percentage weight loss against time. As can 
be seen, glass compositions in Figure 3-5 show decreased solubility (~85%) with an 
increase in Fe2O3 content as seen from prior investigations [92, 185]. Figure 3-6 
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shows the plots obtained for glasses with fixed Fe2O3 at 4 mol%. This graph shows a 
gradual decrease in percentage mass loss over time (~40%) with increasing P2O5 
mol%. Table 3-6 gives the degradation rate in g cm±2 h±1 for all glass compositions 
investigated in current study indicating approximately two order in magnitude 
difference between phosphate glass composition investigated. 
Table 3-6: Rate of degradation in (g cm±2 h±1 ) for glass compositions studies. The 
numbers represent mass (g) loss per unit area (mm2) over time (t). Values after ± 
represent standard deviation computed from three replicates 
P50Fe4 P45Fe4 P42.5Fe4 P40Fe4 P40Fe2 P40Fe0 
7.86E-07 
±1E-07 
7.47E-07 
±6E-07 
1.5E-06 ±1E-
06 
2.72E-06 
±6E-07 
6.26E-06 ±6E-
07 
1.27E-05 
±6E-07 
 
Figure 3-5: Effect of increasing Fe2O3 content on degradation behaviour of PBGs 
containing fixed 40% P2O5 content; error bars represents standard error of mean 
where n=3. 
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Figure 3-6: Effect of increasing P2O5 content on degradation behaviour of PBGs 
containing fixed 4% Fe2O3 content; error bars represents standard error of mean 
where n=3. 
3.3.6 Biocompatibility 
3.3.6.1 Alamar Blue Assay 
The alamar blue assay (Figure 3-7) demonstrated the metabolic activity of MG63 
cells for up to 168 hours (7 days) on the phosphate glass formulations investigated. 
Tissue culture polystyrene (TCP) was used as internal control. An increase in 
metabolic activity was seen up to 96 hours, with little further increase by 168 hours. 
Statistical analyses revealed no significant difference between all the glass 
compositions studied.  
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Figure 3-7: Metabolic activity of MG63 cells, as measured by the Alamar blue assay, 
cultured on PBGs up to 168 hours; Error bars represent the standard error of mean 
where n = 6. No significant difference found (P > 0.05) between glass samples. 
3.3.6.2 Alkaline Phosphatase Activity Assay 
The alkaline phosphatase (ALP) activity was normalized to the DNA content of the 
samples investigated. No detectable ALP activity was measured up to 48 hours and 
an increase in activity was found from 96 hours to 168 hours, Figure 3-8. Statistical 
comparison of ALP activity on all glass samples (excluding TCP) demonstrated no 
significant difference except for the most durable P50Fe4, which showed 
significantly lower activity compared to other samples. 
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Figure 3-8: Alkaline phosphatase activity of MG63 cells cultured on PBGs for 168 
hours. The data is normalised to DNA concentration of samples. Error bars represent 
the standard error of mean where n = 6. * indicating significant difference between 
PBG samples. 
3.3.6.3 Elution Study 
From the neutral red uptake (NRU) assay results (Figure 3-9) it was found that the 
relative cell viability for the highest concentration of sample extract (100% extract) 
was found >70 % of the control group (no aliquots) which, according to the 
definition given in ISO 10993±5, implies that the glass elution products were non±
toxic. A gradual low neutral red uptake was observed for all glasses containing >40% 
P2O5 implies lower cell numbers on these surfaces. However, these values were still 
greater than control group and could be due to the slower release of Ca+ ions in to 
the medium or higher concentration of inorganic phosphate released from these 
glasses. Only neat aliquot results are reported here as there were similar trends for 
the lower concentration studies, i.e. 25, 50 and 75% dilutions. 
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Figure 3-9: Effect of neat aliquots of PBGs elution products (eluted for 7 days at 37°C) 
on MG63 cells viability, as measured by the NRU assay. Here, Higher NRU implies 
greater number of viable cells. Error bars represent the standard error of mean where 
n = 6. * indicating statistical significance. P50Fe4 was significantly lower than the rest 
of samples excluding TCP. 
3.3.7 Glass Fibre Production 
Fibres were drawn from three compositions; P40Fe4, P45Fe4 and P50Fe4. These 
compositions were selected because they were the most durable glasses and had the 
longest chain length. The latter indicates these glasses should be easier to draw into 
fibres. It was found that with increased phosphate content fibre drawing became 
easier. With P50Fe4 and P45Fe4 fibre drawing was almost continuous and gave 
~70±80% conversion of glass into fibre. While P40Fe4 broke several times during 
fibre drawing and conversion rate was around 30±40%.   
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Figure 3-10: Melt drawn P45Fe4 glass fibre bundle, shows ease of fibre drawing with 
higher phosphate content 
3.3.8 Single Fibre Tensile Test (SFTT) 
Fibre diameter, tensile strength and modulus were measured and are summarised in 
Table 3-7. Fibre diameter was found to increase with phosphate content from 19 to 
25µm. There was no significant difference found between tensile modulus of the 
different compositions which was between 61-75 GPa for all samples with a 
maximum of 75 GPa found for P45Fe4. However, an increase in tensile strength, 
from 370 to 450 MPa, was seen with increasing phosphate content of the glass from 
40 to 50 mol%. 
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Table 3-7: Tensile strength and modulus of glass fibres drawn from different glass 
compositions. A single fibre tensile test (SFTT) was used along with laser gauge to 
measure diameter. Number after ± represents SD where n=30. * represent the data 
provided by Reda Felfel. 
Glass code 
Average diameter 
(µm) 
Tensile Strength 
(MPa) 
Tensile Modulus 
(GPa) 
P40Fe4* 17 ± 2 370 ± 8 61 ± 4 
P45Fe4 21 ± 3 418 ± 75 75 ± 14 
P50Fe4 20 ± 5 456 ± 144 51 ± 12 
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3.4 Discussion 
From research conducted on similar PBGs, in terms of modifiers and degradation 
rates, it is reported that they show favourable response for cytocompatibility, which 
has generally been correlated with their reduced solubility. In addition, ions released 
from the glass during degradation (mainly calcium and phosphates) may also be 
beneficial for bone healing [96, 186]. However, glass compositions previously 
studied have been linked to concerns of poor chemical durability, pH effects, and 
unsuitable release kinetics of degradation products [119]. Therefore, application 
specific optimised degradation rate of PBG formulations are required; with emphasis 
firmly fixed on their biocompatibility properties.  
PBGs were produced investigating the hypothesis that with increased iron oxide 
content the degradation rate will decrease and that the chain length is increased with 
an increase in phosphate content. Six phosphate±based glass formulations (in the 
system P2O5±CaO±MgO±Na2O±Fe2O3) were produced with fixed magnesium and 
calcium content at 24 and 16 mol%, respectively.  
Chemical compositions of the glasses were confirmed by using EDX analyses which 
was expectedly found within acceptable error margin of 2% (Table 3-2).   
The density of bulk glass is known to be influenced by the cross±link density and the 
packing structure of atoms in the glass. Therefore, it gives an indication of the degree 
of the change in the glass structure with change in the glass composition associated 
with addition of modifying metal oxides. An increase in density with increased 
Fe2O3 content and a decrease in density with increased P2O5 content were observed 
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(Figure 3-4). This trend can be explained by the structural changes in the glass due to 
formation of Fe±O±P bonds. Fe3+ can act as a network former within the P±O±P 
back bone due to its dual nature of tetrahedral and octahedral coordination. As the 
ratio of Fe3+ to P3+ decreases; less Fe±O±P bonds forms which lead to less denser 
glass.   
Thermal analysis showed a gradual increase in all thermal property values (Tg, Tc 
and Tm) with increased iron content. The Tg were found unchanged with the 
increased phosphate content from 40 to 45% and increased for 50% (Table 3-5). This 
was expected as increases in Tg with increasing iron have been reported previously 
[103]. Parsons et al. reported a gradual increase, from 295 °C to 384 °C, in Tg with 
increasing iron content from 0 to 20 mol% in a ternary glass system [103]. The 
increase in Tg was proposed to be due to an increase in the cross±link density of the 
glass network which also improves the chemical durability. The increase in Tg with 
50% phosphate content could be due to the change in structure of the glass from 
ortho to metaphosphate [184].  
The structures of glass samples were investigated with IR and XPS analysis 
techniques. The identification of the peaks observed in the IR wavenumber range of 
1400±600 cm±1 has been well documented [187-189]. The four peaks present (Figure 
3-2) are all generally believed to be due to vibrations within the phosphate 
tetrahedron. The peaks at approximately 1260 cm±1 and 1100 cm±1, and the range 
1050±850 cm±1, are due to non±bridging phosphorus±oxygen bonds. It has been 
reported by Burling, that sodium phosphate glasses containing smaller amounts of 
Ca or Mg produce four peaks at ~1250, 1100, ~900 and 750 cm±1 in IR spectra and 
with an increase in the amount of Ca or Mg the peaks at 1250 cm±1 and 1100 cm±1, 
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shift in position to form what appears to be a single broad peak. As the levels of Ca 
or Mg increase, the peak positioned at the higher wavenumber decreases in favour of 
the growing peak at the lower wavenumber [184]. Therefore the broad peaks (Figure 
3-2) are actually the combination of asymmetric and symmetric stretch of P±O±P at 
700 cm±1 and O±P±O at 1100 cm±1 respectively. The peak at approximately 750 cm±1, 
which was assigned to P±O±P stretching, can be seen to decrease in intensity as the 
Fe2O3 concentration is increased. The structural changes are evident from the 
changing amplitude of the absorption peak at ~1250 cm±1 (PO2 asymmetrical stretch), 
which demonstrates depolymerisation of the phosphate network with decreasing 
P2O5 content [190]. The fraction of non±bridging oxygen decreases and cross linking 
increases due to the formation of P±O±Fe bonds in the glass network as Fe2O3 
replaces Na2O [85, 109]. This agrees with the XPS data (Table 3-4) stating that the 
chain length and hence the concentration of P±O±P bonds decreases with increasing 
iron levels that indicated depolymerisation of PO4 tetrahedra with increasing Fe2O3 
and longer chain lengths with increasing P2O5 contents. Although, the chain lengths 
measured by XPS are slightly longer than calculated, the trend was correlated well 
with the theoretical model with the exception to P50Fe4 where the measured chain 
length was significantly higher than calculated. This difference in chain lengths 
could be associated with the dual nature of Fe, which is assumed as Fe3+ only in the 
calculation while it serves as network modifier (Fe2+) and network former (Fe3+) in 
the glass system. 
The degradation rates of the glasses investigated decreased with increasing Fe2O3 
content (see Table 3-6 and Figure 3-5). As multivalent (Fe) was added in place of 
monovalent (Na+) cat-ion a decrease in degradation rate was expected [103]. 
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Strohner et al. proposed that this was due to formation of Fe-O-P bonds that are 
more resistant to hydration than the P-O-P bonds [104].  Decrease in solubility with 
increasing P2O5 mol% was also observed (see Table 3-6 and Figure 3-6) as reported 
in quinternary/complex glasses elsewhere [85]. The proposed mechanism for this 
decrease is that the phosphate chains are longer and require more time to hydrate 
before they can dissociate from the glass and dissolve [85]. The pH values, of the 
degradation media for all the glasses investigated in our study, remained unchanged 
throughout the degradation period due to the buffer effect of the degradation medium 
and therefore appeared to have had no effect on the degradation rate of the glasses. 
Three glass formulations [(40+x)P2O5±16CaO±24MgO±(16±x)Na2O±4Fe2O3] where 
x= 0, 5 and 10 were drawn into fibres using in house facility. It was found that 
increasing the phosphate content made the fibre drawing easier which can be 
correlated with the increased chain length as found from XPS analysis. The fibres 
were also tested for tensile properties and found similar in terms of modulus (Table 
3-7). However, an increase in tensile strength was observed with increased 
phosphate content which is most likely due to greater orientation of phosphate chains 
with increasing phosphate content [191]. These properties closely match with 
quaternary PBGFs tensile properties reported by Ahmed et al. [86, 109] and 
Cozien-Cazuc [168]. 
Elution study with NRU (Figure 3-9) revealed that glass elution products had no 
toxic effect on cell viability, in fact all elution products from faster degrading glasses 
with lower phosphate content had an encouraging effect on cell viability. Direct 
contact cytocompatibility studies for all the formulations investigated showed 
cellular response, in terms of cell viability, metabolic activity (Figure 3-7), 
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proliferation and differentiation (Figure 3-8), comparable to TCP up to 168 hours of 
cell culturing. However, P50Fe4 glass composition showed relatively lower cell 
ALP activity. It was hypothesised that this could be due to cytotoxicity of the 
products released from this glass; the cytotoxicity is believed to be increased with 
increasing phosphate content in the glass [119]. Uo et al. investigated the 
cytotoxicity of water soluble ternary (Na2O±CaO±P2O5) glasses with increasing P2O5 
and CaO contents using elution products from the glass and alamar blue assay as cell 
viability marker. They found that cytotoxicity increased with greater than 50% P2O5 
content, whilst decreasing with CaO content. This effect was attributed to a reduction 
in pH and higher ion concentration in the media. However, the glass studies in Uo et 
al. study were all fast degrading and thus they reduced the pH of the distilled water 
from 7 to 1 [119]. In current study, to establish the role of degradation products on 
cytocompatibility; NRU assay was conducted on PGV¶ HOXWLRQ SURGXFWV ZKLFK
revealed that degradation products appeared to have a positive response on cell 
viability as long as they are not over concentrating the media with degradation 
products.  
Abou Neel et al. investigated the effect of Fe2O3 addition to ternary and quaternary 
phosphate glasses, and showed a positive effect of increasing Fe2O3 content on 
osteoblast±like cells and attributed this towards two fold decrease in degradation rate 
of the glass as discussed and seen above. It was suggested that an addition of 4 to 5 
mol% Fe2O3 in the system (50P2O5±30Na2O±(20±x)CaO) was suitable for a 
desirable cell response [92]. 
Quinternary compositions (37P2O5±29CaO±10MgO±24Na2O in mol %) with 
additions of silica and titanium were recently investigated [101]. It was reported that 
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the addition of TiO2 decreased the solubility of the glass in water and in simulated 
body fluid. It was hypothesised that dissolution rates of the glasses affect the 
proliferation of osteoblast±like cells (MC3T3±E1.4 murine preosteoblast). They 
cultured cells for 24 and 72 h, with an increase in cell proliferation seen with 
decreasing solubility of the glass. It was suggested that resorbable implant materials 
require the adjustment of dissolution rates to facilitate cell adhesion and proliferation 
[101]. 
The cytocompatibility of PBGs has almost always been attributed to the reduced 
solubility of the glass. However, current study found that, although increasing Fe2O3 
content decreased the solubility of the glass this had very minimal effect on ALP and 
cell metabolic activity, which remained unaffected. Therefore, an application±
VSHFLILFGHJUDGDWLRQUDWHLVQHFHVVDU\WRGHILQHDGHJUDGDEOHJODVVµDSSURSULDWH¶ IRU
that particular application. For example phosphate glass for optical use is considered 
to have suitable degradation rate around 10±5 gcm±2h±1 or less [192]. However, this 
would be insufficient for use as a degradable material for bone repair. It is suggested 
by Parsons et al., that a degradation rate of around 2×10±7 g cm±2 h±1 or better is 
required for phosphate glass fibres used as reinforcement in totally resorbable 
composite for bone repair application that could take up to 8±12 weeks [103]. The 
most durable glass found in this study (P50Fe4 which had a degradation rate of 
7.8×10±7 g cm±2 h±1 (see Table 3-6) is still faster than the suggested optimum rate. It 
was calculated from the empirical model generated for the formulations investigated 
in this study that 4 to 5 mol% Fe2O3 affected degradation rate the most without 
affecting structural properties significantly; further increase of Fe2O3 would 
significantly change the structure of the glass.  
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In summary, PBG formulations (in the system P2O5±CaO±MgO±Na2O±Fe2O3) were 
found cytocompatible with slow degradation profiles and the possibility to be drawn 
into fibres thus establishing them as potential fibre reinforcement materials in totally 
biodegradable composites. 
3.5 Conclusions 
The structural changes investigated with IR and XPS analysis indicated 
depolymerisation of PO4 tetrahedra with increasing Fe2O3 and longer chain lengths 
with increasing P2O5 contents. Degradation rates of the glasses investigated 
decreased with increasing Fe2O3 and P2O5 contents. Cytocompatibility studies 
showed favourable cellular response (up to 168 hours) and all formulations with the 
exception of P50 Fe4 showed no statistically significant difference amongst different 
glass formulations at any time point. It is also suggested that after certain durability 
is achieved, further reduction in the degradation rate has no effect on 
biocompatibility. The elution study proved that the glass degradation products can 
affect cellular responses. It appears that PBG degradation products may help cell 
viability as long as their surface is stable enough to maintain cell attachment and 
proliferation. 
On the basis of the results it was decided that although P50Fe4 composition was the 
most durable and easy to draw into fibres it affected the ALP activity of the MG63 
osteosarcoma cells negatively. Therefore, P45Fe4 was selected as reinforcement for 
polymer matrix composite. 
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CHAPTER 4. SURFACE TREATMENTS 
FOR PHOSPHATE GLASS 
4.1 Introduction 
Totally degradable PGF reinforced PLA composites have shown real potential for 
replacing existing metallic bone fracture fixation devices, in terms of their initial 
mechanical properties and degradation profile [23, 27, 157, 159, 193-195]. However, 
these composites fail to provide a suitable mechanical strength profile over the 
required healing period of bone (8±12 weeks). Typically it has been seen that some 
of these composites can lose 50% or more of their strength within the first week of 
degradation [23, 27, 157, 159, 193-195]. This rapid decrease in mechanical 
properties can be explained by two phenomena; early hydration and loss of the 
polymer/reinforcement interfacial properties [23, 140, 158] and polymer swelling 
during degradation generating hydrostatic forces that crack the reinforcement phase 
[6, 23].  
Introducing covalent bonds and/or hydrophobicity at the interface can potentially 
delay hydration at the interface region and decrease polymer swelling, which can 
help to reduce the internal stress of the system [7]. Two potential approaches used to 
achieve improvement in interfacial shear strength (IFSS) are surface modification of 
the reinforcement phase with plasma (physical and chemical modification) or surface 
functionalisation with chemicals such as coupling agents/compatibiliser/cross-linkers.  
Coupling agents are chemical substances capable of reacting with both the 
reinforcement phase and the polymer matrix within a composite, promoting a 
stronger bond at the interface. This enables effective stress transfer across the 
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fibre/matrix interface, improving overall mechanical properties [165]. Surface 
treatment of glass can also promote glass/polymer adhesion in the non-covalent 
immobilization by hydrophobic and pi stacking interactions. 
A number of studies have investigated a variety of chemical treatments to improve 
the fibre/matrix interface, characterised by IFSS measurements [25, 26, 159, 169, 
178, 196-198]. A common example is 3±aminopropyltriethoxysilane (APS), which 
has been used both for silica based glass [197] as well as PBG fibres [25, 196, 198]. 
It was reported that APS improved the IFSS significantly for silica±based glass, 
however, very little or no improvement was seen for PBGs. Alternative treatments 
that have been considered for a variety of reinforcements like hydroxyapatite (HA), 
Bioglass® and phosphate based glasses include: phosphonic acids [169]; 2±
hydroxyethyl methacrylate [159]; bisphosphonates [25, 199]; hexamethylene 
diisocyanate (HDI) [178] and more recently PLA oligomers [26]. In general, silanes, 
phosphonic acids, PLA oligomers and HDI were reported as promising routes to 
improve the IFSS. However, the mechanisms of improvement and extent of this 
improvement varies for different chemical treatments, for example silanes and 
phosphonic acids has been reported to make a covalent bridge between polymer and 
reinforcement while, PLA oligomers has been reported to improve IFSS by making 
hydrogen bond with reinforcement.   
Due to lack of a standard test, several different techniques have been employed to 
measure IFSS values, including: micro±bond fibre pull out test with a polymer 
droplet or block [200-202], shear test [203], quasi±disc type fibre pull out test [204] 
and single fibre fragmentation test [25, 26, 205]. In a comparative study of different 
techniques for IFSS measurement, Piggott et al. stated that it was very difficult to 
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compare results from these different techniques as each method had its own 
limitations which caused inconsistency between results [203]. To evaluate the 
efficacy of different micromechanical tests (single±fibre pull±out test, the 
microdebond test, the fragmentation test and the micro±indentation test) for the 
fibre/matrix IFSS in composite materials a round±robin programme was undertaken. 
Twelve laboratories were invited to participate in this programme. Each laboratory 
was supplied with untreated Caurtaulds XA fibre, a standard surface treatment, 
quantity of epoxy resin, hardener and catalyst and curing route were also followed. It 
was concluded that there is great potential for achieving standard procedures, readers 
are encouraged to refer for more details [206]. Major differences were found in the 
data processing by some laboratories. A degree of scatter was observed which was 
inevitable due to the nature of the fibres, the application of the surface treatments 
and the small sample sizes. It was concluded that, compatibility between laboratories 
can be improved by adhering to a common test technique and data reduction scheme. 
A reasonable scatter within each laboratory indicates that the fundamental 
procedures used in each laboratory are sound. It also indicates that there is great 
potential for achieving standard procedures and reducing the inter-laboratory scatter. 
In this chapter, potential surface treatment agents for PGF reinforced PLA 
composites were investigated for their capability to react with phosphate glass. An 
investigation of the effect of surface treatments on shear bond strength, surface 
wettability and degradation rate was also carried out. Selection was made on the 
basis of previously reported biocompatibility and likelihood of reaction with the 
phosphate glass and PLA. A few of these chemicals such as hexamethylene 
diisocyanate (HDI and amino phosphonic acid (APA) were investigated for other 
biomedical applications and have never been utilised for totally degradable fibre 
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reinforced polymer composites. The effectiveness of the surface treatments was 
assessed through use of a modified shear test to determine IFSS values and by their 
ability to retard degradation of the glass. A shear test method was selected since the 
main aim of the study was to ascertain chemical surface treatments that could 
improve IFSS significantly. The shear test should directly test the adhesion qualities, 
with minimal contribution from the matrix and glass fibre reinforcement, details of 
the shear test will be discussed in materials and methods section. An investigation of 
the surface treatment agents¶ UHDFWLRQ ZLWK PBG was carried out to optimise the 
reaction conditions using two surface analysis techniques; Fourier transform infrared 
spectroscopy (FTIR) and X±ray photoelectron spectroscopy (XPS). Effect of surface 
treatments on the surface wettability was measured using sessile drop contact angle 
measurement and effect of this change in surface wettability on glass degradation 
rate is also reported.   
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4.2 Materials and Methods 
4.2.1 Glass Synthesis 
Phosphate based glass (45P2O5 16CaO 24MgO 11Na2O 4Fe2O3 in molar %) was 
prepared following the protocol reported in chapter 3 section 3.2.1, using the 
following precursors: NaH2PO4, CaHPO4, MgHPO4.3H2O, P2O5 and FePO4.2H2O 
(Sigma Aldrich, UK).  
Having obtained the Tg of the glass via DSC, it was re±melted and poured into 
graphite moulds (9 mm or 4 mm diameter) at 5 °C above the Tg and left to anneal for 
60 minutes. After this the furnace was switched off and allowed to cool slowly to 
room temperature. The glass rods obtained from the mould were cut into 9 mm 
diameter, 2 mm thick discs for chemical analysis, 4 mm thick discs for degradation 
studies and surface energy measurements or 4 mm diameter and 10 mm length rods 
for IFSS tests using a low speed diamond wheel saw (Model 650, South Bay 
Technology Inc.).  
4.2.2 Surface Modification for Phosphate Glass 
Eight different surface treatments were selected: Glycerol 2±phosphate disodium salt 
(GP); 3±phosphonopropionic acid (PPA); 3±aminopropyltriethoxy silane (APS); 
etidronic acid (EA); hexamethylene diisocyanate (HDI); sorbitol/sodium ended PLA 
oligomers (S/Na±PLA) and Amino phosphonic acid (APA). All the chemicals except 
the PLA oligomers were bought from Sigma Aldrich (U.K) and used without further 
modification. The PLA oligomers were synthesised following the protocol reported 
elsewhere [26]. The surface treatment solutions were prepared in a range of 
Chapter 4 Physical, Chemical and Mechanical Analysis of Treatments  98 
concentrations (0.05-0.25 Molar) in suitable solvents: all phosphonic acids (PPA, EA, 
APA) and APS in 90:10 ethanol/water; GP in distilled water; HDI in 
dimethylformamide and PLA oligomers in chloroform. Glass (discs or rods) were 
dipped coated with prepared solutions, washed with respective solvents and cured at 
~200 °C. The procedures are shown in the flow chart in Figure 4-1.  
 
Figure 4-1: Flow chart of PBG sample modification with different chemicals. Solvents 
(double distilled water (DDW), Ethanol, dimethylformamide (DMF), chloroform) were 
selected on the basis of solubility of surface treatment agents. 
4.2.3 Fourier Transform Infrared (FTIR) Spectroscopy 
Infrared spectroscopy was performed on a Brüker Tensor 27 spectrometer, operated 
in absorbance mode. Spectra were recorded in the region of 600 cm±1 to 2000 cm±1 
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wavenumbers using a standard MKII *ROGHQ*DWH6LQJOH5HIOHFWLRQ$75V\VWHP
with heated plate (Specac Ltd.). Samples were 9mm diameter, 2mm thick discs. 
4.2.4 X-ray Photoelectron spectrometry (XPS) 
XPS analysis was used to investigate the surface chemistry of the modified PBG 
(mPBGs). A Kratos AXIS ULTRA with a mono±chromated Al KĮ ;±ray source 
(1486.6 eV) was operated at 15 mA emission current and 10 kV anode potential. For 
XPS measurement, glass specimens were mounted on a sample holder and readings 
were taken from three different areas. Drift of the electron binding energy of the 
peaks due to the surface charging effect was calibrated by utilising the C1s peak of 
the contamination (285 eV). 
4.2.5 Push±Out Test for IFSS Measurement 
A push±out test was adopted to measure the maximum force required to push out 
PBG rods encircled with a PLA disc. This value was then used to calculate the IFSS. 
The test was derived from a single fibre pull out test [207] and it was expected that 
the push out test would follow the same trend of embedded length versus load curve 
as reported by DiFrancia et al. for the single fibre pull out test (Figure 4-2). Polacek 
and Jancar also used a modified form of single fibre pull out test to calculate the 
IFSS between their fibre reinforced composite axially joined with particulate 
reinforced composite [208].  
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Figure 4-2: Different events during the single±fibre pull±out test are indicated: 1) crack 
initiation 2) frictional debonding 3±4) crack completion 5) frictional zone steady pull±
out and 6) end of frictional zone (pull out). Figure adapted from [207]. 
The interpretation of the load versus extension trace obtained from the single±fibre 
pull±out test varies from researcher to researcher. However, consensus of these 
reports is that with debond initiation, the interfacial crack initially propagates with a 
significant amount of friction. As the applied load increases, the effects of friction 
begin to diminish. After some fibre length, the debonding becomes a steady±state 
event and thus the force required for crack propagation becomes constant. This 
steady±state debonding continues until the end of the fibre, at which time sliding 
commences.  
Samples were fabricated by melting 1.6 g of PLA (3051D Natureworks Plc) around 
the 4mm glass rods in a PTFE mould with a symmetrical cylindrical cavity at 210°C 
for 45 minutes (Figure 4-3a). The glass rods were aligned with the axis of symmetry 
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to the cylindrical cavity and any extra flash on the sides of the glass rods was 
removed. The design of the mould ensured a constant thickness (2±0.25 mm) of the 
PLA disc around the glass rod.   
A universal tensile testing machine (Instron 5900 Systems) was used to perform the 
push±out measurements at room temperature. A custom made metal fixture was used 
to mount the specimens (Figure 4-3b). A cross±head speed of 1 mm/min was used in 
all measurements and the test was stopped when a plateau on the force axis was 
reached. Maximum stress, stress at failure and deformation at failure were recorded 
using the data processing software supplied by the tensile tester manufacturer. 
 
Figure 4-3: A schematic diagram of (a) Push±out test sample with all dimensions L = 
length of glass rod; d = diameter of glass rod; l = thickness of PLA disc; b = diameter of 
PLA disc (b) push out test setup 
7R FDOFXODWH WKH LQWHUIDFLDO VKHDU VWUHQJWK ,)66 ĲD IURP H[SHULPHQWDO GDWD WKH
following equation was used: 
 
Where, ĲD is the average IFSS, Fmax LV WKH PHDVXUHG ORDG DW IDLOXUH µd¶ LV WKH
GLDPHWHURIWKHJODVVURGVSHFLPHQDQGµl¶LVWKHDGKHVLYHMRint length. 
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4.2.6 Degradation Study 
After surface modification with functionalization agents, the glass samples (9 mm 
diameter, 4 mm thick) were placed into vials containing 30 ml of phosphate buffered 
saline (PBS) in accordance with the degradation standard test conditions: ISO 
10993±13:2010. These were placed into an incubator at 37 °C. The starting pH was 
measured to be 7.5±0.05, using a bench top pH meter (pH 212 Hanna instruments). 
At predetermined time points, the discs were taken out of their respective containers 
and excess moisture was removed by blotting the samples dry with tissue. The 
solution was also changed at each time point. Their new weight was recorded at each 
of these time points and the data plotted as percentage weight loss over time. The 
measurements were conducted in triplicate. The slope of the graphs gave a 
degradation rate in terms of percentage mass loss per hour, which was determined by 
fitting a straight line through the data and including the origin as a data point. The 
pH analyses were also conducted alongside the weight loss studies. 
4.2.7 Wettability Measurement 
Surface wettability can be assessed by measuring the contact angle of a water droplet 
[209]. In this study, surface hydrophobicity/hydrophilicity was estimated by 
measuring the contact angle of a 5 OZDWHUGURSOHWRQWKHJODVVVDPSOHV¶VXUIDFHV
The distance between the micro pipette and the sample was kept constant at 10 mm 
and the time before image capture was fixed at 10 seconds. The captured image was 
WKHQDQDO\VHGIRUFRQWDFWDQJOHXVLQJ³,PDJH-´LPDJHSURFHVVLQJVRIWZDUH 
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4.2.8 Statistical Analyses 
Mean values and standard deviation were computed six (IFSS) replicate samples 
from at least two iterations of the experiments. Statistical analysis was performed 
using the Prism software package (version 3.02, GraphPad Software, San Diego 
California USA, www.graphpad.com). Two±way analysis of variance (ANOVA) 
was calculated with the bonferroni post±test to compare the significance of change in 
one factor with time. The error bars presented represent standard error of mean. 
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4.3 Results 
4.3.1 FTIR 
IR analysis was performed on mPBG samples in order to investigate the chemical 
interaction of the surface functionalisation agent with the glass surface. The IR traces 
(Figure 4-4) were carefully analysed to confirm the presence of a layer on the PBG 
surface and evidence of any chemical bonding between the two.  
IR peaks due to covalent bonding between the glass and surface treatment chemicals 
were difficult to distinguish from glass peaks, since most of the chemicals 
investigated in this study reacted with phosphate glass through a P±O±X bond 
(where X = Si, C or P). These P±O±X have signature peaks in the region of 
1000-1250 cm-1 wavenumbers, i.e. the region of the PBG signature peaks. However, 
a significant drop in PBG peak intensities was seen after chemical treatment of 
surface and in a few cases (APS, HDI and EA mPBGs) new peaks were found which 
indicated the presence of an alternate layer on the surface of the PBGs. All the peaks 
and their assignments are summarised in Table 4-1: 
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Figure 4-4: IR spectra of (A) Control PBG; (B) APS mPBG; (C) EA mPBG; (D) HDI 
mPBG indicating the covalent bond between PBG and surface treatment agents. 
694 NH
1087 SiʹO stretch
1190 PʹOʹSi
1303 SiʹCH2 
1383 SiʹCH3 
1484 HʹCʹH 
1559 NʹH bend 
(A)
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Table 4-1: Peak assignment from IR analysis of PBG samples before and after surface 
treatments 
Sample Code IR band  (cm±1) Assignment 
PBG Control 
1250 Asymmetric stretch NBO of O±P±O 
1100 Symmetric stretch of NBO of O±P±O 
1050 PO3 end groups 
990 PO± chain terminator 
900 Asymmetric stretch of P±O±P 
750 Symmetric stretch of P±O±P 
APS 
694 NH Amine 
1087 Si±O stretch 
1190 P±O±Si 
1303 Si±CH2 
1383 Si±CH3 
1484 H±C±H bend 
1559 N±H bend 
2364 Si±H silane 
EA 
702 P±O±P 
1180 P=O (shoulder) 
1385 Free (±OH) bending 
HDI 
1260 Urethane C±N, C±O stretch 
1386 CH2 deformation 
1475 Carbonyl coupled with N±H and 
 N±C±N (secondary urea) 
1577 NH deform + CN stretch 
1616 NH2 vibration 
3317 NH2 vibration 
For APS modified glass samples two bands at 1087 cm±l and 1190 cm±l were 
assigned to Si±O and P±O±Si stretching modes. The presence of the shoulder around 
2980 cm±1 was assigned to the asymmetric methyl stretch (±OEt) due to silane. 
These data indicated that the film consists of oligomeric siloxane networks. 
Similarly, on HDI treated PBG samples there were several extra peaks, however, the 
intensity of the extra peaks was very weak. It is clear from IR spectra that no 
absorption band of isocyanate group (O=C=N±R) at 2270 cm±1 on the spectrum of 
HDI mPBG sample was observed. It can be deduced that all the isocyanate groups 
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were grafted on PBG. It is noteworthy that a clear peak asymmetric stretching 
vibration of P±O±C group could not be observed at the position around 
1100-1050 cm±1, which could be lost in PBG absorbance peaks. However, the 
presence of urethane peaks at 1577, 1475, and 1260 cm±1 points out to the grafting of 
HDI onto the surface of PBG through urethane link. 
A shift of around 50 cm±1 in symmetric stretch of P±O±P was observed when PBG 
surface was modified with EA which could also be detected at 700 cm±1 in etidronic 
acid powder. A clearer shoulder at 1180 cm±1 and symmetric stretch of P±O of PO3±2 
at 990 cm±1 also indicate the presence of new phosphate specie on the surface of 
PBG.  
In addition to P±O±X peaks presence of other bands for example, NH in case of APS 
and NH2 in case of HDI and provided with the evidence of chemical reaction and 
new chemical species on glass surface.  
4.3.2 XPS 
XPS was conducted analysing the O 1s, Si 2p, N 1s, P 2p and Na 1s binding energies. 
Elimination of P 2p and/or Na 1s peaks were used as an indication of total surface 
coverage of PBG with surface treatment chemicals. The deconvoluted binding 
energies and their assignments for all the samples are shown in Figure 4-5.  
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Figure 4-5: High resolution XPS spectra of (A) Control PBG O1s and P 2p; (B) APS 
mPBG O1s and Si 2p; (C) EA mPBG O1s and P2p; (D) HDI mPBG O1s and N 1s. O1s 
spectra indicate covalent bond formation and Si 2p, C 1s and N 1s spectra provide 
supplementary evidence. 
An XPS spectrum was used to identify the surface of the PBG sample for different 
elements. Survey spectrum showed no peaks in the binding energy region of Si(2p) 
for the untreated PBG samples. On the other hand, APS±modified PBG, the presence 
of silicon signals Si (2p) in XPS narrow spectra of Si (2p) provides evidence that Si 
element does exist in APS mPBG. High resolution Si (2p) peak was deconvoluted 
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into two peaks; Si±O±Si± and R±Si±O±P. High resolution O (1s) peak was also 
found and deconvoluted into three peaks. The deconvoluted peak at around 533 eV 
and corresponded to P±O±Si±R. 
Survey spectrum of PBG samples also missing N (1s) which was detected in PBG 
modified with HDI. High resolution spectrum of N (1s) from HDI mPBG was 
deconvoluted with two peaks at 399 eV (NH) and 499 eV (NH2). High resolution 
O (1s) spectrum was fitted with three peaks at around 531 eV (P±O±C=O) and 533 
eV (P±O±C), indicating the formation of a urethane link on PBG surface modified 
with HDI. 
High resolution O (1s) spectrum from EA mPBG sample was fitted with three peaks 
around 531 eV (P=O), 533 eV (P±O±P) and 536 eV (P±O±P=O) which were 
different than oxygen peaks detected from untreated PBG indicating presence of 
etidronic acid layer covalently liked to phosphate glass. High resolution C (1s) peaks 
at 286.5 eV (P±C±P) and 289 eV (C±OH) also provided the evidence of etidronic 
acid layer on PBG.  
4.3.3  Interfacial Shear Strength Measurement (Push±Out Test) 
Figure 4-6 is representative of the curves obtained from load versus extension for the 
devised push±out test. It was clear that the push out test followed the expected events 
discussed in Section 4.2.5 (Figure 4-2) for single fibre pull out test with no 
discrepancies. In addition to this, the repeatability of the modified push out test was 
confirmed by the results of three different control (annealed) batches (n=6); IFSS 
was found to be ~6 MPa with a standard deviation between batches of ~1.5 MPa. 
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Figure 4-6: Representative curve obtained from load versus extension for glass rod 
push±RXWWHVWDGDSWHGIRUWKLVVWXG\ŸUHSUHVHQWV; Fmax required for crack initiation 
and debonding. 
The push out test was performed on samples (4mm glass rod) surface-treated with 
different chemicals over a range of concentrations until a plateau or a drop in IFFS is 
reached. Data was analysed for IFSS and presented alongside control (annealed and 
chemically untreated) in Figure 4-7. 
The results revealed that the surface treatments investigated in this study improved 
the IFSS; however, the degree of improvement and the effective concentration was 
not the same over the range. For APS, GP, EA and HDI modified glasses an 
improvement with higher concentrations (~2 M) was seen. However, after a certain 
concentration a decrease or plateau for IFSS values was observed.  
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Figure 4-7: IFSS values as measured by push±out test for 3±aminopropyltriethoxy 
silane (APS); 3±phosphonopropionic acid (PPA); Glycerol 2±phosphate disodium salt 
(GP); etidronic acid (EA); hexamethylene diisocyanate (HDI); sorbitol/sodium ended 
PLA oligomers. * indicating at significant difference compared to control. 
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A consistent 6±1.5 MPa IFSS value was calculated of repeated experiments for 
control (untreated) samples. IFSS was improved gradually with increasing 
concentration of APS and a 3 fold improvement was calculated with 0.1M APS 
treatment. However, no further improvement was observed with increasing silane 
concentration. Similarly, increasing EA concentration had positive effect on IFSS 
which was calculated to be 13±1.2 MPa with 0.15±0.2 M EA solution treatment. 
However, most effective  in terms of IFSS enhancement was HDI which improved 
the IFSS by 4 fold; highest IFSS value 22±2.1 MPa was calculated from glass 
samples treated  with 0.2M HDI in DMF. Other surface treatments such as PPA GP, 
SPLA, and Na±PLA also improved IFFS to 10±1.5 MPa. A modest worsening effect 
of APA with increasing molar concentration was observed on IFSS. 
4.3.4 Surface Modified Glass Degradation  
 
Figure 4-8: Effect of surface treatments on glass degradation profile in PBS at 37°C. 
Error bars represent standard error of mean where n = 3. 
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The results of the mPBG (treated with optimised concentration) degradation study 
are presented in Figure 4-8. The results reveal a decrease in degradation rate of PBG 
samples treated with HDI, APS, Na±PLA, EA and PPA compared to the control 
(annealed and chemically untreated). However, GP and SPLA modified glasses did 
not show a significant difference compared to control.  
4.3.5 Surface Wettability Measurement 
Surface wettability of the glass samples was seen to change significantly after 
modification with optimised concentration of surface treatments. Alterations in the 
contact angle are summarised in Figure 4-9. A high contact angle for APS (~75°) 
and HDI (~65°) treated samples compared to control (~50°) represent a more 
hydrophobic surface while GP and PLA oligomers treated surfaces were found to be 
more hydrophilic as the contact angle was found to be significantly lower than the 
control specimen. 
 
Figure 4-9: Wettability of mPBGs as measured by distilled water contact angle, error 
bars represent standard deviation where n=3. * indicating at significant difference. 
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4.4 Discussion 
In the literature number of surface treatments have been investigated for their 
potential to improve non±degradable [197] and degradable [25-27, 159] composites 
reinforced with particles [169] or fibres [25-27, 159, 197, 198] for a variety of 
applications. In this study, eight different chemicals were investigated as potential 
surface treatments for degradable phosphate glass fibre reinforced composites. It was 
hypothesised that by varying the concentrations of the agents investigated, an 
improved bonding between the glass fibres to matrix could be achieved. Evidence of 
reaction between the agents and PBG were also investigated.  
Phosphate glass (45P2O5 16CaO 24MgO 11Na2O 4Fe2O3 in molar %) was selected 
on the basis of results reported in chapter 3.  
Silanes are well known to self±assemble into mono±molecular and multi±molecular 
layers on surfaces such as glass or silicon dioxide [164, 165, 197]. One end of the 
silane molecule typically has di or tri methoxy or ethoxy functionality whilst the 
other end in case of APS has amine functionality. The ethoxy functionality is 
believed to condense with the hydroxyl functionality on the surface of the glass 
whilst the amine functionality can react with the polymer [164, 165]. It is also 
reported that silane s have a hydrolysable group (ethoxy), which is an intermediate in 
the formation of silanol (Si±OH) groups, for chemical bonding to the surface of the 
filler and the other end has an organic±functional group that entangles with polymer 
molecular chains by reactive group [164]. Both IR and XPS examinations confirmed 
the covalent reaction between PBG and APS (Figure 4-4, 4-5); the absorbance band 
at 1190 cm±1 was assigned to P±O±Si due to condensation of silane onto PBG 
indicating covalent bonding in agreement with previous reports, other absorbance 
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bands also correlated well with the results presented by Kurth and Bein [210] which 
showed that APS had reacted with the PBG according to the scheme presented in 
Figure 4-10. For APS mPBG O (1s) and Si (2p) high resolution XPS spectra were 
deconvoluted to fit two peaks in each (Figure 4-5). Peaks at 532.7 eV and 102.2 eV 
can be assigned to O (1s) and Si (2p) peaks of P±O±Si±R respectively, which 
indicated a P±O±Si covalent bond formation at the PBG surface. These results 
correlated with the results presented by Yang et al. in their investigative XPS study 
of octadecyltrichlorosilane grafted hydroxyapatite [211]. 
Etidronate is a bisphosphonate; a family of drugs used for osteoporosis treatment 
that binds with hydroxyapatite in the bone and inhibits bone resorption. While 
bisphosphonates are analogues of pyrophosphate structurally, they are characterised 
by a P±C±P bond; the linking oxygen is replaced with a carbon, which is resistant to 
enzymatic and chemical hydrolysis. It is known that bisphosphonates bind strongly 
to hydroxyapatite crystals at the sites of increased bone turnover preferentially and 
inhibit the formation, aggregation, and dissolution of the crystals [212]. They may 
also inhibit osteoclast function directly, promote osteoclast apoptosis and interfere 
with osteoblast±mediated osteoclast activation [175]. A study by Panzavolta et al. 
revealed the effectiveness of another bisphosphonate (alendronate) in calcium 
phosphate (CaP) bone cement and showed that this bisphosphonate provoked a 
modest reduction of the mechanical properties [199]. From IR analysis of EA mPBG 
(Figure 4-4), two new peaks at 702 cm±1 and 1260 cm±1 were identified and assigned 
to P±O±P and P=O which indicated the presence of the bisphosphonate layer on the 
surface of EA mPBG. Deconvoluting XPS O (1s) peak from EA mPBG (Figure 4-5) 
revealed three peaks that were assigned to: P=O from EA (530.8), bridging oxygen 
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P±O±P (532.5) and P±O±P=O (533.5) bond of bisphosphonate with PBG according 
to the reaction scheme (Figure 4-10). 
The isocyanate group has also been reported to bind to hydroxyapatite [178]. The 
studies showed that isocyanate could react with hydroxyl groups of hydroxyapatite 
and form a covalent bond between isocyanate and hydroxyapatite. The IR spectrum 
of HDI±mPBG (Figure 4-4) showed several new peaks of low intensity. However, 
no absorption band was found that could be assigned to the isocyanate group 
(O=C=N±R). Therefore, it can be deduced that all the isocyanate groups either 
involved in grafting with the ±OH groups present on phosphate glass surface or 
converted into amine group after reaction with water. It was assumed that HDI 
grafted to the surface of PBG as follows: PBG±O±CO±NH±(CH2)6±N=C=O. It can 
be suggested here that only one isocyanate group of HDI took part in grafting to the 
phosphate glass as the length of HDI molecule prevents the other end to roll back 
onto the same surface again, the same mechanism was proposed elsewhere [178]. 
Although the peak for P±O±C was lost in the area assigned to PBG peaks, evidence 
of this linkage can be seen from the IR spectra of HDI mPBG with C±N, C±O bands 
and NH2 deformation.  High resolution XPS O (1s) and N (1s) spectrum (Figure 4-5) 
confirmed the presence of a P±O±C (532.9 eV) bond and a urethane linkage [178] 
between PBG and HDI which was converted into a primary amine group after 
treatment with water. These results correlated well with the study carried out on HDI 
modified HA [178]. A scheme of HDI grafting onto the surface of PBG is presented 
in Figure 4-10. 
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Figure 4-10: Chemical reaction schemes devised on the bases of inorganic chemistry 
principles and surface analyses (FTIR/XPS) data. 
PLA oligomers with potentially reactive end functionalities like COOH, Na and 
sorbitol have been developed and investigated as potential s for PGF reinforced PLA 
composites [25, 26]. In a study by Haque et al. it was hypothesised that either the 
end functional group should react with the glass through esterification or the 
hydroxyl groups present within the end functional group would create hydrogen 
bonds with hydroxyl groups present on the glass surface. The prior study reported 
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that increasing the number of ±OH groups on the end functionality improved the 
IFSS properties [25, 26, 167]. However, results acquired in current study did not find 
an ester bond between PBG and PLA oligomers which in turn suggested that PLA 
oligomers reacted with PBG via hydrogen bonds.  
Careful analysis of IR and XPS results concluded that APS, EA, HDI reacted with 
the glass covalently. However, there was no evidence of covalent bonding found for 
the other agents investigated. Therefore, it is proposed that these agents formed 
hydrogen bonds or covalent P±O±P bonds, which were difficult to detect due to their 
similarity with the structure of PBG. However, after modification with all surface 
treatments the Na (1s) peak in the XPS spectra was lost which indicated the presence 
of a layer on the surface of the glass. 
Surface wettability tests (Figure 4-9) showed that the APS and HDI coatings were 
more hydrophobic in comparison to the control PBG, which as stated could 
potentially delay the hydration of the interface. The shift in wettability also provided 
further evidence that the PPA, GP and PLA oligomers had successfully been applied 
to the surface of the PBG.    
As hypothesised and observed from surface energy and degradation profiles, the 
hydrophobicity induced by HDI and to some extent APS treatment reduced the 
degradation rate of PBG (Figure 4-8), which could inhibit the interface breakdown 
due to hydrolysis. 
Considering the rigidity of glass rod, self±alignment of test setup and relatively low 
IFSS values, a mode II (in±plane shear) adhesive fracture was assumed for glass 
push out test. The difference between shear strength of PLA used in this study 
(~60 MPa) [126, 127] and maximum IFSS value found for specimen (~22 MPa) also 
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explains fracture of interface in mode II. It was expected that the maximum shear 
stress concentration will always locate in the glass rod near the glass/polymer 
interface on the upper portion of the test specimen. No effect of concentration on 
fracture behaviour was observed for any investigated treatment.  
Improved interfacial shear strength due to surface treatments (Figure 4-7) can be 
explained via chemical bonding theory. It is suggested that covalent bonds between 
the glass fibre and polymer matrix increase the shear bond strength markedly [6, 25, 
169] as seen in the case of HDI, APS and EA modified PBG samples in this study. It 
has also been reported that an increase in the number of hydrogen binding sites on 
the surface of mPBG the greater the increment in IFSS [26], which was suggested as 
the most likely cause for improvements seen in PPA, SPLA, and GP modified PBG 
samples. However, improvement in IFSS due to hydrogen bonding is comparatively 
small and potentially prone to hydrolysis.  
IFSS values were also used to optimise the concentrations of the surface treatments 
and it was found that by varying concentrations, a higher effect of coupling could be 
achieved (Figure 4-7). For example; 0.043 M APS was applied to PGFs by Onal et al. 
[198] with no effect on IFSS, similar results were reported by Haque et al. [25]. 
However, the results here showed a threefold improvement in IFSS for 0.2 M APS 
treatment. Similarly improved results were obtained by using 0.2 M HDI as 
compared to 0.25 M used by Dong et al. [178] thereby; reducing the chances of dose 
dependent cytotoxicity of HDI as reported by Gong et al. [213]. Due to their high 
solution viscosity, the maximum concentration of the PLA±oligomer solutions was 
0.05 M. A plateau or decrease in shear bond strength was seen from the results 
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which could be attributed to complete surface coverage and a polymerised layer of 
coupling agent on the glass surface respectively.  
The results showed that by applying optimal concentrations of potential surface 
treatments, IFSS between PBG and PLA can be improved significantly, which 
should improve the overall mechanical properties of composite fabricated from the 
same materials and may also help to retain the strength for a longer time period by 
retarding the interface plasticisation.  
4.5 Conclusions 
Evidence of covalent bonding between chemical used for surface modification and 
glass was found for three of the chemicals investigated: namely 3±
aminopropyltriethoxy silane; etidronic acid and hexamethylene diisocyanate. These 
three agents also improved the interfacial shear strength and increased the 
hydrophobicity of the glass surface. It was found that by using optimal amount of 
appropriate surface treatment the interfacial shear strength between PBG and PLA 
matrix can be improved significantly, which could help in fibre/matrix load transfer 
and thus improve the overall mechanical properties of the composite. It can be 
concluded that by treating PBG with HDI, APS, and EA all three target parameters; 
IFSS, wettability and degradation rate can be improved.  
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CHAPTER 5. CYTOCOMPATIBILITY 
ASSESSMENT FOR 
SURFACE-TREATED 
GLASSES 
5.1 Introduction 
For a material that aims to be used in medical applications a comprehensive 
biocompatibility assessment is required. In terms of biocompatibility, the degradable 
implant material must have to fulfil even more demanding requirements as they have 
to go through cytotoxicity assessment as well as routine cytocompatibility tests for 
bulk material as well as degradation products. International society of standards (ISO) 
has devised a set of standards for evaluating the biocompatibility of a medical device 
prior to a clinical study under ISO 10993 series. This set of standards provides a 
methodology for choosing the proper biological evaluation test programme 
depending on the device category: surface, external communicating and implant, and 
the exposure period of the material: limited (<24 hours), prolonged (24 hours to 30 
days) and permanent (>30 days) [214].  
Chemical agents used in this project were selected on the basis of potential or 
reported cytocompatibility. For example, phosphonic acid based chemicals have 
been employed as s by Phillips et al. [169], Greish and Brown [170, 171] and 
Tanaka et al. [172] where all the studies reported no cytotoxicity from the 
phosphonic acids used. Similarly, Sánchez±Vaquero et al. [215] and Jung et al. 
reported favourable cell interaction with silane containing biomaterials. However, 
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conflicting report of cytotoxicity or cytocompatibility have been reported for 
hexamethylene diisocyanate (HDI) [178-180, 216]. 
To ascertain cytocompatibility of surface treatments used in this project a three step 
assessment programme was adopted; evaluation of cytotoxicity due to degradation 
products [217]; short term direct contact test using MG63 osteosarcoma osteoblast±
like cell line; long term direct contact study of primary human osteoblast (HOBs) 
cells interaction with short listed modified phosphate based glass (mPBG).  
Cytotoxicity testing is rapid, standardised, sensitive, and inexpensive that represents 
initial phase in testing biocompatibility. It is a means to determine if a test material 
contains significant quantities of biologically harmful degradation products. Short 
term direct contact of MG63 osteosarcoma cells with chemically modified glass 
surfaces was used as a screening step. Finally, HOBs were employed to assess cell±
material interaction including attachment, proliferation and differentiation by using 
cell metabolic activity, early and late differentiation marker assays for osteoblast 
FHOOV 3ULPDU\ +2%V¶ PRUSKRORJ\ ZDV DOVR DVVHVVHG DW HDFK WLPH SRLQW XVLQJ
scanning electron microscope (SEM). 
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5.2 Materials and Methods 
5.2.1 Glass Synthesis 
Phosphate glass (45P2O5 16CaO 24MgO 11Na2O 4Fe2O3 in molar %) was prepared 
following the protocol reported in chapter 3, Section 3.2.1. The glass rod (9 mm 
diameter) obtained from the mould was cut into 4 or 2 mm thick glass discs for 
different tests. 
5.2.2 Chemical Modification for Glass Surface  
Glass discs were treated with optimised concentrations of surface treatment agents 
from the conclusions made in chapter 4 following the protocol reported in chapter 4, 
Section 4.2.2. The fibre to solution ratio was kept constant at 1.5g: 100ml. 
5.2.3 Cytotoxicity Assessment 
Cytotoxicity assessment of elution products was performed according to the ISO 
standard for biological evaluation of medical devices (ISO 10993±5 2009) with only 
one discrepancy of cell±type, MG63 cells line was used instead of recommended 
HOS cells. Cytotoxicity of mPBG samples (9 mm diameter, 4 mm thick) was 
assessed by NRU following the protocol reported in chapter 3 section 3.2.4.5. The 
mPBG samples were eluted in treatment media (DMEM + 10% HEPES for three 
days with a 1mg/ml weight to volume ratio.  
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5.2.4 Short±Term Direct Contact Test 
5.2.4.1 Cell Culture 
MG63 cells (human osteosarcoma), obtained from European collection of cell 
cultures (ECACC), were cultured and sub-cultured LQFRPSOHWH'XOEHFFR¶VPRGLILHG
eagle media (CDMEM) as reported in Chapter 3, Section 3.2.4.1.  
Modified phosphate glass discs were sterilised using dry heat at 190 °C for 30 
minutes and washed three times with sterilised PBS prior to cell culture. Tissue 
culture polystyrene (TCP) was used as a positive control for cell growth. Cells were 
seeded onto the disc sample surfaces at a concentration of 40,000 cells/cm2 and were 
incubated at 37 °C in a humidified atmosphere with 5% CO2 for 2, 48, 96 and 168 
hours. 
5.2.4.2 Alamar Blue 
At the designated time points, culture medium was removed from the wells and the 
samples were washed three times with warm PBS. Protocol for alamar blue assay 
(Chapter 3, Section 3.2.4.2) was followed and fluorescence was measured at 530 nm 
excitation and 590 nm emission using FLx800 microplate reader (BioTek 
Instruments Inc). 
5.2.4.3 Alkaline Phosphatase Activity 
Alkaline phosphatase (ALP) activity was measured using the Granutest 25 alkaline 
phosphatase assay (Randox, UK). Cell lysate in sterilised deionised water was 
prepared using a 3±cycled freeze/thaw technique. The protocol for ALP assay 
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(Chapter 3, Section 3.2.4.3) was followed and the absorbance was measured at 
wavelengths of 405 and 620 nm using ELx800 microplate colorimeter (BioTek 
Instruments Inc). 
5.2.4.4 DNA Quantification 
Samples were washed and cells lysed using a freeze/thaw technique as described for 
the alkaline phosphatase method above. DNA concentration was quantified by 
following DNA quantification assay reported in Chapter 3, Section 3.2.4.4. 
Fluorescence was measured at 360 nm excitation and 460 nm emission using 
FLx800 microplate fluorimeter (BioTek Instruments Inc).  
5.2.5 Primary Hobs in Direct Contact 
5.2.5.1 Cell Culture 
Primary human osteoblast (HOB) obtained from European collection of cell cultures 
(ECACC) and cultured in osteoblast growth medium (417±500) (Cell Applications, 
Inc.) following the same subculture protocol mentioned for MG63 cell line. 
Cells were seeded onto the disc sample surfaces at a concentration 40,000 cells/cm2 
and incubated at 37 °C in a humidified atmosphere with 5% CO2 up to 28 days. 
At the designated time points (7, 14, 21 and 28 days) cell culture media was removed 
and the samples were washed three times with warm PBS prior to the addition of 
1ml deionised water to each well. Cells were lysed using a freeze/thaw technique. 
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5.2.5.2 Proliferation 
Osteoblast proliferation was assessed by quantifying DNA at each time point 
following standard DNA quantification assay protocol (Chapter 3, Section 3.2.4.4). 
5.2.5.3 Differentiation 
To cover different stages of differentiation three osteoblast specific assays were 
selected; alkaline phosphatase activity; collagen quantification; osteocalcin 
production (late osteoblast specific differentiation marker). 
5.2.5.3.1 Alkaline Phosphatase Activity 
Alkaline phosphatase activity was measured using the Granutest 25 alkaline 
phosphatase assay (Randox, UK) using the protocol described in Chapter 3, Section 
3.2.4.3. 
5.2.5.3.2 Collagen Quantification 
Osteoblasts produce a matrix of osteoid, which is composed mainly of Type I 
collagen. Collagen quantification was carried out by using the soluble collagen assay 
(Sircol, UK). 7KH6LUFROFROODJHQDVVD\Ls a dye±binding method for the analysis 
of acid and pepsin±soluble collagens. The assay works by utilising the Sirius red dye, 
which is also known by the name Direct Red 80. Sirius red is an anionic dye with 
sulphonic side chains, it is these groups that react with the side chain groups of the 
basic amino acids present in collagen. The specific affinity of the dye for collagen, 
under assay conditions, is due to the elongated dye molecules aligning parallel with 
the long rigid structure of native collagens that have intact triple helix organisation 
[218].  
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The assay was performed as described in the instructions enclosed with the assay. 
Absorbance was measured against distilled water for the reagent blanks, standards 
and test samples. Collagen concentrations were calculated from the standard curve.   
5.2.5.3.3 Osteocalcin Quantification 
Osteocalcin, also known as bone Gla protein (B.G.P.) is the major non±collagenous 
protein of the bone matrix. It is a vitamin K dependant Ca2+ binding protein, which is 
produced exclusively by osteoblasts and odontoblasts [219]. It contains three 
carboxylated glutamic acid residues which bond strongly to hydroxyapatite [220]. 
Osteocalcin quantification was performed using a commercially available kit 
(KAQ1381 (96 tests) Invitrogen, UK). The lysate was collected and tested for the 
presence of osteocalcin following the kit instructions. 
The Invitrogen human osteocalcin assay is a solid phase enzyme amplified 
sensitivity immune assay (EASIA). The assay uses monoclonal antibodies (Mabs) 
directed against distinct epitopes of human osteocalcin. Standards and samples react 
with the capture monoclonal antibody (Mab 1) coated on the microtiter well and with 
a monoclonal antibody (Mab 2) labelled with horseradish peroxidase (HRP). After 
incubation period (2 hours), allowing the formation of a sandwich: coated Mab 1±
human osteocalcin±Mab 2±HRP, the microtiter plate was washed to remove 
unbound enzyme labelled antibody. Bound enzyme labelled antibody was measured 
through a chromogenic reaction. Chromogenic solution (TMB ready for use) was 
added and incubated. The reaction was stopped with the addition of stop solution and 
the microtiter plate was then read at the appropriate wavelength. The amount of 
substrate turnover was determined colorimetrically by measuring the absorbance 
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which is proportional to the human osteocalcin concentration. A standard curve was 
plotted and human osteocalcin concentration in a sample was determined by 
interpolation from the standard curve [221].  
5.2.5.4 Morphology Assessment 
Samples were washed with warm PBS at 37 °C and fixed in 3% glutaraldehyde in 
0.1 M cacodylate buffer for 30 minutes, after 30 minutes fixative was replaced by a 7% 
sucrose solution. Fixed samples were then washed twice in 0.1 M cacodylate buffer, 
and post fixed in 1% osmium tetroxide in phosphate buffer saline for 45 minutes in a 
fume cupboard. Samples were dehydrated through a graded ethanol series (20, 30, 40, 
50, 60, 70, 80, 90, 96 and 100% in water) for approximately 5 minutes each. 
Samples were then dried via hexamethyldisilazine (HMDS) before being sputter 
coated in gold and viewed with a Philips XL30 scanning electron microscope 
operated at 10 kV. 
5.2.6 Statistical Analyses 
Average values and standard deviation were computed for two iterations of the 
experiments. Statistical analysis was performed using the Prism software package 
(version 3.02, GraphPad Software, San Diego California USA, www.graphpad.com). 
Two±way analysis of variance (ANOVA) was calculated with the bonferroni post±
test to compare the significance of change in one factor with time. The error bars 
presented represent standard error of mean with n = 6. 
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5.3 Results 
5.3.1 Elution Study 
Cytotoxicity of elution products from chemically modified phosphate glass samples 
surfaces was assessed by neutral red uptake (NRU), a cell viability marker, and 
presented in parallel with untreated PBG control sample results Figure 5-1. 
Samples were degraded in a serum free treatment media and diluted to a range of 
concentrations (10±100%) in fresh DMEM to find out the most toxic concentration 
for the cells. In accordance with the definition of cytotoxicity in ISO standard (BSI±
ISO 10993±5 2009) no cytotoxicity was observed since the cell viability remained 
over 70% of non±toxic control (no elution products) for all samples and at any 
concentration. However, Na±PLA, SPLA and HDI treated samples showed lower 
cell viability at higher concentration. For all the other samples no significant 
difference was observed between samples and controls and over the range of 
concentrations. No significant difference (P < 0.05) was found when data was 
analysed for different sample treatments for neat aliquots.  
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Figure 5-1: Cell viability of MG63 osteosarcoma, as measured by the neutral red 
uptake assay, cultured in culture medium with the extracts from modified phosphate 
glasses, x±axis represents concentration of extracts containing media in basal media 
and a summary of neat (100% extract containing media) aliquots from all  treated 
glasses (x±axis represent treatments). Error bar represents standard error of mean, n = 
6. * indicating significantly low NRU for Na-PLA and HDI treated phosphate glass. 
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5.3.2 Short Term Direct Contact Test 
5.3.2.1 Metabolic Activity 
The Alamar blue assay was used to determine the effect of surface modifications of 
PBG on metabolic activity of osteoblast±like cells cultured on phosphate glass 
modified with selected surface treatments up to seven days, Figure 5-2.  
 
Figure 5-2: Metabolic activity of MG63 osteosarcoma, as measured by the alamar blue 
assay, cultured on modified phosphate glasses, x±axis represents surface treatments. 
Error bar represents standard error of mean, n = 6. * indicating significant difference 
of treated samples compared to control (PBG). 
 Metabolic activity was found increasing over seven day culture period, with an 
extremely significant difference between 2 and 168 hours for all surfaces. However, 
there was no significant difference in metabolic activity found for different modified 
glass samples at 2hours time point (P > 0.05) and control PBG. However, internal 
control (TCP) demonstrated an elevated metabolic activity compared to other sample 
at later time points (96 and 168 hours) which was statistically significant (P < 0.001). 
APS modified glasses also demonstrated significantly higher (P < 0.001) metabolic 
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activity compared to control PBG.  The value for metabolic activity after seven days 
was the greatest on TCP followed by APS and untreated PBG respectively. Repeats 
of this experiment have also demonstrated repeatable results. 
5.3.2.2 DNA Quantification 
The DNA content of cells cultured on samples was used as an indicator of cell 
population. DNA (Hoechst 33258) assay was used to quantify the changing 
concentration of DNA with time for MG63 osteosarcoma cells cultured on modified 
phosphate glasses, Figure 5-3. Untreated PBG was used as a positive control. 
 
Figure 5-3 Cell proliferation of MG63 osteosarcoma, as measured by the DNA 
(Hoechst 33258) assay, cultured on modified phosphate glasses, x±axis represents 
surface treatments. Error bar represents standard error of mean, n = 6. There was no 
significant found for treated samples versus control (PBG) at any time point. 
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168 hours. There was no statistically significant difference (P > 0.05) found between 
the final DNA concentrations. 
5.3.2.3 Differentiation 
Effect of surface modification on cell differentiation was analysed by measuring 
alkaline phosphatase activity of osteosarcoma cultured on surface-modified 
phosphate glasses, Figure 5-4. Data was normalised with the corresponding DNA 
concentration at each time point. 
 
Figure 5-4: Alkaline phosphatase (ALP) activity of MG63 osteosarcoma cells, as 
measured by ALP assay, cultured on modified phosphate glasses, x±axis represents 
surface treatments. Data was normalised with corresponding DNA concentration for 
each individual sample. * indicating significant difference of treated samples compared 
to control (PBG). 
For all surfaces, including the internal control (TCP), the alkaline phosphatase 
activity was not detectable after 2, 48 or 96 h. However, after 168 hours of culture, 
detectable amount of ALP activity was observed on all the surfaces with notably 
high values on EA and SPLA mPBGs and low value for Na±PLA mPBG sample. 
ALP activity of cells cultured on SPLA mPBG was significantly higher (P < 0.05) 
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than other samples excluding EA mPBG. However, there was no significant 
difference (P > 0.05) found between other samples and control PBG. 
5.3.3 Primary HOB in Direct Contact 
5.3.3.1 Proliferation 
Effect of chemical modification of phosphate glass surfaces on the proliferation of 
primary human osteoblasts, was measured via DNA content of the cells cultured on 
mPBG surfaces over a culture period of 28 days, Figure 5-5. 
 
Figure 5-5: Proliferation of primary human osteoblasts, as measured by the DNA 
(Hoechst 33258) assay, cultured on modified phosphate glasses, x±axis represents 
surface treatments. Error bar represents standard error of mean, n = 6. There were no 
significant found for treated samples versus control (PBG) at any time point. 
For all samples, including controls (TCP and PBG), the DNA concentrations 
measured were at DSSUR[LPDWHO\  ȝJ PO±1 after 7 days in culture. A gradual 
increase in DNA concentration was observed from day 7 to 21. However, no 
significant change was observed as DNA concentration levelled out and stayed at 
a ȝJ PO±1 after 21 days on all the surfaces. The trend was consistent for all 
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samples and controls. Although, DNA concentration was found comparatively 
higher on HDI mPBG, statistical analysis revealed no significance (P > 0.05) for the 
difference. 
5.3.3.2 Differentiation 
5.3.3.2.1 Alkaline Phosphatase Activity 
Alkaline phosphatase activity of primary human osteoblast was used as early marker 
of osteoblastic differentiation. The effect of chemical modification of PBG on ALP 
activity of primary osteoblast cultured on glass surfaces for up to 28 days is 
presented in Figure 5-6.  
 
Figure 5-6: Alkaline phosphatase (ALP) activity of primary human osteoblasts, as 
measured by ALP assay, cultured on modified phosphate glasses, x±axis represents 
surface treatments. Data was modified with DNA values obtained for each individual 
sample. Error bar represents standard error of mean, n = 6. * indicating significant 
difference of treated samples compared to control (PBG). 
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For all mPBG surfaces and controls (PBG and TCP), an increase and then a drop in 
ALP activity was seen as general trend. However, SPLA mPBG surfaces 
demonstrated an initial increase in ALP activity which remains constant for last three 
time points. APS mPBG samples demonstrated the highest ALP activity which was 
statistically greater than control PBG (p < 0.001). 
5.3.3.2.2 Collagen Production 
Collagen production by primary human osteoblast cultured on selected 
surface-modified phosphate glass surfaces for up to 28 days was assessed and 
quantified by Sircol collagen quantification assay, Figure 5-7. 
 
Figure 5-7: Amount of collagen produced by primary human osteoblasts, as measured 
by Sircol assay, cultured on modified phosphate glasses. Data was modified with DNA 
values obtained for each individual sample. Error bar represents standard error of 
mean, n = 6. There were no significant found for treated samples versus control (PBG) 
at any time point. 
All samples, including the control PBG, showed no increase in collagen 
concentration with time. Collagen concentration was found highest on APS and GP 
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mPBG surface however, concentrations were similar for the remaining surfaces. 
Statistical analysis revealed no significant difference (p > 0.05) between highest 
values found for each surface-modified sample and control PBG. Notably, a 
signature down regulation of collagen production was observed for TCP. 
5.3.3.2.3 Osteocalcin Quantification 
Osteocalcin was detected in primary human osteoblast cultured on selected modified 
phosphate glass surfaces for up to 28 days was assessed and quantified by ELISA 
osteocalcin quantification assay kit, Figure 5-8.  
 
Figure 5-8: Quantity of osteocalcin produced by of primary human osteoblasts, as 
measured by ELISA assay, cultured on modified phosphate glasses, x±axis represents 
surface treatments. All data is modified with DNA values obtained for each individual 
sample. Error bar represents standard error of mean, n = 6. * indicating significant 
difference of treated samples compared to control (PBG). 
Levels of osteocalcin were found not significantly different (P > 0.05) on all sample 
surfaces and between each time point. A repeat of this experiment provided with the 
same trend in results implies the response was consistent. However, when 
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osteocalcin concentration was normalised with DNA, a downward trend was 
observed for all samples including controls. Two±way ANOVA revealed significant 
difference (P < 0.001) between control PBG and mPBGs samples at initial time 
points (7 and 14 days).  
5.3.3.3 Morphology (SEM) 
Morphology of cells cultured on phosphate glass discs was visualized by SEM 
(Figure 5-9 to 5-15). Within each figure a representative image of osteoblasts 
cultured for 7, 14, 21 and 28 days on phosphate glass specimens is presented. In 
general SEM images of human osteoblasts cultured on all glass surfaces showed a 
confluent layer after 7 days of culture with some large osteoblast cell-cluster with 
lamellipodia extended to neighbouring cell resulted in the formation of a denser cell 
layer at the later time points. However, no mature stared shaped structure was 
spotted at any time point on TCP control where the cells were densely packed 
showing spindle±shaped cells arranged like a shoal of a fish. After 21days much 
denser layer/s can be observed with mature osteoblast depositing minerals onto the 
sample surfaces. Collagen fibrils can also be located after 21 days of culture. 
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Figure 5-9: SEM images of human osteoblast cultured on phosphate based glass 
(control) up to 28 days. Arrows indicating at cluster of cells, cell matrix and 
mineralisation.  
 
Figure 5-10: SEM images of human osteoblast cultured on APS modified PBG up to 28 
days. Arrows indicating at cluster of cells, cell matrix and mineralisation. 
A1) PG control 7 Days A2) PG control 14 Days
A4) PG control 28 DaysA3) PG control 21 Days
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B4) APS 28 DaysB3) APS 21 Days
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Figure 5-11: SEM images of human osteoblast cultured on GP modified PBG up to 28 
days. Arrows indicating at cluster of cells, cell matrix and mineralisation. 
 
 
Figure 5-12: SEM images of human osteoblast cultured on EA modified PBG up to 28 
days. Arrows indicating at cluster of cells, cell matrix and mineralisation. 
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Figure 5-13: SEM images of human osteoblast cultured on SPLA modified PBG up to 
28 days. Arrows indicating at cluster of cells, cell matrix and mineralisation. 
 
 
Figure 5-14: SEM images of human osteoblast cultured on HDI modified PBG up to 28 
days. Arrows indicating at cluster of cells, cell matrix and mineralisation. 
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Figure 5-15: SEM images of human osteoblast cultured on tissue culture polystyrene 
up to 28 days. Arrows indicating at cell matrix and mineralisation. 
G2) TCP control 14 DaysG1) TCP control 7 Days
G4) TCP control 28 DaysG3) TCP control 21 Days
Mineralised cell 
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5.4 Discussion 
To ascertain the cytocompatibility of the chemical agents used in this project, as an 
attempt to improve interface adhesion between polymer matrix and reinforcing glass, 
a three step screening approach was adopted which included an indirect or elution 
study, short term direct contact cell viability, metabolic activity and ALP activity 
assessment using MG63 osteosarcoma cell line and finally long term primary human 
osteoblasts culture in direct contact with mPBG to evaluate cell proliferation, 
differentiation and morphological assessments. 
To assess potential toxicity of the chemicals leaching out from the mPBG surfaces, 
combined degradation extracts from PBG as well as coupling agent layer were tested 
for cytotoxicity through neutral red uptake (NRU) (see Figure 5-1). Greater NRU 
was observed for GP and EA mPBG surface compared to the PBG control; 
suggesting that the degradation products (mainly calcium and phosphates) may be 
supportive in cell metabolic activity leading to greater cell number and hence a high 
158 7KLV UHODWLYHO\ KLJKHU FHOO PHWDEROLF DFWLYLW\ ZDV DQWLFLSDWHG DV ȕ-glycerol 
phosphate is often used as a carbon source, essential for the expression of osteoblast 
SKHQRW\SH H[SUHVVLRQ $ K\GURO\VLV SURGXFW RI ȕ-glycerol phosphate (phosphates) 
are reported as positive effecter for induction of gene expression [222]. 
Bisphosphonate etidronic acid is also reported to be beneficial for osteoblast growth, 
however, higher dosages of etidronic acid  are known to impair normal skeletal 
mineralisation [223]. 
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A significantly lower NRU was observed for the oligomer treated samples which 
was suggested to be due to acidic degradation products from the PLA oligomers, as 
their molecular weight was very low (20000 Da) and therefore prone to rapid 
hydrolysis. Ignatius and Claes reported that high concentrations of degradation 
products from PLA had a toxic  influence on  the cell  culture  systems they studied 
using MTT and BrdU cytotoxicity assays [63]. Another study revealed that increased 
inflammation was observed when the molecular  weight  of  PLA/PGA copolymers  
decreased  to  between 10000 ± 20000 Da [224]. Significantly (P > 0.01) lower NRU 
was also observed for HDI treated surfaces. Dong et al. stated that during the process 
of polyurethane synthesis some of the toxic hexamethylene diamine (HDA) could be 
released [178]. Based on information on the chemical structure of HDI grafted HA 
(gHA), Dong et al. reported three possible mechanisms for  release of HDA 
derivatives; i) hydrolysis of the urea linkage in the extended chain; ii) hydrolysis of 
urethane linkage between HA and HDI and iii) ionisation of gHA. The results from 
this study are in agreement with Dong et al.[216] as the cytotoxicity was found to be 
dependent on the content ratios of treatment media in culture medium. 
Due to the lack of evidence for cytotoxicity from any of the coupling agents 
investigated, all mPBGs were included in the next stage of cytocompatibility 
assessment, which included use of osteoblast-like MG63 cells cultured in direct 
contact with the mPBG surfaces and assessed for cell viability, proliferation and 
differentiation. 
All samples including positive controls (PBG and TCP) revealed similar results for 
cell viability as measured via alamar blue assay, with no significant differences 
observed between samples and/or controls at each time point (see Figure 5-2). 
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However, for all surfaces investigated a linear increase in fluorescence values was 
seen from 2 hours to 7 days, which demonstrated that cells were metabolically active 
and there were no adverse effects from the surface chemistry on cell metabolic 
activity.  
Alkaline phosphatase is an early marker of osteoblastic maturation. ALP was 
expectedly detected after 7 days of MG63 culture for all the samples (Figure 5-4). 
Significantly higher (P < 0.05) ALP activity was observed on EA and SPLA mPBG 
surfaces. EA as mentioned above helps osteoblastic metabolic activity and sorbitol 
which is a hydrogenated carbohydrate is reported to regulate osteoblast 
differentiation [225] which could be the reason of the relatively higher ALP activity 
shown by these two samples.  
After second stage biocompatibility assessment, Na±PLA and PPA were excluded 
from the study mainly based on their fast degradation (not suitable for long term 
study) and relatively low cytocompatibility of Na±PLA. However, as HDI showed to 
be the most effective surface treatment in terms of improving interfacial shear 
strength, it was also included in this long term cytocompatibility study. 
Proliferation of primary human osteoblasts in terms of DNA concentration, on glass 
surfaces after each time point up to 28 days, was practically equal to the controls 
(Figure 5-5). After seven days of culture a confluent layer can be seen from the SEM 
images of all sample and control surfaces. After seven days the growth rate, as 
expected, was slower. However, an increase in DNA content implies that; once a 
confluent layer is formed on the surface, proliferation is less dependent on the glass 
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surface as further cell growth was seen to occur on top of the present cell layer, 
forming multi layers as observed by SEM images (Figure 5-9 to 5-15). 
Osteoblasts, when cultured on tissue culture polystyrene (TCP), are expected to be in 
proliferation phase up to 10 days in culture followed by matrix maturation, 
mineralisation and finally apoptosis [226-228]. However, the model presented by 
Owen et al. and Stein et al. used rat osteoblast with a cell seeding density of 
5×105 cells/cm2 and due to this high density a confluent  layer after 7 days was 
reported. Although different cells, media and cell density was used in current 
experimental, it was found that a confluent layer of cells after 7 days in culture 
which is in agreement with the model presented by Stein et al. [228]. 
Alkaline phosphatase activity by osteoblasts in±vitro was expected to be up 
regulated as proliferation is retarded and down regulated when osteoblasts enter the 
mineralisation phase [227, 228]. The up and down regulation of ALP, over a 28 day 
period was observed on all surfaces except SPLA mPBG where an insignificant 
increase or a plateau was observed (Figure 5-6). 
Variation in ALP activity due to surface chemistry alteration is not unusual 
compared to cell cultured on TCP. For example, the alkaline phosphatase activity of 
craniofacial osteoblast cells (CFC) cultured on phosphate glasses over 28 days was 
studied by Gough et al. It was also reported that characteristic up and down 
regulation of alkaline phosphatase activity was not observed. However, highest ALP 
activity was observed at seven days which was down regulated with time in culture 
[111]. This is in contradiction to Dias et al [229] who reported a characteristic 
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regulation in ALP activity with human bone marrow cells on calcium phosphate 
glass ceramics, and correlates well with the results observed in current study. 
Glass chemistry also plays its role in cell metabolic activity. As reported by Burling 
and Ahmed et al, higher amount of magnesium release from the glass may be 
connected with the higher alkaline phosphatase activity seen by osteoblasts cultured 
on phosphate glasses containing Mg2+ [181, 184]. It was also reported that up to 3 
times ALP activity was observed from osteoblasts cultured on phosphate glasses 
compared to TCP control which was not observed in this study probably because 
phosphate glass used in this study was two to three order in magnitude more durable 
and Mg2+ content was relatively lower [181]. Dissolved calcium and phosphate are 
also reported to influence cell metabolic activity as reported by Ma et al., an 
enhanced osteoblast differentiation in the presence of additional Ca2+ concentration 
in the cell culture media and retardation of osteoblast differentiation and 
mineralization in the presence of additional inorganic phosphate concentration in the 
cell culture media [230]. 
For any material to be considered for orthopaedic use it is essential to support 
collagen formation as it is one of the most important markers of cell differentiation. 
Collagen formation was observed after 7 days of osteoblast cultured on all surfaces 
including TCP (Figure 5-7). However, no significant up and down regulation of 
collagen quantity was observed only TCP showed a down regulation collagen when 
normalised with DNA content. This trend is contradictory to the model presented by 
Stein et al where osteoblast±like cells were cultured on TCP [228]. Although the 
same trend of collagen quantity plateau was reported by Au et al [231] with MG63 
cells cultured on TCP control and Consil® bioactive glass particles and Bosetti et al. 
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[232, 233]  with rat osteoblast like cells cultured on bioactive glass powder surfaces. 
Bosetti et al. reported an up regulation from second to fourth day followed by down 
regulation and a plateau in collagen concentration when cells cultured on polystyrene 
wells. Au et al. also reported a constant collagen concentration when human 
osteoblast were culture on Consil® particles, the trend was consistent on TCP [231]. 
Another study, by Leonardi et al., also reported a significant increase from day 1 to 
day 7 followed by constant collagen concentrations at 7 and 14 days of human bone 
marrow cells cultured on a resorbable phosphate based glass ceramic. Although the 
values were ~ 20% higher, the trend was consistent on TCP control [234]. All of the 
above mentioned studies did not present normalised concentration of collagen with 
DNA. A 50 % increase in collagen concentration from 7 to 14 days followed by an 
almost constant concentration up to 28 days in culture was also reported by Burling; 
when craniofacial osteoblast cells were cultured on ternary phosphate based glasses 
and TCP control [184]. The non±normalised data, quoted above, correlates well with 
the results obtained for current study and a rough calculation reveals similar trend for 
normalised data as well. 
Osteocalcin, a major non±collagenous matrix protein, is a highly specific 
osteoblastic differentiation marker. Osteocalcin was found in detectable quantity on 
all the surfaces including positive controls, indicating that osteoblasts were fully 
differentiated to matrix maturation stage (Figure 5-8). Non normalised osteocalcin 
concentration was virtually the same for all samples and at each time point. However, 
when normalised with DNA concentration; the highest amount of osteocalcin was 
found after 7 days of cell culture which was the same on all surfaces including TCP. 
On all samples osteocalcin concentration was reduced after 7 days in culture and 
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finally lowest values were detected after 28 days, this trend was consistent for all the 
surfaces studied regardless of treatment. 
Osteocalcin, as reported by Owen et al.[226] and Stein et al.[228], is a late marker of 
osteoblastic differentiation which is detectable after full maturation of cells that is 
indeed after proliferation to confluence. However results presented in this chapter 
differ from the model presented by Owen et al.[226] and Stein et al.[228]. The 
difference observed here could be due to different surface chemistry, surface 
morphology and origin of cells. The models mentioned above used murine osteoblast 
cultured on TCP and in current study human osteoblast were cultured on 
degradeable/functionalised phosphate glass surface.   
Similar trend of low osteocalcin values at early stage of cell culture with 
insignificant increase or a plateau and then a drop in osteocalcin expression was 
reported by Carpenter et al. [235] when osteoblasts derived from older mouse pups 
were culture at higher density on TCP. In another study by Varanasi et al.,  it was 
reported that when osteoblast±like MC3T3±E1 supplemented by extracts from 
bioactive glass 45S5 and 6P53±b cell proliferation rate was enhanced by 150%, 
collagen synthesis was enhanced and a higher concentration of osteocalcin protein 
was observed. It was reported that osteocalcin was detectable after 3 days and 
highest values were obtained after 6 days with 45S5 glass extracts which was 
reduced at later time points however, no significant change in osteocalcin quantity 
was observed on TCP [236]. In another study by Attawia et al. media osteocalcin 
levels synthesized by osteoblasts cultured on the surface of PMA±ala:CPH (30:70) 
polymer matrices and TCP controls at 14 and 21 days in culture was analysed. It was 
reported that no significant difference found on polymer surfaces however, an up 
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regulation of osteocalcin observed for TCP control [237]. When human bone marrow 
stromal cells were cultured on a resorbable P2O5±SiO2±CaO±MgO±Na2O±K2O 
phosphate glass ceramic an up regulation in osteocalcin/Glyceraldehyde 3±phosphate 
dehydrogenase (GAPDH) gene expression was reported although this increment was 
statistically insignificant from day 7 to 14 [234]. 
Therefore, it can be deduced from the results obtained for collagen and osteocalcin 
quantification that degradation products from phosphate glass and some of surface 
treatments especially etidronic acid, glycerol phosphate and silane may have 
enhanced collagen production and help in up regulation of downstream markers like 
osteocalcin during osteoblast differentiation. However, the mechanism of chemical 
DJHQWV¶LQIOXHQFHRQRVWHREODVWFHOODFWLYLW\LVGLIIHUHQWIRUGLIIHUHQWFKHPLFDODJHQWs 
and is out of scope for the current project.  
Most of the chemical agents used in this project have previously been investigated 
for their cytotoxicity or cytocompatibility and therefore expected to be 
biocompatible. Phosphonic acid based chemicals have been employed as s in the past. 
For example, Phillips et al. grafted a novel allyl phosphonic acid on calcium 
phosphate to produce a chemically bonded composite [169]. Greish and Brown 
developed a biocompatible HAp±Ca poly(vinyl phosphonate) composite for clinical 
applications [170, 171]. Tanaka et al. reported the synthesis of surface modified 
calcium hydroxyapatite with pyrophosphoric acid [172]. All these studies reported 
no cytotoxicity from the phosphonic acids used which correlate and support the 
results found in this study for PPA, GP, APA and EA. 
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Sánchez±Vaquero et al. prepared agarose hydrogels containing aminopropyl 
triethoxy silane and evaluated them for adhesion and proliferation of human 
mesenchymal stem cells (hMSCs) they found that although adhesion was lower on 
APS rich scaffolds, the proliferation rate on these surfaces was higher [215]. In 
another study, by Jung et al., type I collagen was immobilised on HA surface with 
the help of APS it was reported that collagen±grafting on HA enhanced the fibroblast 
adhesion due to the excellent biocompatibility. These reports support the results 
found in this study for APS mPBG and explain relatively high MG63 proliferation 
and human osteoblasts ALP activity for APS modified PBG surface. 
In the current study addition of Na or sorbitol functional groups to biocompatible 
PLA was hypothesised to not affect the cytocompatibility significantly. As reported 
in a study by Mei et al [225], biocompatibility of a sorbitol-containing polyester 
series was evaluated against a PCL control by measuring cell spreading and 
proliferation of a mouse fibroblast 3T3 cell line in vitro. It was found that sorbitol-
containing polyesters and PCL had comparable biocompatibility. 
A number of studies have previously employed hexamethylene diisocyanate (HDI) 
in a variety of applications for medical use; such as a growth factor carrier [178, 216], 
a coupling agent in poly(ethylene glycol)-poly(-caprolactone)-poly(ethylene glycol) 
copolymers[213], as a compatibiliser for bioactive glass nanoparticle reinforced 
poly(L-lactide) composites (g-BG/PLLA) [179] and as a coupling agent in a 
hydroxyapatite reinforced PEG/PBT copolymer composites [180]. Dong et al. 
reported dose dependent cytotoxicity for degradation products from HDI grafted 
calcium hydrogen phosphate on rat osteoblast cell metabolic activity. Conversely, 
biocompatibility with very low cytotoxicity was reported for PEG-PCL-PEG 
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copolymers cross-linked with HDI [213]. Liu et al. reported that in-vitro testing of g-
BG/PLLA composites in SBF showed that apatite was deposited easily on the 
surface of the composite scaffolds whilst in-vitro biocompatibility tests showed that 
introduction of BG or HDI compatibilised g-BG particles into the PLA matrix, 
attachment and proliferation of mesenchymal stem cells was supported [179]. 
Therefore, due to lack of evidence on significant cytotoxicity, from results observed 
in current study or reported in the literature, HDI is a rationale choice for surface 
treatment. However, care must be taken to remove all un-reacted HDI from the 
system.  
Eight different surface treatments were applied to a phosphate glass surface in order 
to make it strongly bond to the polymer. All surface treatments investigated in this 
study were found non-toxic to MG63 cells even at higher concentrations. Human 
osteosarcoma and primary human osteoblast exhibited normal cell functional 
(attachment, proliferation, differentiation) when cultured directly onto the surfaces of 
surface treated phosphate glass. Morphology of cells cultured on treated glass 
surfaces was also found comparable to the control (untreated phosphate glass). 
5.5 Conclusions 
Results obtained for the cytotoxicity/cytocompatibility of human osteosarcoma and 
primary human osteoblast cell lines with surface treated phosphate glass (mPBGs) 
revealed no cytotoxicity from extraction products on osteosarcoma cells. A 
comparable response of MG63 and primary human osteoblast cells with unmodified 
PBG and TCP in terms of cell attachment, viability, metabolic activity, proliferation 
and differentiation was also observed. Although some coupling agents investigated 
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were relatively poor (e.g. HDI, Na-PLA) others (e.g. APS, GP, EA) were excellent in 
terms of cytocompatibility. Variation observed in cytocompatibility could be 
attributed toward unreacted functional groups (e.g. O=C=N) or degradation products 
(e.g. acidic products from PLA oligomers). However, it can be concluded that all the 
coupling agents investigated and their degradation products were cytocompatible and 
had no adverse effect on cell functions and cell morphology. 
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CHAPTER 6. PHOSPHATE GLASS FIBRE 
REINFORCED COMPOSITE 
6.1 Introduction 
,QWHUQDO ¿[DWLRQ IRU ERQH IUDFWXUHV LV D SURYHQ RSHUDWLYH WHFKQLTXH ZKHUH ULJLG
implant plates and screws of metals such as titanium or cobalt/chromium alloy are 
frequently used. Excellent reviews tracing the history of biomaterials development 
and describing state±of±the±art technology have been published and should be 
referred for more in±depth information on this subject [56, 57, 238-242]. However, 
problems such as disuse atrophy due to stress shielding, refractures and need for 
removal operation highlighted the need for an implant that can provide enough 
mechanical support to the healing bone, maintain its mechanical properties for a 
certain length of time (up to 24 weeks) and gradually degrade out of the body 
through normal physiological pathways.  
Polymers such as PLA, PGA and PCL alone have insufficient mechanical properties 
to match cortical bone [4, 10, 13, 20, 122]. As discussed previously (cross reference 
chapter 2), different approaches such as self and particulate reinforcement have been 
adopted without much success. Recent studies investigating PCL reinforced with 
ELQDU\FDOFLXPSKRVSKDWHJODVV¿EUHV (PGF) revealed that these composites showed 
DÀH[XUDOVWUHQJWKDQGPRGXOus values of 25-30 MPa and ~2.5 GPa respectively for 
DQ DSSUR[LPDWHO\  ¿EUH volume fraction sample which was comparable to 
trabecular bone [27, 159, 160]. More recently Ahmed et al. produced composites 
with randomly distributed quaternary PGFs (13.5% by volume) within a PLA 
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polymer matrix, WKHÀH[XUDOVWUHQJWKRIWKHFRPSRVLWHVZDVUHSRUWHGWREHa MPa 
ZLWK D ÀH[XUDO PRGXOXV RI a GPa for both non±treated and heat±treated PGF 
reinforced composites [158].  
However, when a totally resorbable composite is exposed to an aqueous environment, 
it loses ~50% of mechanical properties within first few days due to water ingress, 
loss of interfacial integrity and polymer swelling [23, 24, 158]. Therefore, for this 
project it was hypothesised that a stronger and hydrophobic interface could improve 
the mechanical properties of composite and delays the loss of properties due to water 
ingress.   
This chapter reports production of PGF reinforced PLA composite. An investigation 
for the effect of selected glass-surface treatments on the flexural mechanical 
properties of the composites with degradation was carried out along with primary 
human osteoblast interaction with these composites. 
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6.2 Materials and Methods 
6.2.1 Glass Synthesis 
Phosphate based glass (45P2O5 16CaO 24MgO 11Na2O 4Fe2O3 in molar %) was 
prepared following the protocol reported in chapter 3, Section 3.2.1. 
6.2.2 Glass Fibre Production 
PGFs were produced by melt drawing technique as described in chapter 3, Section 
3.2.5.  
6.2.3 Single Fibre Tensile Test (SFTT) 
PGFs were tested for size (diameter) and tensile mechanical properties using 
Mitutoyo Series 544 LSM±500S laser diameter gauge and LEX810 tensile tester, 
respectively, as reported in chapter 3, Section 3.2.6.  
6.2.4 PGF/PLA Composite Production 
6.2.4.1  Treatment of PGFs 
PGFs, continuous or 20 mm chopped were treated with optimised concentration of 
selected surface-treating chemicals (APS, EA, SPLA and HDI) following the 
protocol stated in chapter 4, Section 4.2.2.  
6.2.4.2 Non±Woven Fibre Mat Production 
Twenty millimetres chopped untreated control or chemically surface-treated glass 
fibres, in small bundles, were dispersed using high pressure air. These fibres were 
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then laid into non±woven random fibre mats (17 cm diameter round sheet) using a 
GRPHVWLFDOO\GHYHORSHG³DLUOD\´PHWKRG(Figure 6±1). 
The air±lay setup is shown in Figure 6-1 which is connected to a powerful vacuum 
pump. Desired amount of loose fibres were gradually fed into the top of the air lay 
table which were collected on framed mesh. The frame was removed and unbounded 
fibre mat was sprayed with PLA/chloroform solution in order to bind the fibres 
together. 
 
Figure 6-1: Air±lay method fixture setup and random fibre mat. Chopped fibres were 
fed into to end of coned shaped metal box which was connected to high vacuum from 
its bottom end. Fibre mat was collected from the steel mesh. 
6.2.4.3 Unidirectional Fibre Mat Production 
The unidirectional (UD) fibre mats were produced from continuous 180 mm fibre 
bundles manually aligned together on a PTFE sheet. Solution was added gently using 
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a spray, to treat the fibre surface. The UD mats produced were rinsed with respective 
solvents to remove unbounded before being dried at temperature of 50 °C for 30 
minutes. 
6.2.4.4 PLA Sheet Preparation 
Approximately 0.2 mm thick PLA films were prepared by compression moulding 5 g 
of PLA pellets (3251±D NatureWorks, plc. average Mw = 90,000-120,000, PDI = 
1.6, Tm = 170.9 °C and Tg = 61.3 °C). The pellets were placed between two metallic 
plates and heated to 210 °C in a press for 10 minutes, before being pressed at 3 bar 
pressure for 30 seconds. The plates were then cooled immediately by transferring to 
a cold (room temperature) press at the same pressure. The PLA pellets were dried in 
a vacuum oven at 50 °C for 48 hours prior to use. 
6.2.4.5 Composite Production  
Both random and unidirectional composites were prepared using a film stacking 
process followed by hot and cold press. For non±woven random fibre reinforced 
composite; 7 PLA films and 6 fibre mats were stacked alternately within a 170 mm 
diameter, 1.6 mm thick mould cavity between two metallic plates covered with 
PTFE sheet. This stack was then heated in the press for 15 minutes at 210 °C and 
pressed for 15 minutes at 38 bar. The plates were transferred to a second press and 
allowed to cool to room temperature at 38 bar for 15 minutes. The same protocol was 
applied for the unidirectional (UD) composite except that only 4 UD fibre mats 
stacked between 5 PLA sheets within the mould cavity dimensions of 
170 mm×100 mm×1.6 mm (l×b×t). The resulting laminated composites were cut 
using a band saw into 32 mm length, 15 mm width samples for physical testing. The 
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fibre volume fraction of the composites was obtained using the matrix burn off 
method, according to the standard test method ASTM D2584±94. The target fibre 
volume fraction of the composites was between 20% and 35% for nonwoven and 
unidirectional composites respectively. 
6.2.5 Degradation Study for Composites 
Specimens of nonwoven random and unidirectional composites were placed 
individually into 30 ml glass vials. The vials were filled with PBS (pH=7.4±0.2) and 
maintained at a temperature of 37 °C. At predetermined time points the specimens 
were extracted and blot dried before weight measurements were recorded. The 
samples were placed back into vials with fresh PBS solution. At each time point, 
replicates (n = 3) of each sample were measured and the average reported. The data 
was plotted as percentage water uptake and dry mass change against time.  
6.2.6 Flexural Mechanical Properties Measurement 
The initial flexural strength and modulus were evaluated by flexural (three±point 
bend) test using a Hounsfield Series S testing machine. These measurements were 
done according to the standard BS EN ISO 14125:1998. A crosshead speed of 
1 mm/min and a 1 kN load cell was used. The measurements were conducted on wet 
samples for following reasons: a) Drying of wet samples rapidly destroys their 
structure leading to a decrease of their strength in measurement conditions [20], b) 
Drying of wet samples cause partial restoration of ionic bonds that could lead to 
misleading results [7], and c) To get the mechanical properties of the composite 
closer to in±vitro conditions [23]. The measurements were carried out in triplicate. 
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6.2.7 Physical (SEM) Analysis  
Composite samples cross section was exposed via freeze fracture by immersion in 
liquid nitrogen. The specimens were sputter±coated (SC500, Emscope) with 
platinum and examined using a XL 30 scanning electron microscope (Philips, UK) at 
an accelerating voltage of 10 kV.  
6.2.8 Cytocompatibility of Primary Human Osteoblast to the 
Composites 
6.2.8.1 Primary Human Osteoblast Cell Culture on Composite  
Primary human osteoblast obtained from European collection of cell cultures 
(ECACC) and cultured in osteoblast growth medium (417±500) (Cell Application, 
Inc.). Same protocols and conditions were used as described in chapter 5, Section 
5.2.5.1. 
6.2.8.2 Proliferation 
Osteoblast proliferation was gauged by quantifying DNA at each time point, cell 
lysate was used and standard DNA quantification assay protocol (chapter 5, 
Section 5.2.5.2) was followed. 
6.2.8.3 Differentiation 
To cover different stages of differentiation three osteoblast specific assays were 
selected; alkaline phosphatase activity (early marker); collagen quantification; and 
osteoblastic differentiation specific osteocalcin production. 
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6.2.8.3.1 Alkaline Phosphatase Activity 
Alkaline phosphatase activity was measured using the Granutest 25 alkaline 
phosphatase assay (Randox, UK). The cell lysate was collected and the standard 
protocol stated in chapter 5, Section 5.2.5.3.1 was followed.  
6.2.8.3.2 Collagen Quantification 
Collagen quantification was done by using the soluble collagen assay (Sircol, UK). 
The assay was performed on cell lysate as described in chapter 5, Section 5.2.5.3.2 
according to the instructions enclosed with the assay. 
6.2.8.3.3 Osteocalcin Quantification 
Osteocalcin quantification was performed using a commercially available kit 
(Invitrogen, UK). The lysate was collected and tested for the presence of osteocalcin 
following the kit instructions (chapter 5 Section 5.2.5.3.3). 
6.2.8.4 Morphology 
Samples were fixed in and dehydrated before being sputter coated with platinum 
following the protocol stated in chapter 5, Section 5.2.5.4. Prepared samples were 
viewed using a Philips XL30 scanning electron microscope operated at 10 to 20 kV.  
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6.3 Results 
6.3.1 Initial Mechanical Properties 
From the flexural studies conducted (three±point bend), it was observed that the 
initial flexural strength of non±woven randomly dispersed PGF reinforced composite 
was increased by approximately 20 MPa with silane treatment. However, a drop of 
~5 MPa was seen for HDI treated samples in comparison with untreated control 
samples (Figure 6-2). The flexural modulus, however, was found to decrease from 
11±2 GPa (untreated non±woven composite) to 8±2.5 GPa for HDI±treated, 10±.7 
GPa for APS treated and 10±2.6 GPa for SPLA treated PGF reinforced composites. 
Due to small sample numbers (n=3), statistical analysis revealed no significance 
difference (p > 0.05) between control and APS/SPLA treated samples. 
 
Figure 6-2: Initial flexural mechanical properties obtained for the untreated and 
surface-treated non±woven randomly dispersed PGF reinforced PLA composites 
produced with approximate fibre volume fraction of 20%. Error bar represents 
standard error of mean where n =3. 
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The (three±point bend) flexural mechanical properties measurement was also 
performed on unidirectional PGF reinforced composites, the initial flexural strength 
of control PGF reinforced composite was found 215 MPa which was increased 
significantly (p < 0.01) with silane and SPLA treatments to 300 and 260 MPa, 
respectively (Figure 6-3). However, lower flexural strength was measured for HDI 
treated samples (~190 MPa) in comparison to control samples which were found 
statistically not significant (P > 0.05). 
 
Figure 6-3: Initial flexural mechanical properties obtained for the untreated surface±
treated unidirectional PGF reinforced PLA composites produced with approximate 
fibre volume fraction of 35%. Error bar represents standard error of mean where n =3. 
* indicating the significant difference with respect to control. 
The flexural modulus (Figure 6-3), unlike random fibre composites, was found to 
have increased with silane and SPLA treatments from 20 GPa (for untreated UD 
composite) to 22 and 25 GPa with silane and SPLA treatments respectively. No 
change was observed for HDI treated UD PGF reinforced composite compared to 
control. Statistical analysis revealed that modulus value for control sample was 
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significantly different (p < 0.01) to SPLA treated sample. However, no significant 
difference (P > 0.05) was observed for APS and HDI treated samples compared to 
control. 
6.3.2 Physical Analysis with Degradation 
Figure 6±4 presents images of PGF after treatment with optimised concentration of 
EA for 15 minutes (left) and 5 minutes (right). It is clear that PGF severely corroded 
and turned white when exposed to EA for 15 minutes. Although, with 5 minutes 
treatment PGF did not change their colour but the resultant composite (Figure 6±5) 
was very brittle and thus excluded from study. 
 
Figure 6-4: PGF showing severe corrosion with EA exposure for 15 minutes (left) and 5 
minutes (right). 
 
Figure 6-5: EA modified PGF reinforced composite shows severe corrosion and 
inferior mechanical properties 
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Non±woven random PGF reinforced composites were produced with surface-treated 
and control PGF. It was observed that after treatment, fibre bundles were formed 
which resulted in non±uniform distribution of PGFs within PLA matrix (Figure 6±6).  
 
Figure 6-6: Snap shots of random fibre composites APS (left) versus Control (right) 
shows non±uniform distribution of APS mPGF compared to control PGF within PLA 
matrix. 
Cross sections of composites were exposed by freeze/fracture and examined with 
SEM, Figure 6-7 and 6-8 shows the representative images of all the samples as made 
and after 28 days degradation in PBS at 37 °C. Figure 6-7 are the images taken for 
non-woven random PGF/PLA composites and Figure 6-8 are the representative 
images for unidirectional PGF/PLA composites. 
It can be noticed from figures that within non degraded composites, fibres were well 
bonded with polymer matrix after treatment compared to untreated composite where 
clean fibres and holes can be spotted. However, no obvious difference between 
treated and non-treated composites can be noticed after 28 days of degradation, 
which correlates well with the results observed for flexural mechanical properties. 
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Figure 6-7: SEM images of HDI treated random PGF reinforced PLA composite before 
(left) and after (right) 28 days of degradation in PBS at 37 °C. Arrows indicating at 
long fibre pull-out and holes representing interfacial integrity loss while circles 
pointing out short fibre pull-out and strong interface between PGF and PLA matrix. 
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Figure 6-8: SEM micrographs from top to bottom: untreated (control) composite, APS 
treated, SPLA treated, HDI treated unidirectional PGF reinforced PLA composite, 
before (left) and after (right) 28 days of immersion in PBS at 37°C. Micrometer scale-
bar = 50µm. Arrows indicate holes and long fibre pull-out due to interface failure and 
circles highlight intact interfacial integrity and short fibre lengths. Better interface i.e. 
shorter fibre length was observed in case of HDI treated composites compared to 
others after 28 days of immersion.   
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Figure 6±7 and 6±8 shows that with treatment a better interface between 
unidirectional PGF and PLA matrix was established as the length and number of 
fibre pulled out of PLA matrix was smaller than control. However, interface failure 
can be seen for control, APS and SPLA treated samples after degradation. HDI 
treated samples on the other hand were found to maintain interfacial integrity to a 
greater extent. It is also noticeable that short random fibres were better impregnated 
within the polymer matrix compared to unidirectional fibres due to relatively lower 
volume fraction (20% for random and 35% for UD PGF/PLA composite) and greater 
number of layers (6 layers for random and 4 layer for UD PGF/PLA composite) used 
to prepare non-woven random fibre reinforced composite. 
6.3.3 Water Uptake and Degradation of Composite 
Figure 6-9 represents the percentage wet mass change profile of control and treated 
UD PGF reinforced PLA composites plotted against time (up to 28 days). During the 
initial phase, the mass gradually increased for all the composites. However, a 
saturation point was reached for control and HDI treated composites after 2 days 
which was followed by a plateau (0.75%). A continuous increase in mass due to 
water uptake by SPLA and APS treated samples was resulted in composite swelling.  
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Figure 6-9: Water±uptake profiles obtained for untreated and ±treated PGF reinforced 
PLA UD composites produced with approximate fibre volume fraction of 35%. Studies 
were conducted for up to 4 weeks in PBS at 37 °C. Secondary y±axis presents the 
profile of SPLA series only. Error bar represents standard error of mean where n =3. 
Dry mass change with degradation versus time is presented in Figure 6-10. It shows 
that for control and HDI treated samples the mass loss was negligible. Highest mass 
loss of 0.2% and 0.4% was observed at time point 7 days which was then dropped to 
0.1% and 0.2% for control and HDI treated samples respectively. However, 
relatively greater mass loss (1.4%) was observed for APS treated samples up to 21 
days which was levelled out at 28 days. SPLA treated samples lost were found to 
lose 0.6% of their weight up to 14 days which was increased drastically to 3% at 28 
days.  
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Figure 6-10: Degradation profiles obtained for untreated and ±treated PGF reinforced 
PLA UD composites produced with approximate fibre volume fraction of 35%. Studies 
were conducted for up to 4 weeks in PBS at 37°C. Secondary y±axis presents the profile 
of SPLA series only. Error bar represents standard error of mean where n =3. 
6.3.4 Retention of Mechanical Properties with Degradation 
All variety of UD composites (control and treated) specimens were degraded in PBS 
at 37 °C up to 28 days. Three point bend flexural tests were conducted on these 
samples at predetermined time points to investigate mechanical integrity retention 
with time. For all the samples a drop in flexural strength was observed; SPLA 68%, 
APS 46%, control 35% and HDI 31%. However, for all the composites except SPLA 
rate of mechanical strength loss was approximately 1-2 MPa per day after 7 days of 
degradation (Figure 6-11).  
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Figure 6-11: Flexural strengths of control and APS, SPLA AND HDI treated UD 
PGF/PLA composites. All degraded Samples were tested wet after immersion in PBS at 
37°C. Due to rapid loss of mechanical strength SPLA series sample was not analysed 
after 14 days. Error bar represents standard error of mean where n =3. 
Final flexural strength of APS (91 MPa) and HDI (101 MPa) treated composites 
were found to be higher than control (80 MPa) after 28 days of degradation in PBS. 
However, statistical analysis revealed no significance (p > 0.05) between control and 
APS and HDI treated samples. 
A gradual loss in flexural modulus was also observed for all samples other than 
SPLA series that were dropped to ~6 GPa after 7 days. SPLA treated samples lost 
their mechanical integrity and excluded from study after 14 days. HDI treated 
samples were found to maintain the highest flexural modulus after degradation 
where final modulus was found at approximately 16 GPa compared to control and 
APS treated samples that was found at 13 GPa (Figure 6-12). However no difference 
of statistical significance (p > 0.05) was observed. 
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Figure 6-12: Flexural modulus of control and APS, SPLA and HDI treated UD 
PGF/PLA composites. All degraded samples were tested wet after immersion in PBS at 
37°C. Due to rapid loss of mechanical strength SPLA series sample was not analysed 
after 14 days. Error bar represents standard error of mean where n =3. 
6.3.5 Cytocompatibility of Composites 
6.3.5.1 Proliferation 
To investigate the effect of chemical modification of phosphate glass fibres with 
selected  within the composite on the proliferation of primary human osteoblasts, 
DNA concentration of the cells cultured on the surfaces of different composite 
surfaces were measured over a period of 21 days, (Figure 6-13). 
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Figure 6-13: DNA concentration of primary human osteoblast cells, as measured by the 
DNA (Hoechst 33258) assay, cultured on modified PGF reinforced PLA composites; x±
axis represents surface treatments. Error bar represents standard error of mean, n = 6. 
No significant difference was found amongst the samples. 
For all modified samples the DNA conFHQWUDWLRQZDVDSSUR[LPDWHO\ȝJPO±1 at 
 GD\V LQ FXOWXUH ZKLOH IRU ERWK WKH FRQWUROV ZKHUH a ȝJ PO±1 DNA was 
measured. Enhanced osteoblast proliferation can be seen as DNA concentration 
LQFUHDVHG WR a ȝJ PO±1 between 14 and 21 days of culture on all the surfaces. 
However, two±way ANOVA revealed no significant (p > 0.05) effect of treatments 
compared to control. TCP was used as internal control for experiment validation. 
6.3.5.2 Differentiation 
6.3.5.2.1 Alkaline Phosphatase Activity 
Alkaline phosphatase activity (ALP) of primary human osteoblast cultured on 
composite surfaces for 14 and 21 days is presented in Figure 6-14.  
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Figure 6-14: Cell alkaline phosphatase (ALP) activity of primary human osteoblasts 
cultured on UD PGF reinforced PLA composite surfaces, as measured by ALP assay, 
x±axis represents surface treatments. All data is modified with DNA values obtained 
for each individual sample. Error bar represents standard error of mean, n = 6. * 
indicating significantly low ALP activity with respect to control. 
For all sample surfaces similar trend of alkaline phosphatase activity was observed 
where a down regulation in ALP activity was measured from day 14 to 21. Statistical 
analysis demonstrated no significant difference for ALP activity between treated 
samples at any time point. Two±way ANOVA analysis revealed significant 
difference (p < 0.01) between control and treated samples on day 14 only.   
6.3.5.2.2 Collagen Production 
Collagen production by primary human osteoblast cultured on selected modified 
phosphate glass fibre reinforced composite surfaces for up to 21 days was assessed 
and quantified by Sircol collagen quantification assay (Figure 6-15, 6±16). 
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Figure 6-15: Collagen production by primary human osteoblasts cultured on modified 
UD PGF reinforced PLA, measured by Sircol assay. All values were normalised with 
DNA values for corresponding sample. Error bar represents standard error of mean, n 
= 6.  * indicating significantly low collagen concentration on HDI treated sample 
compared to control.  
 
Figure 6-16: Collagen production by primary human osteoblasts cultured on PGF 
reinforced PLA composites, as measured by Sircol assay. Error bar represents 
standard error of mean, n = 6. 
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Although, statistically not significant (p > 0.05), an upward trend in collagen 
concentration was observed over the period of culture on all surfaces. When 
normalised with the DNA concentrations all samples, including the controls, showed 
no significant change in collagen concentration with time. Figure 6±16 shows that 
that amount of collagen produced on the surface of HDI treated composite was 
significantly lower (p < 0.01) than the control composite. 
6.3.5.2.3 Osteocalcin Quantification 
Osteocalcin concentration produced by primary human osteoblast cultured on 
composite surfaces for up to 21 days was assessed and quantified by ELISA 
osteocalcin quantification assay kit (Figure 6-17, 6±18).  
 
Figure 6-17: Quantity of osteocalcin produced by of primary human osteoblasts, as 
measured by ELISA assay, cultured on PGF reinforced PLA composite surfaces, x±
axis represents surface treatments. All data is normalised with DNA values obtained 
for each individual sample. Error bar represents standard error of mean n = 6. * 
implies that osteocalcin level on day 14 was found significantly higher than treated 
composites. 
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Figure 6-18: Quantity of osteocalcin produced by of primary human osteoblasts, as 
measured by ELISA assay, cultured on PGF reinforced PLA composite surfaces, x±
axis represents surface treatments. Error bar represents standard error of mean, n = 6. 
Levels of osteocalcin were found 0.6±0.05 ng/ml on all sample surfaces and at each 
time point. A repeat of this experiment provided with the same result implies the 
response was consistent. However, when normalised with DNA concentrations, 
downward trend in osteocalcin concentration was observed (Figure 6-17). Statistical 
analysis of normalised data revealed significant (p < 0.001) difference between 
control and treated samples on day 14 only. 
6.3.5.3 Cell Morphology (SEM) 
Morphology of cells cultured on phosphate glass fibre reinforced PLA composite 
discs was visualized by SEM (Figure 6-19). Within the figure, are the representative 
images of 14 and 21 days in cell culture; showing adherence of cells to the surface of 
all surfaces. Cells were found to cover the surfaces homogeneously.  
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Figure 6-19: SEM images of human osteoblast cultured on (from top to bottom): 
untreated (control) composite, APS treated, SPLA treated, HDI treated unidirectional 
PGF reinforced PLA composite, after 14 days (left) and 28 (right)  days of culture. 
Micrometer scale-bar = 50 µm. Arrows indicates at complete coverage of composite 
surface with cell matrix and circles pointing out glass fibre. 
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In general, SEM images of primary human osteoblast cells cultured on composites 
and TCP up to 21 days shows spindle±shaped cell with lamellipodia extending to 
neighbouring cells and thus making a sheet like structure after 14 days. After 21 days 
in culture cell became more mature and small nodules were located on all surfaces 
except SPLA treated samples. Production of collagen fibrils and deposition of 
mineral was also noticed after 21 days culture. 
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6.4 Discussion: 
High tensile modulus glass fibre reinforcement for polymers is well known to 
improve the resulting composite¶V PHFKDQLFDO SURSHUWLHV [1, 23, 24, 27, 140, 144, 
158-160, 195]. The resultant modulus could be predicted with a simple rule of 
mixture formula and expected to be different in different directions of force. 
 Modulus of Elasticity in longitudinal direction (Ecl) 
Ecl = Em*Vm + Ef*Vf 
 Modulus of Elasticity in transverse direction (Ect) 
1/Ect = Vm/Em + Vf/Ef 
Where: 
Em = Modulus of elasticity for matrix 
Vm = volume fraction of matrix 
Ef = Modulus of elasticity for fibre 
Vf = volume fraction of fibre 
Reinforcement with these glass fibres enable polymer composite to sustain higher 
tensile loads and consequently prevent a sudden failure of fibre reinforced composite 
which in case of bone fracture repairing implant would be catastrophic for patients. 
An ideal implant should provide strong support in the early stages of the 
implantation period and allow a gradual transfer of load to the healing bone during 
the later stages [4]. This goal could only be achieved with a totally resorbable 
implant that can provide high initial mechanical strength and then a controlled 
gradual loss of mechanical properties with time. 
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A number of composites with self [20], particulate [137, 156, 170, 179] [115,189±
190] and fibre [23]  reinforcements have been developed with sufficient initial 
mechanical properties for bone repair applications. However, these composites are 
reported to either not have enough initial strength to support load±bearing bone 
fracture repair or lose their strength rapidly within the first few days of degradation.  
A few studies have investigated this rapid loss (>50 % mechanical integrity loss 
within 1 week of exposure to aqueous environment) of mechanical properties and 
reported that it was due to water ingress in the polymer/matrix interface which led to 
polymer swelling, plasticisation of interface resulting in an inefficient load transfer 
between the phases [13, 20, 23, 158, 243]. 
Chemical agents such as different silanes, poly-HEMA and phosphonic acids are 
being employed to improve load transfer between two phases of composites with 
some success [25, 26, 244, 245], resulting in improved initial mechanical properties. 
For this project eight different chemical surface treatments were selected which were 
passed through various screening stages; chemical bonding with PBG, IFSS 
improvement and three-step cytocompatibility assessments.  
Four out of eight treatments were selected to be employed within PGF reinforced 
PLA composites. However, etidronic acid (EA) was found to be corrosive for PGF 
and thereof excluded from current study.  
Two different types, non-woven random PGF/PLA and unidirectional PGF/PLA 
composites, were produced using film staking followed by hot and cold press. 
Composites were tested for initial flexural properties as well as retention of flexural 
properties with degradation in PBS at 37 °C. 
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After treatment and washing out unbound, chopped fibres (mPGF) were found 
difficult to separate, this resulted in non±uniform distribution of mPGF within the 
composite. This might have led to a comparatively low flexural modulus composite 
with larger error in mechanical properties measurements for treated composite 
specimen. In spite of this inhomogeneity and low modulus an increase in initial 
strength for APS and SPLA treated composite specimen was observed. It was 
observed that the initial flexural strength of non±woven randomly dispersed PGF 
reinforced composite (~125 MPa) was increased by 20 MPa with surface treatments 
(Figure 6-2). It was also noted that with air±lay method approximately 10 to 20 
weight % fibres were lost and hence the fibre volume fraction was difficult to 
maintain. 
A significant improvement (from ~210 MPa up to 310 MPa) in flexural mechanical 
properties of UD composite was observed for APS and SPLA modified phosphate 
glass fibres (mPGF) reinforced PLA composite compared to control (untreated) 
unidirectional PGF reinforced PLA composite (Figure 6-3); implies that the surface 
treatment of PGFs improved the interface between PGF and PLA and thus provided 
an efficient load distribution resulted in enhanced mechanical properties [161, 165]. 
However, comparatively lower initial flexural properties was observed for HDI  
(Figure 6-3) treated sample which could be due to the fact that HDI grafting on PGF,  
which involves soaking fibres in DMF and distilled water, may have reduced the 
fibre strength which was reflected in comparatively low flexural properties. 
A positive effect for silane on glass fibre reinforced composites has been reported by 
Jiang et al. who reported a marked improvement in flexural mechanical properties 
with APS treatment on Bioglass® reinforced poly caprolactone [154]. In that study, 
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DPLQH VLODQH WUHDWHG JODVV ¿EUH FRPSRVLWH KDG D <RXQJ¶V PRGXOXV RI  GPa and 
200 MPa in strength compared to 9 GPa and 130 MPa modulus and strength, 
respectively, when treated with propylsilane. In another study on PCL composites an 
improvement of 10 MPa in flexural strength was reported by Khan et al. when PGF 
were treated with Poly(2±Hydroxyethyl methacrylate) HEMA [159]. Similarly, 
Haque reported a 20 MPa flexural strength and 3 GPa flexural modulus 
improvements in PGF reinforced PLA composite after SPLA treatment [167]. These 
reports attributed the improvements to a better shear bond strength, compatibilisation 
and/or concealing of micro±cracks between the phases. 
UD composites samples were analysed for water uptake, mass loss and retention of 
mechanical properties with degradation. A quick loss of mechanical properties was 
observed for all composites. A rapid loss of mechanical properties of fibre reinforced 
composite is well reported. For example; Khan et al. (PGF/PCL) [28, 159, 160], 
Ahmed et al. (PGF/PLA) [158], Haque  (PGF/PLA) [167] Felfel et al. (PGF/PLA) 
[23, 24] all have reported a rapid drop in mechanical properties within first week of 
degradation. 
Degradation of totally resorbable fibre reinforced polymer composite is a 
combination of physical degradation (e.g. polymer swelling), degradation of polymer 
matrix in case of totally resorbable composite; break down of interfaces between the 
fibre and matrix and loss of fibre strength due to corrosion. Interface degradation can 
set off wicking (a form of capillary action between the loose fibre and matrix 
interface). Water filled capillaries can decrease the mechanical strength of fibre 
reinforced composites. It is also known that there is a direct relation between fibre 
volume fraction and water uptake which suggests that low volume fraction of fibres 
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can be impregnated into polymer matrix better than high volume fraction. It was 
reported by Felfel et al. that water ingress for UD composite was higher than random 
fibre composite which was attributed toward better impregnation of random fibres 
into polymer matrix as compared to UD fibres [23].  The results presented in current 
study agree with the conclusion made by Felfel et al. 
SPLA treated samples were found to take up water (Figure 6-9) that resulted in a 
swollen composite. Similar response from SPLA-mPGF/PLA composite was 
reported by Haque et al., they reported a 1.2% water uptake after 7 days of 
immersion in PBS at 37 °C. It was also reported that SPLA treated composite lost 
~50 MPa (from 160 MPa) of their strength with 7 days of immersion [167]. This 
behaviour of SPLA treated samples can be attributed to the hydrophilicity of SPLA 
which led to degradation of SPLA oligomer and hence autocatalytic degradation of 
PLA matrix. One possible explanation for comparatively high water uptake could be 
the fact that after dip coating the UD mats with S-PLA oligomer, no soxhlet 
extraction was carried out and thus there were more hydrophilic SPLA oligomers to 
absorb water compared to random fibre reinforced composite.  
APS treated specimen although took up higher amount of water than control samples 
yet maintained superior mechanical properties which can be attributed to 
PGF-APS-PLA bridge formed by covalent bonding and/or to the hydrophobicity at 
the interface. 
No significant difference in water uptake (Figure 6-9) and degradation (Figure 6-10) 
was found between HDI treated samples and controls. However, HDI treated 
samples were the strongest at the end of study (Figure 6-11 and 6-12). This retention 
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of mechanical integrity suggests a strong covalent bond between reinforcement and 
matrix and hydrophobicity at interface within the composite. 
Mechanical properties of a polymer are (up to a certain molar mass) directly 
proportional to the chain length. Therefore mechanical property retention of 
polyester (such as PLA, PGA or PCL) based composites can also depend on the 
degradation of the polymer via hydrolysis of the ester group in the polymer 
backbone. Hydrolysis of polyesters is catalysed by protons (i.e. in an acidic 
environment). PLA has been known to hydrolyse more readily than other aliphatic 
polyesters. The acid dissociation constant (pKa) of oligomeric PLA is 3.1. Therefore, 
the dissociation of the acid end-group is expected to result in an acidic environment 
and contribute significantly toward acid-catalysed hydrolysis. As the reaction 
proceeds, the carboxylic acid concentration and the rate of hydrolysis increase, and 
the reaction is said to be autocatalytic [246], which can result in loss of mechanical 
properties of the polymer. This also highlights that the approach to reduce hydration 
(by improving the fibre/PLA interface) is therefore likely to improve mechanical 
performance not only by prevention of swelling and cracking, but by also delaying 
polymer hydrolysis. The effect of autocatalysis of the polyester matrix was reported 
to significantly affect the mechanical properties of PGF reinforced composite [243]  
Scanning electron microscopy (Figure 6-7 and 6-8) of non±degraded and degraded 
composite sample cross section correlates with the results observed for water up±
take. Hence supports that the composite lost their strength gradually as the water 
uptake due to capillary action increased with time. Total loss of interface for S-PLA 
oligomer treated sample can be seen from the SEM images of degraded samples. 
Conversely, with APS and HDI treatment interfacial integrity of the composite was 
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intact. The degree of this interfacial integrity retention was greater for HDI treated 
samples compared to APS treated and control composite which was reflected in the 
flexural strength and modulus observed for the samples.  
Although, biocompatibility of PLA is well established in the literature and 
cytocompatibility for phosphate glass and chemicals selected for surface treatments 
in this study was investigated and reported separately in chapter 3 and 5 respectively. 
Human osteoblast interaction, cultured directly onto a composite surface, was 
investigated bearing in mind that the surface properties, synergistic effect of 
degradation products and their concentration for the composite would be different to 
those for the polymer, glass and surface treatments alone. 
A small number of studies have reported cytocompatibility of PLA based composites 
with various reinforcements like HA, Bioglass or PBG comparable to tissue culture 
polystyrene [1, 140, 157, 158, 247]. However, the cell culture duration for the 
studies (~7 days) was not long enough to observe the effect of degradation products 
as well as changes in surface structure due to degradation. For example, Ahmed et al. 
cultured a human osteosarcoma cell line (MG63) on annealed and non±annealed 
phosphate glass fibre (~14% by volume) reinforced PLA composite and imaged 
live/dead stained cells attached to the surfaces of the composite specimens up to 7 
days in culture through confocal laser scanning microscope. It was reported that both 
PLA (alone) and the heat±treated fibre reinforced composites maintained higher cell 
viability as compared to the non±annealed fibre composites. This was attributed to 
the slower degradation of the annealed fibre reinforced composites [158]. Andriano 
et al. prepared poly(ortho ester) reinforced composite with randomly oriented, 
crystalline microfibers of calcium±sodium±metaphosphate with or without silane 
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treatment. Only cytotoxicity was investigated using tissue culture agar overlay up to 
24 hours by direct cell contact method and L929 mouse fibroblast cells. It was 
reported that the component materials showed no acute cytotoxicity [1]. 
Cells can be exposed to all components of a composite by culturing them on cross±
section of composite and hence a short term study would be sufficient. Brauer et al 
produced a methacrylate±modified oligolactide matrix reinforced with slow 
degrading phosphate invert glass fibres of the glass system P2O5±CaO±MgO±Na2O±
TiO2. MC3T3±E1 murine pre±osteoblast cell were seeded on cross±section of the 
prepared samples and cultured up to 8 days. Short±term biocompatibility was tested 
in an FDA/EtBr viability assay and a cytocompatibility of the composite materials 
was reported on the basis of live±cell density attached to the surfaces [140]. 
For this study, primary human osteoblast was selected because the intended 
application of these composite is load±bearing fracture fixation. Cells were cultured 
up to 21 days on composite surfaces to encompass all cell function from initial cell 
attachment to proliferation and differentiation with degradation products coming out 
from both PLA and mPGFs. 
DNA concentration was measured as an indicator of proliferation which was found 
~0.2µg/ml after 14 days of culture for all the samples (Figure 6-13). A positive 
proliferation trend was observed on all samples. DNA concentration was found 
~0.3µg/ml after 21 days on all samples. There was no significant difference found 
when 2 way ANOVA was carried out.  
Typical down regulation in ALP activity from day 14 to 21 was observed (Figure 
6-14) which correlates well with the results observed for osteoblast cultured on 
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mPBG. Although statistically not significant, highest ALP activity was observed for 
control composite sample where the cell proliferation was the slowest.  
Collagen concentration was found to not change with time when normalised with 
DNA concentration (Figure 6-15). Same trend was observed by Kim et al. when 
osteoblasts were cultured on bioactive glass nano±fibre filled PLA composite up to 
15 days [247]. 
A down regulation of osteocalcin concentration was observed when normalised with 
DNA content (Figure 6-17). The trend was consistent when compared with the 
results reported in chapter 5 for osteocalcin production by primary human 
osteoblasts cultured on mPBG.  
Scanning electron microscope images (Figure 6-19) of primary human osteoblast 
cultured on control and treated PGF composite showed typical cell adhesion, 
proliferation, collagen production and mineral deposition with no discrepancies 
between samples. Osteoblast were found fully confluent after 14 days on all surfaces 
showing spindle-shaped cells arranged like a shoal of a fish and cells cultured on 
composite surfaces showed presence of collagen and mineral deposition. After 21 
days as the top PLA layer was degraded some fibres were exposed with cells 
attached to them. At 21 days cell clusters were found on control and APS treated 
samples which were absent on S-PLA and HDI treated samples this behaviour 
correlates with values obtained differentiation markers.  
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6.5 Conclusions 
Selected surface treatments (APS, SPLA) for PGFs improved the initial flexural 
properties of composite and some (APS, HDI) also slowed down loss of flexural 
strength and modulus with degradation. This improvement in initial flexural 
properties can be associated with the improved shear bond strength at the interface 
due to covalent bridge between glass fibres and polymer matrix provided by surface 
treatment. Delay in mechanical property loss (with APS and HDI treatment) with 
degradation also confirmed the hypothesis that hydrophobicity at the interface would 
retard the interfacial integrity loss and consequently loss of mechanical integrity of 
composite. All modified and control composite demonstrated cytocompatibility 
comparable to control, supporting their use for implantable devices. 
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CHAPTER 7. GENERAL DISCUSSION, 
CONCLUSIONS & 
RECOMMENDATIONS  
7.1 General Discussion 
Throughout history bone fractures have been treated with immobilization, traction, 
amputation, and internal fixation. Over the past 40 years, advancements in biological, 
mechanical and material sciences have led to contemporary fixation techniques [248]. 
Excellent reviews on the subject of biomaterials development for bone fracture 
fixation and describing state±of±the±art technology have been published [56, 57, 
238-242]. Historically, metal has been the most popular material for fracture fixation 
and, whilst it has excellent results, it is not without its problems like stress shielding, 
corrosion, pain and growth restriction [248].  
An ideal implant for bone fracture fixation should support the fracture during the 
initial phase of healing and then gradually lose its strength with the same rate of 
strength gain by the healing bone [15]. Over the last two decades the use of 
biodegradable materials has expanded to include fixation applications. Degradable 
polymers available as implantable material include polyesters (polylactic acid, 
polyglycolic acid), polylactones, polyanhydrides and poly(ortho esters). However, 
for orthopaedic applications a degradable polymer should possess mechanical 
properties close to cortical bone (bending strength 100±200 MPa, E = 10±30 GPa). It 
is also required to degrade at a steady pace comparable to bone healing. Furthermore, 
the degradation products should also be biocompatible and resorbable through 
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metabolic pathways. Currently available polymers do not satisfy this combination of 
requirements. The most common biodegradable polymers previously used in 
orthopaedics were created from L±lactide, D±lactide and glycolide [249, 250]. The 
rapid degradation of pure polyglycolic acid and the slow degradation of pure poly±
L±lactic acid or polycaprolactone implants eventually led to the utilization of co±
polymers. However, implants made out of polymeric materials alone are usually 
mechanically weaker than conventional metallic fixation devices or cortical bone.  
The difference between the strength/modulus of cortical bone and commonly used 
polymers led researchers to reinforce the polymers with high modulus degradable 
fibres like bioactive glass or phosphate glass [27, 154, 158]. Although, initial 
mechanical properties of such composites were reported to match or even exceed the 
requirements, a rapid loss of mechanical integrity was reported [27, 140, 154, 158, 
251]. This rapid drop in mechanical properties of composites was associated with a 
loss of interfacial integrity between the polymer matrix and fibre reinforcement and 
is the motivation behind the current project.  
The aim of this project was to develop a totally degradable composite for bone 
fracture fixation applications with emphasis on improving the fibre/matrix interface. 
The composite was intended to be used as a load bearing bone±plate/screw fixation 
system. Therefore, initial flexural properties matching cortical bone (Flexural 
strength 100±200 MPa, Modulus = 10±30 GPa) was desirable [17-19, 29].  
Healing occurs in three distinct but overlapping stages: the early inflammatory stage; 
2) the repair stage (soft callus formation around the repair site; and 3) the late 
remodelling stage. The soft callus formed around the repair site is very weak in the 
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first 4 to 6 weeks of the healing process and requires adequate protection in the form 
of bracing or internal fixation [252]. Therefore, the intended resorbable implant 
required to maintain its strength for at least during the repair stage (4-6 weeks). As 
stated above, rapid mechanical integrity loss was identified as the major problem 
with such devices [27, 140, 154, 158, 251]. This rapid loss was attributed to 
hydrolytic interfacial break down and aimed to be addressed by introducing 
hydrophobicity and covalent bond between glass fibre and polymer matrix. The 
starting material (polymer matrix, fibre and coupling agent/surface treatment 
chemicals) for a degradable composite was carefully selected based on the criteria of 
their degradability, biocompatibility and mechanical properties. For matrix material, 
several degradable polymers such as polylactic acid, polyglycolic acid, 
polycaprolactone, poly (ortho ester), were considered. However, polylactic acid was 
the obvious choice because of relatively high strength, suitable degradation rate and 
biocompatibility. The major biodegradable fibres, includes bast fibres/plant±
originated fibres (e.g. flax, hemp, jute, ramie, kenaf, abaca), alginate fibres, and 
polymer fibres (e.g. poly (lactic acid) and poly (hydroxyalkanoate)). However, to 
LPSURYHWKHVWUHQJWKDQGVWLIIQHVV<RXQJ¶VPRGXOXVDGHJUDGDEOHJODVVILEUHZLWK
strength closer to E±glass fibre (tensile strength ~2000 MPa; tensile modulus ~ 80 
GPa) was required. Silica glass fibres (e.g. bioglass) are generally considered as non±
degradable. However, Kursawe et al. synthesised nano scale (4 to 5 nm) degradable 
silica fibres for medical use through sol±gel route. Tensile strengths of the silica 
fibres up to 300 MPa and tensile modulus up to 20 GPa was reported [253]. Similarly, 
all the degradable fibres reported above exhibit inferior mechanical properties 
(strength ~ 300 MPa) compared to E±glass fibre. Phosphate glass fibres are easy to 
fabricate and exhibit high tensile strength (up to 550 MPa), high tensile modulus (up 
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to 80 GPa) and controllable degradation rate. The phosphate glass system (P±Ca±
Na±Mg±Fe) was investigated with an aim to take advantage of the effect of network 
modifiers like Ca, Mg and Fe on degradation rate and cytocompatibility of the 
glasses in conjunction with increasing chain length, attributable to increasing 
phosphate content, the latter results in an ease of fibre±drawing and stronger fibres 
[86, 109, 167, 168, 196]. The ratio of bridging to non±bridging oxygen within 
phosphate glass network was calculated from binding energy peaks of O1s from XPS 
data and used as an indicator of chain length (Table 3-4). It was found that phosphate 
glasses containing higher phosphate content demonstrated longer chain lengths. As 
hypothesised glasses with longer chain lengths were easier to draw into fibres and 
were found to be stronger when tested with single fibre tensile test which was in 
agreement with published work [191]. Cytocompatibility examination of phosphate 
glasses were carried out and it was concluded that all glass formulations 
demonstrated cytocompatibility in terms of typical cell adhesion, metabolic activity, 
proliferation, differentiation and normal cell morphology (Figure 3-7 to 3-9). 
Degradation rates had no effect on cell functions such as adhesion, proliferation and 
alkaline phosphatase activity; however, degradation products affected alkaline 
phosphatase activity of cells. Due to time limitations for this project, no 
identification of degradation products was carried out. However, it is reported in the 
literature that different glass formulations release different ionic species which were 
dependent on time scale as well as the size of ionic species. For example, Ahmed et 
al. investigated different ion release (Ca++ and Na+) [85] and different species of 
phosphate oligomers [87]. It was suggested that phosphate glass with different 
degradation rate and formulation may release different ionic products in variable 
amounts, chain length of phosphate oligomer released in the media were proportional 
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to the amount of phosphate in the glass formulation.  Similarly, another study [94] 
suggested that ionic species and their amounts were dependent on glass formulation 
and degradation rates. However, no correlation was made between the degradation 
products and cytocompatibility. A correlation of the results for cytocompatibility 
acquired in current study and cumulative release of different anionic species from 
similar glass reported elsewhere was attempted. The species found were represented 
as orthophosphate, cyclic trimetaphosphate, pyrophosphate and linear polyphosphate. 
The comparison suggest that with higher phosphate content and faster degradation 
rate longer chained phosphate oligomers were released which were detrimental for 
MG63 cells [94]. Results, for the loss of alkaline phosphatase activity with higher 
phosphate containing glasses in current study are in agreement with the conclusion 
drawn above. 
It is well reported that the rapid loss (>50% within 1st week of immersion in 
degradation medium) of interfacial integrity due to water ingress may result in 
premature fracture of composite [1, 158, 254, 255]. The most frequently used 
methods for surface modifications involve chemical surface treatment of polymer 
matrix or reinforcement but also to some extent roughening or plasma treatment. 
Chemical surface treatment is usually done to increase the low surface free energy of 
glass or ceramic. This is achieved by the creation of polar functional groups such as 
hydroxyl, carboxyl and amine that make the surface more hydrophilic [256]. 
Although hydrophilic surfaces provide better adhesion to the polymer, the interface 
is susceptible to hydrolytic degradation due to water uptake. Hydrolytic degradation 
of interface could result in catastrophic failure of the composite.     
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It was hypothesised that strengthening the interface with more hydrophobic 
chemicals should result in stronger composite with slower loss of mechanical 
integrity with degradation. Eight different glass-surface treatment agents: glycerol 
2-phosphate disodium salt (GP); 3-phosphonopropionic acid (PPA); 
3-aminopropyltriethoxy silane (APS); etidronic acid (EA); hexamethylene 
diisocyanate (HDI); sorbitol/sodium ended PLA±oligomers (S/Na±PLA) and 
amino phosphonic acid (APA), were selected on the bases of their potential to bind to 
a phosphate glass surface and/or their reported biocompatibility. Ideally a functional 
layer on glass surface should provide a strong bridge between glass fibre and 
polymer matrix through covalent bonding. It is also required that the layer should not 
hydrolyse easily. Evidence for covalent bonds between the phosphate glass and 
3-aminopropyltriethoxy silane, etidronic acid and hexamethylene diisocyanate were 
found through IR±spectroscopy and XPS, but not the other chemicals tested (Figure 
4-4 and 4-5). It was supposed that glycerol 2±phosphate disodium salt, 
3-phosphonopropionic acid, sorbitol/sodium ended PLA±oligomers and amino 
phosphonic acid were linked through hydrogen bond with phosphate glass (Figure 4-
10).  
It was suggested that the surface treatment agents with greater number of ±OH ions 
(e.g. sorbitol ended PLA±oligomer) improves the interfacial shear strength better 
than with lower number of ±OH ions (e.g. glycerol 2±phosphate disodium salt). 
Significant improvement (from ~7 MPa to ~22 MPa) in interfacial shear strength was 
observed with 3±aminopropyltriethoxy silane, etidronic acid, hexamethylene 
diisocyanate and PLA±oligomers. However, the effect of other surface treatments 
was comparatively small (2-5 MPa) and disappeared with the exposure to an aqueous 
 Chapter 7 General Discussion, Conclusions and Recommendations  196 
environment, supporting the suggestion that these were linked through hydrogen 
bond rather than covalent link. The effect of PLA±oligomers on interfacial shear 
strength and mechanical properties of composite was also disappeared within first 
three days which was attributed to their hydrophilicity and hydrolysis of hydrogen 
bonding with phosphate glass. Hydrophobicity was induced with 3±
aminopropyltriethoxy silane and hexamethylene diisocyanate treatment and no 
change in hydrophilicity was observed for etidronic acid treatment. Conversely, 
glycerol 2±phosphate disodium salt, 3±phosphonopropionic acid and PLA±oligomers 
treatments resulted in hydrophilic surfaces (Figure 4-9).  
The interactions leading to adhesion between two bodies arise from either 
mechanical retention, interatomic forces acting across the interface due to the 
formation of covalent and/or ionic bonds and complex formation across the interface 
[257]. Two major areas of investigation in the field of fibre±matrix adhesion in 
composite materials are: the fundamental role that fibre±matrix adhesion plays on 
composite mechanical properties and the method used to measure fibre±matrix 
adhesion in composite materials. To gauge the interfacial shear strength between 
glass fibre and polymer matrix, despite the extensive comparative studies [165, 200-
207], no standard test has been agreed upon. Therefore, for the purpose of this 
project, a modified push out test to estimate interfacial shear strength between glass 
and polymer matrix and the effect of surface chemical treatments on interfacial shear 
strength was devised. A glass rod pushed out of encircling polymer disc was used as 
a model to estimate the interfacial shear strength. Although, this model was found 
reliable and repeatable, it cannot be extrapolated for exact quantity of glass 
fibre/polymer adhesion strength. 
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A simple rule of mixtures expression can be used to predict composite properties 
when the applied load is coincident with the fibre direction. Drazel and Madhukar 
[255] suggested that fibre±matrix adhesion affects composite properties in different 
ways depending on the state of stress created at the fibre±matrix interphase. At 0° to 
the fibre alignment, tensile and compressive strength increases with increasing 
interfacial shear strength, however no effect on flexural strength can be observed. At 
90° the tensile and flexural strengths of the composite increases with increasing 
interfacial shear strength. A short beam shear test and three point bend test were 
considered to measure flexural properties of composite and the extent of effect of 
interface on it. Short beam shear test can determine interlaminar shear strength of 
parallel fibres with minimal information about flexural strength. However, 3±point 
bend test was selected for current study because, when applied at 90° to the fibre 
orientation, 3-point bend test provides the flexural mechanical properties as well as 
information about contribution of Interfacial shear strength on flexural properties. 
 Surface treated glasses were screened through a three stage cytocompatibility 
assessment. Although, some dose dependent toxicity in terms of lower neutral red 
uptake (Figure 5-1) was observed for PLA±oligomers and hexamethylene 
diisocyanate, all the surface treatments fell in the category of non±cytotoxic 
according to definition given in ISO 10993±5.  Surface treated phosphate glass did 
not affect the cellular functions like initial attachment, proliferation, markers of 
differentiation indicating alkaline phosphatase activity, collagen production and 
osteocalcin production were not greatly different than untreated phosphate glass or 
tissue culture polystyrene. Normal osteoblastic morphology was also maintained on 
all tested surfaces, as observed by SEM (Figure 5-9 to 5-15). 
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Collective analysis of the results obtained for interfacial shear strength, surface 
wettability and cytocompatibility helped to decide on four to be employed in 
composites; 3-aminopropyltriethoxy silane, etidronic acid, sorbitol ended PLA±
oligomer and hexamethylene diisocyanate. P45Fe4 glass fibres treated with 
optimised concentrations of surface treatments before being sandwiched between 
PLA layers and pressed. Phosphate glass fibres treated were found severely corroded 
when treated with etidronic acid (Figure 6-4 and 6-5), therefore, excluded from the 
study. Fibre reinforced composites can be prepared with different fibre arrangements 
(short/random fibre, long unidirectional, woven fibre). Each arrangement has its own 
advantages and disadvantages. For the purpose of this project, two different types of 
phosphate glass fibre reinforced PLA composites (short/random non±woven and 
unidirectional) were produced. The effect of fibre length, strength, orientation and 
volume fraction are well known to affect the properties of a composite [258-260]. 
Felfel et al. [23] reported ~10-15 higher flexural properties for unidirectional 
phosphate glass fibre compared to random short phosphate glass fibre reinforced 
PLA composites. It was also reported that the unidirectional reinforced composite 
absorbed greater amount (0.2 % more than random) of water due to insufficient 
wetting of phosphate glass fibre with PLA [261]. It is also known that fibre volume 
fraction is directly proportional to water uptake and composite strength [262].  
Therefore, relatively lower flexural properties were found for random/non±woven 
fibre reinforced PLA composite (Figure 6-2) compared to unidirectional phosphate 
glass fibre reinforced composites (Figure 6-3). Initial mechanical properties of 
3-aminopropyltriethoxy silane and sorbitol ended PLA±oligomer treated 
unidirectional phosphate glass fibre composite were significantly higher (~20 MPa) 
than control composite, reflecting the effect of stronger interface due to the glass 
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fibre surface treatment. Conversely, samples treated with hexamethylene 
diisocyanate, the most effective  in terms of interfacial shear strength, showed 
relatively lower (~5 MPa) flexural strength and modulus (~1 GPa) which was 
believed to be due to the chemical attack of the phosphate glass fibre during the 
hexamethylene diisocyanate grafting process, which involved 15 minutes exposure to 
distilled water. 3±aminopropyltriethoxy silane and hexamethylene diisocyanate 
treated composites did slow down the loss of mechanical integrity of the composites 
(Figure 6-11 and 6-12). Sorbitol ended PLA±oligomer treated samples lost the 
mechanical integrity after 14 days in PBS at 37 °C. SEM images (Figure 6-7 and 6-8) 
of samples treated with 3±aminopropyltriethoxy silane and hexamethylene 
diisocyanate revealed relatively unbroken interface while sorbitol ended PLA±
oligomer treated sample and control lost the interfacial integrity. Degradation rate of 
hexamethylene diisocyanate, 3-aminopropyltriethoxy silane and sorbitol ended PLA±
oligomer treated phosphate glass (Figure 4-8) correlates with the rate of water uptake 
for the composite prepared with the same surface treatments (Figure 6-9). Water 
uptake plays a major role in interfacial integrity loss which results in loss of 
mechanical integrity of a composite [23, 24, 140].  
Human osteoblasts cultured on composite samples revealed no significant difference 
between composite samples and control in terms of cell functions (attachment, 
proliferation and differentiation) and morphology (Figure 6-13 to 6-19). However, it 
should be considered here that cells were exposed to three completely different 
degradation products of phosphate glass fibre, surface chemical agents and polylactic 
acid. A synergy was expected that acidic degradation products from polylactic acid 
may increase the degradation rate of glass fibre and/or react with the layer. 
 Chapter 7 General Discussion, Conclusions and Recommendations  200 
Potentially hexamethylene diamine could be leached as a result of hexamethylene 
diisocyanate reaction with lactic acid. Results from cytocompatibility study 
suggested that all three phases and their degradation products were compatible with 
cells even after long term exposure.  
The targets set before starting this project have been achieved to a degree. A 
comparison of results obtained for flexural mechanical properties and its retention in 
this study to the similar reports [1, 23, 24, 27, 140, 158-160, 254] clearly indicates 
that a stronger composite with greater ability to retain its mechanical integrity has 
been produced. Despite all the variations of fibre volume fraction, polymer matrix 
choice, and fibre type; the maximum initial flexural strength values of ~80 MPa to 
~200 MPa and flexural/tensile modulus values of ~5 GPa to 30  GPa has been 
reported by various authors [1, 23, 24, 27, 140, 158-160]. These values were 
decreased to 40 MPa to 50 MPa and 1.2 GPa to 15 GPa strength and modulus 
respectively after approximately 4 weeks of degradation in vitro. The composite 
produced in this study were found to have initial flexural strengths and moduli in the 
range of 200 MPa to 300 MPa and 22 GPa to 25 GPa respectively. After four weeks 
of degradation at 37 °C in phosphate buffered saline the best composite 
(hexamethylene diisocyanate±modified unidirectional phosphate glass fibre 
reinforced PLA) was found to have 105 MPa strength and 16 GPa modulus in 
bending. The initial improvement was attributed to superior fibre strengths, 
compared to the one reported in literature [86, 109, 167, 168, 196], as well as 
improved interfacial shear strength. The retention of mechanical integrity was 
attributed to better interfacial shear strength as well as hydrophobicity of the 
interface. With all the improvements achieved, mechanical properties of composite 
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are still closer to the lower limits of the targeted mechanical properties. Therefore, 
further improvement in terms of fibre tensile properties, polymer choice (more 
hydrophobic and strong), fibre volume fraction, treatment and composite design are 
required.   
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7.2 Conclusions 
The following conclusions can be made from the work carried out for this thesis: 
Phosphate based glasses containing higher content (~45 to 50 molar percent) P2O5 
possess long chain lengths and therefore can be drawn into continuous fibres. 
However, phosphate glass containing higher amounts of P2O5 can be 
disadvantageous for cellular functions as the inorganic phosphate known to be 
detrimental for cell functions. By adding 4±5% Fe2O3 into the quinternary glass 
system the degradation rate of the glass can be reduced without significantly 
affecting the structure (chain length) of phosphate glass. After certain level of 
durability is achieved degradation products do not play a major role on cell functions. 
There is a requirement of correlation between a range of glass desolation rates and 
cell activities to define a threshold of degradation rate effective on cell functions. 
A chemical agent (e.g. 3±aminopropyltriethoxy silane, hexamethylene diisocyanate, 
and etidronic acid) able to bind with phosphate glass covalently and also has the 
other functional group to make covalent bond with polymer, can improve the 
interfacial shear strength significantly. Of the surface treatments tested, covalently 
linked chemicals with phosphate glass can also improve the hydrophobicity of the 
glass surface. If a chemical reagent attaches with phosphate glass through hydrogen 
bonding (e.g. phosphonopropionic acid, glycerol phosphate, and sorbitol ended±PLA 
oligomer), the effectiveness of on interfacial shear strength will be proportional to 
the number ±OH ions present on glass surface. However, this effect is susceptible to 
aqueous environment. Also, because of their hygroscopic nature phosphonopropionic 
 Chapter 7 General Discussion, Conclusions and Recommendations  203 
acid, glycerol phosphate and sorbitol ended±PLA oligomer made the glass surface 
more hydrophilic. 
All the surface treatments used in this study were found to be cytocompatible i.e. did 
not affect the cellular functions negatively. Improvement in interfacial shear strength 
due to surface treatments (3±aminopropyltriethoxy silane, hexamethylene 
diisocyanate, and sorbitol ended±PLA oligomer) can improve initial flexural 
mechanical properties and hydrophobicity at the interface (3±aminopropyltriethoxy 
silane and hexamethylene diisocyanate) can slow down the mechanical integrity loss 
Therefore, finally it can be concluded that; phosphate based glass fibre reinforced 
polymer composite can be prepared with a strength and modulus comparable to the 
cortical bone and that a sufficient mechanical integrity can be maintained for an 
extended period of time if a surface chemical layer (coupling agent, compatibiliser or 
surface graft), providing covalent bonding and hydrophobicity, is used to improve 
and maintain the interfacial shear strength between phosphate glass fibre and 
polymer matrix. 
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7.3 Recommendations for Future Work 
The work carried out over past three years and current knowledge of totally 
resorbable glass fibre reinforced polymer composite for bone fracture fixation 
applications can be progressed on following recommendations: 
By changing the chemistry of phosphate glass, more durable, continuous fibres can 
be drawn and woven phosphate glass fibre reinforced composite can be prepared. 
Effect for addition of trivalent cation (iron content) on degradation rate of phosphate 
glass was investigated as a part of this project. More interesting trivalent cations such 
as Ti3+, B3+ and Sr3+ should be investigated for their effect on degradation and 
cytocompatibility along with structural changes of phosphate glass. It is expected 
that these modifiers would help in terms of cytocompatibility/bioactivity (Ti3+ and 
Sr3+) [95, 96, 263] and/or degradation, density (B3+) and fibre drawing (B3+). 
The push±out test devised to estimate interfacial shear strength between glass and 
polymer, in its current state, cannot be applied directly to glass fibre and polymer 
matrix interfacial shear strength. Further modifications such as using thicker fibres 
(~100µm), embedding in thinner polymer disc would be more applicable. Glass fibre 
can be pushed out by a micro±indenter style setup with continuous compressive force. 
Due to susceptibility of surface treatment layer to water, interfacial shear strength of 
modified push out samples should also be investigated with degradation in vitro. 
Biochemical agents such as 3±aminopropyltriethoxy silane, etidronic acid and 
hexamethylene diisocyanate should be used to ensure a covalent bridge between 
polymer matrix and reinforcing fibres. However, surface treatments such as sorbitol 
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ended PLA±oligomer or glycerol phosphate can be employed if the composite is 
made out of hydrophobic polymer such as poly±caprolactone. 
The results showed that cytocompatible bisphosphonates are effective on improving 
interfacial shear strength and hydrophobicity. However, due to corrosive behaviour 
of etidronic acid and time restriction etidronic acid treated composite could not be 
prepared successfully. It is suggested here that reaction conditions (concentration, 
exposure time, curing temperature etc) for etidronic acid and other bisphosphonates 
such as alendronate, and pamidronate should be optimised and investigated further. 
Bisphosphonates and other water susceptible compounds can also be used within 
partially degradable composites (e.g. PLA or PCL reinforced with bioglass or 
hydroxyl apatite fibres). 
On the basis of our results and current knowledge about the mechanism of 
mechanical integrity loss which suggests that in addition to loss of interfacial 
integrity, polymer swelling also plays a major role which can be avoided by using a 
strong but hydrophobic degradable polymer as the matrix material. A blend or 
copolymer of polylactic acid, PGA and PCL could possibly achieve this. 
Encapsulating the glass fibre reinforced polylactic acid composite within a 
hydrophobic/slow degrading polymer could also slow down the water uptake and 
hence slow down the loss of the interfacial integrity. Finally, to ensure tissue±
compatibility of treated composites an in±vivo study is recommended. 
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